var title_f24_11_24752="C-spine axial load";
var content_f24_11_24752=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F82225&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F82225&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 505px\">",
"   <div class=\"ttl\">",
"    Response of the cervical spine to applied axial load",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 485px; height: 247px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    When the head is in the neutral position, with the normal cervical lordotic curve, forces transmitted to the head are dissipated in the cervical muscles and ligaments, as depicted in image A above. When the neck is flexed to 30 degrees, the cervical spine is straight and becomes collinear with the axial force which is directly transmitted from one vertebra to the next, as depicted in image B above. At the time of impact, the cervical spine buckles under the compressive load, as depicted in image C above.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_11_24752=[""].join("\n");
var outline_f24_11_24752=null;
var title_f24_11_24753="Crohns abscess CT";
var content_f24_11_24753=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F72882&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F72882&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Right lower quadrant abscess in Crohn's disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 376px; height: 289px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEhAXgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5WpRSuNrsByASKTmgBRz0pAM5pR7UuOfWgBNvpSYPpU0aB89gBlqbIQThRwOlAERGKKeRxWhZaVcXIDuBBASMyScDHt60AZuDirVnpt5e/wDHtbyOP72MD866ezstOs41dYmmlwSskpGAR7f41XnvL0yqZHdY3JAVRgAn9KAKEXh6cjM88EfOCobcwPoR61P/AGTp8EhWWeWcjsgx3qUW1wR5hyAG6993+NXY9Nklwpcbhzt6Z/z1oAyxb26KPKt42BGctk4/OpYVBUk29qpB5PljjpgYrYGjIELNOqDOcg+3ShbKys58tN5qkYKngfn6UAYRjLMQ4QcdkGD14yO1OisHllwgDnPZeoropoYyCpihXJwCvII/wqW3ja1+YRjGeVzllPb+dAGLFokgUOQNufTnjsasW+mCWVdke2Mkjdj9fatV7mdY97oN+DllPBx0P0FT2N8l0mwKrSYUnC9/X8f8KAKVhZrCUX5doGScZ6/56V1eiqjybHUYwDyox7Hnt7Vz8cXkzqQ23ORwc8mun0xoRJG8gXpw2OuPb160AdEltAAN24gdCf0OKme1hjIyGyBnkZ5qlLeW4hX5gEHAwM5HH69PxNVZNbhUbR90c5J5Hp/hQBJd2cUgBUkIRn021zWsQRxSKreYrDsOcZ/r/j7VrjViX2vtQnnIzye2ar3LW9+HXGDyvTgHt/n60AcpMFLuEjBAB4Q4zn/9VV2RUVR5j+Z2G/oOta82nRrI+y42HOBnp/n39KqzaHLJhyGbP8SdOO3/ANegDI+0zRhhEJTk9nyPyPX/APXUKXk/lFbu2trpWGN0sILEfXr/AJFW7u2kjCYgfGOPlxgdKWykRJWM4O3ooYYxnnP4en0oAz/I0OdSbuzuLU8AvbvlR6fKagk8LfaG/wCJTf2t3liFjZvLk9uvB+oq8qI8zAqWQjK9s+n4df1NNNoSxeHcCDt5OMc5z+lAHKX9hc2MpS8t5YGz0kXGaq969Ei1aU2rW17Gl9AM/urgb9p9M9QfpzWY+kaNqW420j6bMVyEfMkZOfXqKAOOorX1jw/qGlEG5hDRH7ssTB0I+orJ7/4UAJRSnNJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAZpaSl+lAC0cmgdOlA6etADixKhRwBT7eJ7iZYoI2klY4CqMk1LZWkt5OkMKbpGOPQD3J9K6uyEejyfZ7AmS7k+V5iO/+z6CgAt/D0OnxK9y8dxeEZKfwRH/ANmP+cVZttFn1K6V1ZmUZAXBwPfB7f410mkaILi2FzfuUtlG9y/GSO5rntZ8dywtJa6AkUNopISUrlj7gdqANqDwp5CK+pTxW8a8/NjiriaNp92rLHMsgHGVYEf54/KvKNQv7u/nMt7PJNIepds0y0vJrSVJYJGR1ORgkUAevS6NCMCOA5XO4ZA/z/8AXqFNOhdWkkDKV6ApXN2vjYIEE0UrgYBZMAgdwB3ro4/F+l4yJvvDGGHbHegDJuhaOZrdXkyx6BCDnrkHsf8APNWF8O25jD/bxtIyQ6YJrqLGDTNYj8xdokYcunGfcio9b8NvdmFYpAQihSD1b6/h/KgDkhYwI6j7SwA6rjhT68en+FTpZ+VcNMr+ZkZUN9eSf8K2pvDgS5WNGwWIy7gjd+FPuvD9x55SNl8rPC55PfP9PxoA5q4spp5yGkCLj07dj9KuaVaRwyBX3FgeOx9c57itU6a7S7VgYYPJbk9OtXbXRp/tKECJbcLzyS6t7dsY5/GgDNWza3JYxqU3dWHAz6+/v9aiuNYt4LeQMRuU5G7+ZHrW/q88NtEIx8u1sEHlcEYIrzzVoxJcMNqrGDjr1H+cUAZcmsXd9d7ZGbaznGDj+Vac15JDhUJZwDwowD7/AFxVaxtYrd97BjgkHng+3/16Lq9gtVBYAtkgKvH0/pQBfTULwbSpOQTyMgD6etNTUG2SHzdhBwCG49P8a5y61e5lfEf7mPH3V5P41SlleXJkbex9Tn8qAOyi1KFdw81G+UDc3Qn6elamiaxJbzsyMJFfHysNwx9f6+9eavww56DvTo5pIuYZWTPXacf5FAHv9peadqULLciBDgbt2P51FqHhnSbsjywVbuUbjHrj8K8Tt9dv4mz9oLZ/vANkVsWXjW9twFIAUnnYcH2/GgDsL3wO8YBt52eMZyncf571h3ejXto5Bhl2rk7hkFf/ANdadp8RESNNxJwOQyfrXQ6R4y0XVG23EkcTP2kJX8jQBwDpIrIssJkjAOCV+bPofWomgikL/Z2ETFQNrnjPUj6//W5r1u+8P2N9ErRx/cG5GBz+tcrf+Ep1ORCs6Ak/Lw2Dz/OgDiY7+40xvkdhEXw0b8hh3GOlV7220rUmdlj+wXjksCrDyT+Hb8PyrUvbIxAq+SAxG1+ecdAf6/Wsq4sWC7lKyR5x94Z4oA5/U9MudPk2XEZ2/wAMi8o30PeqOK72zmaSJrZitxbFctbSLuGRxkHsfpzVDUvDcdyrT6M/zZJNo5+YAd1Pcex5oA5EiipJYnikKSKyMDyGGCKjoAKKKKACiiigAooooAKKKKACiiigBaKd2NA5NAC55xUttBJcXCQwoXlc4VV6mmoM8Y7V2ulWCaLpXnXKIdRuF3Rq2D5S+v1NACQ20WlWclnEyPfyY82bB+Ve64rf8P6Za2cX9o6vLHbWvbzOr/SoPCOlzXV4JZMCBfneTu57Dmuk8TaYNVtWt5GLKPu4PKnsRQBynj7xRaX1hHZaVcNIjfLLhSAF6gV54Sd3HryfSuin8MX6SlAFY5wcZHPpzUX/AAjWqq4BtH3HphhQBh9Bxx7032PU10I8L6px/owGOoLgEUp8LaiqqzwxjPON/PvQBgqNv55FPHAya2o/D1014bcPb7sbvvk8V1em/Di6vFWSfULeFSM8RknFAFLwNrxi22TxAkcq44OPf6V6zp0paBZHH3uHyeSD/SvDdbtYtF1aS1sZpX8n5TMTgsfb2qbSvE+q6flYLosvHyONw6980Ae9zbHIYAlycZ2/d47/AOcVWlOwDy4yARuJx3rD8E+Lzr8xt5rUR3CrksDx/nnNdpcLsbYqjJ5UHp260AcrPFdXEzK5wmQQc7e3enXkssFuXiOGXGRjnJ7j3/xrXv1AKOeMEgMxwD6/jXnniDUPkYJvxgryfu89Pr70AU9WuUmkG+RgQS37vkA/14/lWF9kjeWJvnkOflyODz+tMM0srMVf5CQdg7564rv/AAV4Su9QhN1HZGadUby4mzhvTJ6dfzoA4jW2TSrEx7Q13IMIG/gX/P8AWuNkJkbdglj1966zxRoeuW97NJrVnPDMW2nehAA7AHuKwms5CxByuOOnT6igDO2kk96cVbB54960Y7KQLygyegz0qQafICpCn244NAGSVOM4565xTNpxnrWydOlIYlH28nhTkik/smdhkI3AyTgmgDGKnAweT2ppBzjAHHrW62kyq43RyAZxu29BSLo1xIvywynnH3DigDCYEkdaXkHPOB+Fb0Hh/UZz+5tJ5Nxx8sZPP5VoweCNenI8jRr9+M4ERFAFnwp4uvdOtvIkn82FBja7dj/MV6Do3jWzv2IaTyiOTuI5rzO+8F6/pzK15pV1BuxjKcH2zWbqml3enkC7iaNmGdpGMigD2jUG02/jDt5EiEbdwP54x0rkbvwvKZmfS5QTnlX4/wDrV51Z6teWjBoZz83UN/Wul0LxxJasFu1O3dncozgfSgC5NpzIx+2xNbyqOHxgE9uP0FZV9b3VvIZEdXKrkOvWvRNN1Wx1y0P3ZV5+cNyPwPIrL1bw80bbrLPlYyEccn6GgDiG+z6rAo1JXMpOFuUXLZ7bs9R7fWsHVdGu9PCySKHt35SdOVf/AAPsa7Y6TLuRWiEMwIAX+96D0FWoWWCCaKeFZYCR5lvIMg+49/8A61AHlhBA6UYwa6zxN4YW0he/0pnn0/I3BvvxE9iPT0Ncuw7CgCKjFOxikoASilJz7UlABRRRQAAUUdqKAHjgcdaeOecCmgZ/Crmm2Ut9fQW0GN8r7Bu6CgDe8HaMLuZ764RvsVtyOOHcdq6VdOn1aczIocyOEBK9BjrVnUxFZ6bBpkBCrCvzAfxN6k1r6YYtA0dr2/mCSg52kct6DHrQBp29rHZ2SW8bkFT1A59z9TUMjssQjw2QezdR0qC08Q2eqxSPZrIWQ/MrDkHt0pro10q7Wba7Y4XB/wA+vSgCSRklT5g4Kn5D/d+nr61q24DID/EACAOpOOn86ht7KeNQX24xgnHT6VfWAxRqEZipGf8AEfSgDMv4gEkz82QBg9/xrCuSFhlaQjanPHTPp+tdNNCcg7toYbdx7D/D/wCtWJqWkPeSm3DFYsAk5xwB0+lAGTai2bUU+Zd5UNnPJ4/p/Suys9QZYHEcTSk5GF6npXOWNgIbolrQgRowHHD8/wAuK6XRpkktvMCbW6bD1Bz0P6UAclrXgl7+8a6RmiEjb2RcED3+tRWXgGKO4jNzLK8R5KABTivT4IwuXdcZxx1/yagnhie9jKA567j+H6//AFqAJ9B8PWOmWubO1SIsgDFeT9Cfyq1dE4BVzwCCOcdf8/lVuzj/ANHxztzgYJxn2/OorieMRCRgCMFSVyfw+nvQByviG7V7YhiQV4I645PH/wBf3rmbfwxe6td4SNmLE5+bjnp9K7fTNIbWNRKwco3C4Xnpg4/xr2fwj4Vh0iFGaJPN2gdOntQB5n4N+DcNuyTai3mMADhuDnPavYtJ0W2022WC1jCqvGQOTxWnFGFIHJB6ZH+eKnWMKVOTyPSgDPm0+GdSs0cbqf4WUH+f0qmfDthIzM+n2p4ySYVP58c1vBABznr19Kd5RCnnIIxzQBzy+FtMySbC0wMA/uVx+PFTjw5p+4lbO33Hg5iXke/FbvlgMSP4fQe1O8rgdQAM0AYA0KyVnH2W39sRjihtDtFA2wRAk9kAz+FbnllWUHt1x0oERwe2D9c0AYx0S1DAfZolyc8IKf8A2RCcgwxn/gIrYWMY3t/h7UqghwuFAIweOlAGP/ZUSgnywAAFXApRYLljsXcRzitgx5RgeO/H+FRsCqZIJ46Y/WgDBv8ASYrmNkmjDhvmIK85r51/aR0VLO3spoYmWPJU8dR7/wCfWvqSROuTlccgj/Oa81+MXhoeIfC9zEqHzIgHTHH4GgD4enTDYPTnk1Wwc8Z4rW1O0a3nZJE2uCcjHArOdfmzk5Jx9c0ASadf3NhdJPaStFKpzuHP6dx7V6L4e+IEdyqWmupt3ceegwM57+n1rzIADk88cdqTGMYHBHXFAHvbWMMmJvkMbYxOD9cA0XGkRThVmHzZG0+vsa818HeLp9MP2O6bzbN8ALJzs/8ArV7DasptEniO+3flcgcCgDjvsrabdSmSLfFLuR0c5DjuOlcN4q8OJBvv9JUmz+9NEDkwHP8A6DXsOp2q3EBZmVgeQx6Dj+fSuHmhudNuWmRwwDbSG5EgPXd6mgDydxjI6Uwg967vXPDK36S6hokZP8U1ovVCepT1HtXFOpUnIKY6j0oAh7Uhpx4pCMdaAEopaQUAFFLRQBPHycCu08GW62Vu+qSnEjHy4OM89Ca4+0iea4SKMEl2AFei63AlnYw2kTOiQRgAKMZY9fx/xoAsaS32icyqonfcQSeeT/Ssfx6bmXUY1dy6RrgEcjnniu48J2CW+mo2MsF3MTjgkVavLJLhlMyKeerDrxQBwvgK3vLe687ytts/32bjj0r1azghmjjdQsmBgt7Vi2Vu8SqmwsueARj/ADxXS3H7vTQyKpYnnI4oASa4hlmW2VMk4Utnp/niti60rZAj2p8xujD0rizuWcNuYFu4HBPp9K09J1aS3dGLZ5xjrn1P6fSgC2+nEqSudzHkEelNtNLkaQwuShcnn+6K7LR7iwvQpGFkPO0469q2o7GKSRHOcD5g2OnagDyrUbRLaRoepQAfQY9e9UbGFIYiECgDkADr65/Ouy8d2cNnA8yIwdcORGm5iO4A7mvNJb3VVl22WkuWU9bl1UZ7DAOT+dAHaO6xwFmZEAX5mJwoX3NSaFLFfwC5tm8yJs7ZB0Izg4z/ADry/WND8W6uym9VZhnCxRzKqL7BQcfnzXo3gC3vLbw3bWuoWk1rc2paP95/GuSQRg89cZ9aAN+4Jji/dgZJGATjHbisq4VpT5RVi+7naeD+dad7OUtpdoViM4x3/wA881R0qyee+icK/PHJ6+n86APR/hxoQgtTdAE7mO3I4x3xXoEcWORyP5VT0iE29pAiptCqBwOK0kY9SwGeOmfyoAWOIA7goBwOc1KsQXAUD05HWo0LBzntn8P85p+4khvegBSCMEEYHc08L1O0Hr/P1pqcZCg4z3NKWwxDdPTFADyA2RgcdcUjLznk4oVzgH1OOaFJLDJwMetAChSAOASOwoKZGMdeaTcckhuOvNI7jcoJHsPWgACKMZB/GlRRjjkfzo6DJA56e9MydoIBA/WgCTbj/wDVTGTOSO4z9DSg4GPU8k0hPHfnvQBHKnG5jnHJrOvIVmUq4DBs8EZrUZQ568Y7DtUEsfygFRgGgD5E+Pfgr+z7t9RsbfbG5zJgHj3/AJV4ZPHsY5yVPHsa/Q3xRoVvqtnJb3MIlBBGCPwxXzF8UvhFJYPNe6F+9XkvblgG/wCA+v0oA8HJP3WJJ6YHH4U0jHXmrU9o8UjJIhRhnKuMEVC0RBzjg+lAEQI7133hLxw+l29tZ3OWt0JDFhnA7YrgnXDZwfxpYQSdqnJPFAH0RbTRXsBa3ZHQ5yoOQR6/XvWXd6eJIBC2fJGQD02+mff61w+gay/h6+jO4m0k4Oedv4GvVLSWG9g3xGJ1cc7Od3egDhPIuNKvUbzmWL7yOowMd/p0qr4j8PWXiItc6ayw6mV3On8E3+Brr9Tt1SJ/OQ/Z5DgnHK/4Vhosmj6jHJABNbMGwCcjp7d6APHbm3ltrh4LiMxyxna6ngg+9Qn9K9W8SadBrtuvnqkWpniGfoJP9l/frXl97bS2lzJBcI0c0Z2srDGDQBXooooAKKKKAOz8A2Pm3j3kgXyoVIUnu2Og962JVk1LVIYgnyBhvXGMD/GptHhWy8PWsIwk0q+c7dPw/LFXvDFuRdvO2wt0J/pQB2umRIkaxQjcBkqB0HuKtWMXzgOhZQOAf51U08GObcwPJ69MittCMfIAA3GAefpQBQuI284JBtTOduOn1+lVbb7aNNj/ALWjXeGJJUZwueM4rpLWIIQzBSSevr9ParFxbxlFbb8vUnFAHJyfKSVUc8kMegqHyxh+SVIGCBgn0z71rT2wLb8rjkjvj1pFsmcN0C9ytAFbTXmSMZ3q4OcKcEH3xXZ6Jr0oHlXLNjIwxOT/AJ4rn/sZHEi42fKDt+8COhNOW1uF5jB+Qc7Rn8DQB0/ikLcWkciZf5doxj9PeuKtNOkmkbKblPpxtA64rro2F1p4hfIbHQHvgcfXtTLe38lRtXABxnOOT/n8qAM6Ox8pAMgkjjPTH19KcZXQAY3Oo5APQen+fetpUV423YY4Pp9TiqLWjGUZGA2COOpH/wBb/wDVQBBbZkIOz5WzkPx/kVraFBuvYBuJUyDcKrwJ5UfGCRzjHA5/l7VvaLEY9QjdvlQnp/eoA9MteI0wxwRxwcfjVsIcAA/Kv4Zqva48tACGJ9e9W4nGQQCPdqAGhQRx0ByfrSbBvD/NvwVHuCc5x+H5U9QNwPTk4+v+NOT0zg54PSgBcnjOcjnrSqMA8ZFMU5IK4YAnrT125I3EgUALwRk+tRpwNzZGCQM/XinNKoAY8HtXmvjvx4NOWWHTnTzVyNx659h/WgDu73ULayUNcXCRDqNzBfr1rhPEXi61j8RWa2dxHMkf3hG4IIJrx7VtT1jVJ2kvLiZxITwenXuD0q/4G02OS7jE4ZpEfIx3Pqf1oA+kdNvIr2COe3k3xsOg6fWru0YB5I6nPNcXoaz6LIVdmkgc5JPX8BXUwX8EoQK53sDweDxQBaKAnnqaCvOSfTmiLrx0+lG7duHIPtQA4g7xjp6VEwLBsdR/k1IxHODnH/6qY+MgsfUDrQBWuVDqwx6ivPvHNkPJY8cA9q9EkVuhHzDkk15/8QrlUs5BGVLlWA+tAHzhq8ouvEbWt1psF4rHlXjAJX0yOa73R/AXhm5gSWfw/BE7rkoXbIPXoTUfh3SoDfGZoN0jNgsTgE57GvTNMsN4DGN8AYIz2oA+evib8Opotsug6PiJRz5PJ+mCea8vPhrV1cF9OuY167mQgAeuTX3FqNmgtHJQgBTgHt/n1rzDVPDGr64kirIIImBAVe6jtQB89XGfshjdGAjYsoAyckc1tfD7xI1heCzu23W0h4Lfw/8A1q7HX/hzqdhBK7IJFxuJj6njpj/PWvMdRsHglPyOsinO4rgmgD3byVvw2VyjgjB/PpXMahYPZSGGZA1qRlcj7vP5/SrHw21T7ZpGyY/v4QQXYE7gfaupu7Vby22yR5yowfSgDyTU4JbO5ZXOIGIIY9Se341W1vR11+yQxFBfxL+6f/nqv90n1966nUYZo7xre6jZ4HG1W6BfrWPc2clm8iN+7VcmNgc546fUfnQB5LNG0UjI6lWU4KkYIPpUdejeKtEOq6c2pWsQF9EM3Cj/AJar2IHqB1rzth6UANooooA9V1Bz5iog2hcIoJBwBxgY7Vt6FCY7XGA2Tk8dR26dqxYFMl98x4UkHPc+vNdhptukViArYVucdufrQBbVl42fe2jg+nvWzZ5MeMMew+n1qho1g95cJHHkqe47D1rtYdGjsbdpJFMhUFiqLuJ9gByT6d6AMPz44Ii07qBGhZy/ygAdST2/H0qt4b1R9a36gTLFppYxW0Z4MuDzM3uSMKOwBPU1514t1fUvE2uRaPFZzafbvMIxBICsjkn7z+g74HAx3r1W1tRYxR21ugSGFRFEqdflGOaANDyI3KsCMk7uRjnH+eKVrYICDlRuBAHc4zxUSSHBAcMx4FQ3E5iOCSueduccjrQBecoAQpJzz/u9iKEGM7CFYcEAAA8dP/r1UhmG5GGSCMjjhRVyZlIULgkAHGM496ALC25EQztfbjpwT6/h71LIqgKVwGI4PXNVbUTZPAIPU46+uKvmIsBuyD0G7px/T/PNAEMafMcHDD+8uPz9/wDGkVsyHGCCMkHjA9ealmRsgl2XryQOB6UyNTtBZevHPQ9v8/SgCxbWokmd8ODjI7f5PtU0jvBcrIdq4BYKOn+en61FFNJEoIy2T0I6e9aYube6tUDhRMRkFu31oA7Hw9fJeWu7IEi8bfT3rcjKhQACTj6/hXl+m37affh422oeGVj29a9B0vVIL63V42znqOuOcUAX4iwByDjk5A/SpgDgHrxgGo0OCOn4VICwOMjA9aAGhMZz8hPBIPWggkZzwAe3f6U6TlccZ+vWq93OsMbNIwAHfpQBl+KLz7HpMj7sfLgV86+JdVjS9E7gGZ+u7+EelemfEXXFu4zAD8oPBBwDjp7V4pqqu16AF3o3WR0zkeuKALsWpajdq6W8TMcDc7Lyfc4qz4R1SXTdajaUHbuCkhsgH3H5f1rR0a5tisVhZqsb7cyvjL7vSoNfsILPWLJkSRG8wfNt+Xr+p/XigD6G0edLm2S4YZBQZBXpUT2jz3QaBf3gOS6D+tP8KQf8SeAv90qCRnHPpmt2OOOPG1VyemB1oAbaGQR7ZdpboWHSpgV25TA/+tTCQrYJBJz+faqV9eRWts07FdgHOTj6UAXmkwAQQcjj/GkLAHkjPuOn+FeU6z8TLKDUvIikUIDwQMZ/+tU8PxFszaB2mRxjuw+Y/wCf60Ad9qOow2tuxdwMDqa8Q8ca+l9rKWKMWlbA2r1H1Hr7VzvjL4qM5liszuYnh+oA6ZNWvhBoFzqssusXx81pmGGbnA/z/M0AeheF9GCATyIduMkk5C+5/Ku4toY1t1Me3bjII5zn3pdPtVtgijtyeO9WpuFwFAHoOgoA5/VcbljXo5H3h+lTR28aJjaqhscg9qz72TzdRZhx5YJz6U1rtt6KzrnbkkDv9KAJNW0hNRtvI3GNTzuU8/SvLPil4CgfS3urVQsqjsOXHv8Azr2G0lV4AMg4H5VU1SNbqzlibqQQvGaAPjvw1fS6BrzLKW8l22OBXtFnIsscZD8sMnPv/WuH+KPhJLK6+0wRqYnOSAeM/X+tW/AGqrcWf2aeVfNjbHPcD+dAHQ61povI5MxkuO3Tt6+tc3Pp6HfDKNxZQFYryeO/tXclgWYYjAUdAcfWqN7au+Sp+bOemOKAOEghNuDtQZ6fOc8ensDXnPjfQls5hfWMLJYyNtdQP9W/p9D2Ne3XWmu8Bk8tgcfTiuSv7OCdprW/RkhmBEiZ+XPZh70AeIHiir+s6fJpuoTWsuMxtgEdCOxooA9N0WMS3DGRiVA3bmOO/wDKusVwUWFXyxb+HgY9a5nSR9+QKu0nGM4BPrz3FdPokHmXyKNzenY8/wBaAPS/A+mi3tmmKAFsgDHauoMW4DdgkHnjH0qLSbcQ2scQ4wvAH9K1IkUnOSeDg4/WgDDvvDun3mo2GpXECte2ZJhl7jIIIPqOcj0NYuoWkcV5MR97PA98Cu88oBQA2B6jtXJeKYViuGZgMN2xgCgDm5PkMfy4YAlgPXOfzqq65ZmfIVhuB3evpSXM/wAm7dwOCDzj2z/ntXJa5rEtzIttaBipPJ3fpQBuXeswonkQOJZOhAGMY+npW9owLxIxbJJ4yMZHHI/w9a4/w9p4kn3PE+/duLNx+OP89q9As0EakEoSDkEjn/8AXQBoW8Ij54zjb1wMfX+lSQsuSG5C/Lkjt2quXyMkfL1K9QR1/wAipo2bCuwKgc8DNAE7ADr8yH1OfmqIxtOCdudvU4yOPxpiOOMjJU8jtz3z09qkmna3gKx4Tg5OPX/P8qAJBpspVnG85wSQef8A9dVfInRdzDbzwMZ/P347Vvade/ZtOU4XdgqB1z7Zpt5eRXUBUjhurYxjvQBipbfwMXbcxfLNnk9QoPT+VaOnXU2nSmS3JK7cALjio4Yw7DIzgbQPcdR/9eppjHFAAcbnyB60AbVtql3d3UShiEQjLKvB/wDrV0GnX0ssGLuKOGUMV2icSBgOjAgDg+hAIrg7W9ltbeRUzGD8xYc5P9OuaI78glpJG+YDOOhxxn2FAHoN1qcVtES7gZ4x3rz7xRr9zOzJj92eMjp/n+tRanemcYQkFB93+vpXLteSSI0JfbgEE/40AY+qTNJNI1xhkZt3LAMPb61VnvIxAwhiJYYwcf5/L3q7dyrHL82LjnGWXp1yT+VZ9xdJbwT3MrQpZRDKn7x75HHf/GgDLvp3s5kvbdHtZGxyOQ3P866C8nGraTDPMCZeo2jO0/SvPrnx1bXPkh7Ry0bZ6gZ/wNeieGFTUGtpEEkW5d4hIGR3zx36UAev+E9aeHQrSOWOXekQXA56ehrVsvFdhPcPFGzh4uGBQ/Kff2rzy61IwN5KSFAAFBQkD6AVY0zV/KT5CpY4O4jnA/p7UAd5f+JbW3i8x2YIBnIQ5/Gvnz4z/E65uo47LSZJbe1fJeXu/HQemDXpU1416XB2vG4xgYzn+gryv4m+HoLjTJEiASRPmjyuAT1Of8+lAHis2rXUsrM87l+5LZz7/wD1qli8QXscBgd/Mj7h+o+hpBotyWZpIvKjA5dz0/xPoKsSeSkCW0CRnHO7Z8xOefr6UAW/C9s+p6vACrnfIN5znaM859f/ANVfZXgjT4NP0yGKGNVTb1B46fr9a8q+CHg6NLWK9uYB5si7skZKjPv39a91t7NLXakSY4yF7YoAsEgISCQPpyKpSxtCsuJZZXkkL4Yghc4+VfQcfqattkj5ui9Mc1VvMhXf5j3HpQBykV0lxqckcZMh3bSMdOuT7VozWKuM+XjjHXnj/P61j6bexR6xeBBznJwvU+n1ro03zrjIXBzjuaAKkEXlkb1yM546Gp5l+QlcgZOc9qayiN2LHnnv92qWo6hFFattYMeRjGO1AHnPxUSBtGnEvlgHoD614Bb302k6vHJaH51cgrnAwOo/XrXsvxAt9SvYFfyZpEd9v7tc4HqfQV5D4i0OewIeaF1fGcEYHXj8P/r0AeqaNqaalaxXdqQVIG4Nzgiul0yJru7VG3KT/H3x1r588H+IH0nUF87cIJOHG7APv+FfQnhHZqLrcQkmM8ht/WgDo4tJQwMkib+DgEV5z8SvC0kG24twSFGeM4r2e3hLxpluSOoHWqfiCwW9sZo3GSR8v16ZFAHx94405p7RLzbiaAAS5PJXsfeius8aWRstSkQ8KQY339weKKAGWO8RDGDkcgjse1dp4WMcFzHcXZKQplpOM59OOufpXD2oYsBlgegwNxx713fgxzHexo5UcEYP0oA9Z0yaWS2R7jbufLLtGPlJ+UH3x1rRErIoIy3TIAzxnnHvWTYyFjgcHGOD04rZheQBCFyeRtPXrQBOSfLBUg8dc9K5rxembQSdcHk+/r9K6KWNGRVljEiBg2M8Ag5B/MVS1uzW8sJoyDuIyAMZz1oA8H8SasYHKxKGYDnr09K42TUGkuAo4Y9CuBkf4f4V1HjCyaOeRZCSQxYqTjJ9j/jXGwRH7QVc7FzlVXjbQB614SZWsUYFs9C7f1NdVEWdlWL7/A2sOT9a4zwkTFYxBDtVs4BJOc133hm6ijuFd8Htyfug0AbM0UNrbKZFGepHQE+/vWPJeAO2xSik8Adc/X1rY8WxStGCoJRxg46cf1rmreGR1HmxvwcFQRQBoW1xGD8+53xnC9D/APXqW7uFmAChnx0I9xnpVFNwJUAkHOQOB+daG5LeNmk/eSsPl45H0oA0bawMlrB5iFAcfL0De3+fSql4Bbyv90jJAHXAz0/l7dKnTV3mskhYKWQ8c9vase6ut8oLO3mEnb2Jx/n60AWJLoQlizEjpgdfpUei3ov2kQKpjBwNxAJOOOf89Kypw90TsO1Oypn5vr9K09FsGtLUkJmTHGRg/jjt/wDWoAuXUhyFi46jaeQf/wBX9ar7vkVgWbnk+p7k/wCFaE0DrFudd7bRkIMA5xnJrmPGeprpOjXk6qTMsWU3Mevb/wCt7UAcN8R/Hh0udtO0hlN0oxLJuyI89vr7dq89s/G2oxXC/a2E8ZJ3LyDg9SCP5VzWozy3VxJNK7O8jFmY/wARP1qlvOcqSPX1oA+gNINpq+lPcRy745o9vD5K+xx9ahu/DcV5oUWm287QQo2QfvHPcH2rx7w94jvtFlDWcm1Sd5jZsqa9c0jWo7zSo7u2X5WB3oOdrd+O/wBaAMa5+HlvFas0V/JPM3Tao/Ufh1+lelaDZNGlo5IMip5bHoSeKxdP1GACNJGCOQSQFAz78dq6C3vD5CuoQAHDMoxhR/kCgC3fKqSmVOuAM84I9v8AOarWsyKR8u1mOCyjGR3xVyO5icpFPJ1UDPTiopYFyrM6mMfMeQCQO59/agDUsUkYMywiMHv2x71wPxJ1AKypGQCnzEv06f5/SusvfENrZWPkQEAfKxHJI/8Are3WvKbyC88U6uyRM7qh3PKw+VBg9P0oA464M9xO7OjGGP72DxnsD/nvV/wLpKat4rs7eWNEUS7sMcgjPAH8/wAK9Ot/AVlHZLANzs5LFnPU45x+HesKHRP+ET8V219Ad0SOvA5IX0A/rQB9JaHYRWdqiwpkDjg8/l+VbbOflJOAeMD9KxPD1+l7YRyQbTvTPpj2+taM7FSRnlj1HTFACMz7g2cr6etUNVvY4LdjKygDpV52AX5gMfWuJ8XXQaRYS5zu3bPw70AOaCNpiUMgJG44bBx9a6LTP3aeW5+ZRk59D05rkNM1FrkeVGGwMcd66EmXyQQxHyjIUdPegCbV3RVLISeOSBn/ACa5K/m2PHyXG/DMf4T/AJ4reaGQrtdjg/KN3es7XrdYVG04K4P/ANf3oA07e0WeHLRry2OmK8/+KWhwyaFcuIk3KvJ6Yx+Ga9H0mTfaxEsMlccDFcb8TJBNpF+ieWDgoGJ4Yj/CgD5M2o178uAQcnIPHpX0j8FFP9iRLJglTjBHAFfPelWktxqOEy5Y4wP1/wA+9fVPw70f7BpVsAFCpGFOCfwP1oA7cFVVQfT05qtPls4IxjoasZYBSwHfjuPxqKUfMwJGD260AeHfF3TP9JlmjBMmN447+ooru/iJYLcabIcEkgq2P0ooA8QsiGMRw5JHRx26/wA67Xw0FS6R1cleRg5/L+VcJYTtIkKbRgjgAYP+eK6nQrtsMBgFW9P1x6f4UAet6JIJVHyfKfuk+n9a6BCVwevvnmuF0DUxsRdwz/tcV2FtLvVTkEmgC5IQU3EKVPPXgmkfMtufLfy3ZSA/XB9cdD/KkVVdU4HqcdqahAm8sk47c0AeSeNfD09u0zy3ct88hBJnVVAGP4UUALz9c15Vc2hjY5PfkcevX/61fR/jOy+0WhmQfMAOozgV4J4lsglyWjEhJ6gdPcfWgDofC12EVQQUKghcHkjv/k+prurCUErsO0ZBIAyfz7//AFq8g0ecxuFaQY6jJ5Xt+fb0713tjcmCJpAVORgAHI2+3+fSgD1CHWY5bMQ3bHAX7xGenqKZD5ElswUfvN25ST149q4+0uvMG45VychfQVp/aVEZLN8+BlV6fQe1AFu4u2DlSq8H5iF4PfPtVWe8VAS/ysoJwcdzjH/1+lU7uRHUMWyvGWPB9vwrj9S8TDTtbFrr6iOCTmG7jUmMrnGGXqpB4J5oA3DrUtvOW8n5cnBzjA9/TpUNpfS6hcOtozbxglWHX/Jpun29jflp7C4hugxxlHD4/I8Vr2Fils5EULbjgkZwaANiysjFCPMcGQ43E8gf/W9q0HXKogPDsDuXOSPU/wCfSqdpex7PnD45Jzj9frVe+8R2lp/rgztxgd8CgD0+ysYktkDRlht+Ysf51heMfDWnappU4mgCkKWOeBgc1qadrNtPYx3CSoUKA4B6exrC17W5JxLEiFIiMEnnOaAPnf4h+CbOzhnvLNkjjQ/cD56j27mvJZEO7b8vYjHpX0R8Qrb7X4cvkgWTzMAr3zjt9K+eJgT8zDAzgUANjODxgfTGa19D1e50m7DwMzRnho93yt7f/rrpvh0tjd272l5bxTSb/kVkBZuO/wDnvXU6rZ6QqhJNNtGJ6AKA2fw6D39qAJdFvE1i2W4twEZgANx6Y7Y+tdbZJIsaee5aMjDZxtPr/LrXA6Y89vbO2jWVvDImchyTkdc8/Xkepq5Hba3rRAuWIiwG2bsKQR/kfhQBN4p1V7m5k+zoNsR27lOcjI+b9K6n4a+Cb3xDAl/qN9cR2gY7IwSWLe5/wrmdEhaK4ls7uHeI8ZLcLn1Pr1FfSXgyGJNAsvJQbVQEEYx/+ugDybx54Hhtbi1isJZA0gywY5wB6e+ataTp1npFq0UQCMvBJOST/k13vja3xcQzcYxt57HP+feuRvBCOHAUA4BPUfX/AD60ANW4S4AWIBgRz2H0GfyqjqdvBdP+8jV2JILYz09P0q3KUeKMxsHbYBkLgEe2e1VpBhWbftVcbcdMeh+n9aAK2ka/L4du41XebB22OD/CfX1r1G01aO9jEkLqFK5yT+XFeVw2wvtUiiOJIw3Lduv+fyr1LTtDs4JGbqVUDaG4APQ4oAg1nW7a2fyFkUSleCOcZ9643X4JJ/MmjuR5gPJIGeen0/8ArV3F1pcMTEGMHcQefQetUrnQre4R9sG3Jx1Gc/1oA5LwXIBKVd1kfdjBPOf8a71EKwuV2ntnHPvXM6ZpC6bqLKflEh2g5+6fSuwhU7Fy2eD+f+NAFQFGX5cdOc1R1SwS7wrfNxznp61oPGfnYFiODnHB9qhG5SVwS2M59R2oA5W/ml0ONmDF4+pJPQevHpmvNPiR4pivLHy4CCcdhkf/AK69D+Iu5NJmkcMka5+Y/wCFfNMZl1C8wqgBXyO/J5/GgDpvhVoLajrUUhzsjw7Ejn6V9OadbpbwIVGSF259s9K4z4UeHhpek+fPGVlmJPOTtFd+CUQgMN2cED1oAryfMyjkZPWjnbye3HH+f8aVVzguc+hodlO4nr0I7igDm/GTqmj3O7+5xk96KofES4SLR5g5xu4HvRQB886fKvkOAW4OBg9T05+mTWjZXclrP5iAyK/3jkkH3+tYkEiRTsuRgqDwSMDHT6VfiU4MirtXHPU9e1AHaWF+s0JljkOCRgp1P19K7jw5r2xEjlPAGRz29a8Ys746deuj5Nuxyw5IHv8AWuygulZFkQBkc8t2P/16APbreRHVWUjacGppoVkIZFwydMelea6Nrc1sqLvJj6Mv+e9d3puoR3KF42U8dAeRQBozxJNEVIGGXHsM15B4z0cQTTMYk9OBkj2/r9a9fifKgsW59BmsXxTpi3luWAO9R09RQB83tbeTqTLGMISBtA4z3GT3rqbW6CxKyKCFwSCeSfX9KNc0kw3LlUIGduMYCj0HtXPvNPBIMsVQYxz2oA7fT9YiHl+aBgkBT/e47fTvWg2owsyIHRmA9evv9K4lJoZbdTCPm/iH8gPTn+vNVlmeN33yOpJ7jG4f0oA7uS83BSrDB+ZmYgBR/n9TWH4rsRrWgXEWAZYYzNb8cbh1BI7EAj8BXLXeqyxIiBpFQcgkDk/T+lSaL4glg1EI8mY2bJ/Prj0/woAu6Rp9v4Qvra61qxhu9LudkkOpKCHt2IBAcA/d7/17V6ml1FPEj28okDjerBtynPTB/wA96y4Zbe+sGjlRZbaYbXUjII9CPT2qyoSOJFjjjjjVflXgKijjAx/KgCwzebG6MQWP3c8c+v1964jUNBu7q6Jgm/dB8ndk9e316n8a7QyDaqnB4xgjoPf6/wCFSW0bA/NkiQ8L0I9RQBV8M2FxaqVaR8qdp2k7fw/L9K6qaVY7cl8xZzhupHqcetUreQozZLY6Ajn/AD2pLt/NjwrEbTnk+3T9aAMHUbtTK6KWYHOGYcY9PpXinirwpPaXjzW+JLaV2ZdoPy55wfQV7JqEkagO7Irk4z68f5/KsGGWGSRlWNZjgjr95vUD8fzoA4/wp4dutKD3zyIZCnyxqeRnjk9vStmDQ7/UpHkuUDFjkYT8if8APpXqng7wPJeQpc6h8sHBWIDBb3NekWGh2VmQsNtGmOASM8UAeF2XhRnQNcKwOcgnPX/Gt2PRmAhdCyyIOPlxu9/rXtQgjPAVVAX7oHamzafaHcJIU7LkjoP/ANdAHiMmhzffKs+TvwF5A9j3Nel/Du+iXSTaOwjkgbaUIzgE8ECtC68OqA0lsZAwGRG3SuEvY7iz1dnQeTKPkbbwDQB2fi24WXai7C0anPHIziuKg0XddSSTklduNjHg49qmaW4dizsGXqDz+HT/ADzU0U0katvPzqepHB9ce3+FAFa6XykXKk44+cc1mToGDnapXdnaxxWpqM8JG0k44IJ749Pbv/Sst5IjE4wrMEABLdf8/wCNAFdZvImhdG8tQ27cBgE/0r0/w5fTXluDKpAOCpPXHrmvIrt2Ekbu6gc5IOBjPf8Az6V6Z4W1eyMCxrKvy8YJGT680AdDdIXTDNgHoe4/Cmq+FCkkqOMdf1q4ZI3AIwOM4Hc1m352EP5pXtjoCaAGXUcc6sCoboN1V7eXyMrKWx/eyeOnH/16spIrBcBSMZA6Z/zikIDLt2goR8uDigCcyg5xz09qYxjZdo9cfMPSsueZ7XmNgR3B5OOeffpWPqXiuCEMqc4znjoO2aAM34kXph0maIA7jla8y+GnhH+0NQWcptiznPoBXVX7XGv3iowzGxwVbv6V6V4c0lNMsUQKRIQM7eaANCKKO3hjRcDAGB9KWLJ+duGzjrzUjxANubPByMdR9KhluI4UPmttUEc/1oAV2AIJPB/GqEs2wvuZAob5cE5xj+L3znp2xWLrPiERACAZGOG/z2rz3xd4qOmWpZ5vnfhBnk/X6UAP+KurJMj20UhbYMEq3OT6e9FeXzalLfK0sxQAtuJ7n2P9KKAM6dFt5VcKdgxye/v9K0YuVSQfcA5Gf8KqqyywsqHJHUnpVixKCJtwIUfLgDI/+vQBBrEUj2YeNPmiBOR0APUe9O8L6qLYrBc7jC/3WLZCn3FXpMFT5icMcHHp/nv1rmdUhNpc8KRE3GMdD9B/P6UAetwOjozZYqARxwfw/wDr1r6ffSW8wKOV9MHr7HPevMfCniJBttrpvkOFUnqPb+XNdysyyIGjY/MScgDn/PrQB6XpWvQkKJ2CsuMN2zXQu6Sw/u8MpPQeleRQSlTkck84yAf/ANdbWna3LaDdDIXI/g6A4oA2fFGhhoZZUiygXJx1B78d/wD9VeYa3oD+WP3WeuCRgGvaNJ1qG+TDELKw/wBW3X/9VZ3iDQ96l4RlGGSmOnuKAPDbfTGCb1cJtHKHr9fTFRSwvMdjZBGec9s969FvdLjZtsibcZ6Hqff2rFufDpG7yzncMYYZ/Pv/AF5oA4S706443RBcdicEj1/pWQxCPgHI3cgA8d84/wAa9COnTCNgIySDgsDyD/nisq/8PyXW2aKNy+DlsdD7/wCcUAR+FNZazYxShmjY5yvOPTr3rvYNQimkxlNhG44OR/8Arry670m5sdjYdduefaq41aeCUlXODyAB29s9T/8AWoA9fgurfyjtl+TJGOhXtgVatb9VdID83HynPA9q8qg1F7zT3jR/KuBhgVOfw/xrOsNTurS8yZXD9CS3GOe3pQB75DPC4Ug5dewz/nFQ6zexWdnJJvAGMAGuCtdfuo7BGRkEpAP38Hr1+n681la7rolj3TO0z53MofCj8PT/AOvQBd1e9kv98cbMEY/ebuPf0rvfhd4UW4mN5coTEvK7u5zxmvK9K1p7jUYIGjULMQANv+frX1D4JtVt9Kttv8S7jznPA/zmgDaULbqF7KeQOxpTcRMoBXryPrUjwxygMxbGOvT3qncIUz5S5z0ycY9cUATLdKvzsV55HPQHtUi3ADDJynJU+tZzSMmeBgdQR0HoKjZ9pYHOAOVB6D+vWgDe82NOFILFRkZ9e1YfiHTI9RtvNVALlBwTxn2NRxyFGLcsfQjH+f8A9dbDcxA7gc857YoA8u+2Ks/kyllZCAc8dKxfEetx6daieGMMzNwS3ANaHxEZdMumkK4D5bGM7s157JMmv2hit5XXklVY4yO5NAC/8JWst3K9w427flPTBH+z6+3FWbnxPYR2/myyooXB2nqfpXmOuCXS7x4wh4+8wOc/j681hahdyTL5jMR7EYXHtQB2Gt+MJ5rpfsEhCHOCTgH3q94Z8U3VoYXdtyclQDkAHH+FeeWSSXDEImSp5yO57V6H4D8NrdPGZEARXG4Buuf6f4UAex6F4zJ2Dzsx7fmUr/j/APqrprrW0u9PeSFhvIyB6nHH+feuKn8NjyECybR90kdR9P8AGl8z7NaCGBhnO3Ocg+1AG9a65J5LyFOVwAvQ59T/AIVWuvFE8atgDaB8wznPaufgkuzlRKg6EhR+v+fanwxb3Jchz1FAFbUvFN9eMY4F2Jnhie47e+ai061uLtw8hZ5CB+Z/n+FbMVgrkAxqW+9zjnPp712ehaIIFEt0qljhgmPu+nPc0AReGNB+zAT3AyVHyDrjPWupJCPwxwOtVby6jtUzIwXB7Vy2r+ITI2yBwoJwcUAbGqa1Faoy53MBnHWuI1TVp58lnKNwVHpVa5uJJXIkfPXnPBrJ1KdIIHZ8hV+8Wzz70AQ61qa2lq807mNVBILHIY+n1rxHxFrr6tetK8jGIMQoUY288/WrnjvxSdSkkgtHxbISBtPBxXDuzqwUOdxHHsKAO10mfzIE5URqWKso4IoqnYSCOCLDfPjnjAz6YooAui4EE7Fsq/Kc4HXrxVy0nO8BhkHjGRgf/WqtqttFJGt0mPKm5BU561jQzXCXG1dwXk9O3rQB2XzskhQAHGGA9Pb2rP1O3MqYOUOePl/Q/wCfSk0y/wB2c8N6DHP4elaNwTPDkAEDJ9CKAOViijhkw+7jowPT2P8AjXYeHtcaIJHcsWj/ALw4I9B71yWoRSIzMCrrtA6VnLPLISiMVIxyaAPbrS6juE3xszc8bfWtODBUD7ynouO9eSaBr89mAkz5zjG7jjpz7V6DpWrQ3sIlR2bGAc/5/IUAbWmam07SNBHMvlSmMO4AD46smOoFegaFr0V2Ire5O2bGOnB9/wCledrKqsSg4J6EdcdsVftLlkAKnceh7Z/xPagDvtT0RLiR5bXarkZIzkHH+elczc2c0GUmjMfGMmt7w7rxlKwT/wCsHRweD9f8K6ZooZk/eR+YWPAxnrQB5h9lBiJEWGI3FaijsFicybGPYkt1Pp7n+telT6FayHfH+6OOSoyPcVl3nh2UkNHtbsMUAeaarZxSyM0kJDE/KuTj/PvXLXWj26ylkYlieAg/zjv+leqaro1yvmDyyDgBWYbl98j0965i/wBIjMhMbkY6qeMc/wD1/wCVAHAtpi28ivsKrvwM9D6/5+tV76xSaUTW5hWQHHHU+px6d67m802CZRFJIS/IGDjisweGpMoLTdJ1wFHP/wBagDldRmvUtkjZQCp3bwPvD1z6e1Os0truGOUxkyjCsM9APUHt6V29t4K1i/dBJaP5YPDt9DWxb/CC8Lh0vPIPtg9evH9KAPPrLS5W1KCW1D+aZFOAMkf5619V6BFKtjCdpV/LBYNzjj+dcj4S+H8GjyxyPM8zjnJ52nvXotvGigANgYxgUATBGYZJB7A4+n60xLYGTcSxHTkfy96UzKA2Oo9ulI1wh+YEfKOcnH60ANezjLE4Hyjjjp71D9gXKsoYN3A7VJ9uibI3K3PODT4rpScKynJBPPSgCn/Zy89ApGf8anFu+QvAH54q4siYJOO+T6Ck3gnrwf5//roA8h+KemS3VzaTAnygOGB4I968eeSK01tIbaILC7kMQ54z/wDX7fSvqXxHpEOtWUsFw5GRjcvX/wDVXmsnwitxeCf7SX29A3A//XQB5nrvhRNWQ3EE5iOCSSvX8+9ccPCcxjIOWRTkZHXB7fz/AJ17vqXgfVEwIH/cgf6sn5iPrWHeeF7+E48mQfLgDBy3P+f0oA8w07Q/Jn2+RuwhGQQc4Pb8OK6zStPu7KVDEyIccENwF9fcV0tnobhXMqgO3TA/kDViGxSRgFDPnnhcEj6fhmgCGCe+MaxuxcngFWz07/TrU8cQKZkGTxzn8s/hV+3tn8seXg7e2MH/AD7fWtXT9MuLlBttj83AJFAGEluYyxUlWPYds+v4Vc0+xllHlRIRuBGMdPcmutg8Nxja88jHHIVelbFpBFbx7IkVVHGB1oAy9K0OGzCSMQ8w6E8gf/XqfUtVt7OMqGDSnkJ6VV13W47JWiiO+Rjzt6LXD3t8zkeZMC3IPv3xQBY1DVftM53vvHTJ6EZrNmk8wueARyB2P19u1VQ/JEjgjJbpjrUV1drEgLkbAcnd1/D2/wA4oAlnu0gXMg25GTxXl3xB8Tgh7W3lDIeWO7nPp9al8beMpYHaGyCiUj5mPI69q8lv5zK7NIxLMeQaAHXTguXOG3Dqex9PrTLSPzJVLglfx5pXtjsBnbZjkL3p/nJbvyCQDwuKAL11OttbEKPnccH0HtRWVd3LSuTuJUDAB7UUAbvh3V/LX7DeMRAx+Vifun+lW9TtZ7eQvExeEj5SfQ/yrksnnvXQ6DrBhj+w3uHtXPVuSp+tAEySKrjY3I6jPWth78mFHUYDnDAt6VkahAbW4fy8eWec9iPeqyz7E+QZJO7bjPPr7UAb10EuELw/McZIHb3rEuopFcuu7yx8wz/npU2n3rRucvtB5I4OT/n1q/5YmQtEBnPTOTz3x/SgDJZ8gFQQQM8noP8ACtDSNWnsJl2SE7efm6fUf59KgvLTcSQQpU/d9qpshiblTgcnPb/P50AexaHrsOpW6qJVWVeqnqfrW3HK5wV4xxtrxG1vjG6tGXjZOmDzz712mjeLUZVivBjbhQRz+H/16APSbcsHyJGHoScf5Ndp4Y19vlt7sg8EJIeg9vyrzfT7+O4RWtuVJHzf0/z71qpLhw6j5MY6DBPt/n+dAHsUEheNcneDwCBVxAWCj05yK4Tw3rW2QQXBJVuFZsDn0+lde92wkgjgi3yTEgMfuIByWY+nYDufzoAtuke3OByfYg//AFq5vWPC0N64lt5DDIPvBhwwz09s11O0Nu3YPt3pGC7BtAHuKAOesfDNjAoMkIlkXB3Hn860LeK0hIxHEkijkKAcHPrU2pXSWNk8shC4OMnjH1rj28YaXDeMlzcqozg7VJx9aAOta9t45ACc4ODg8elXo5Yp8lFOMcn0HrWBbTafqcay2k8TgDHv+VbVvH5eFQg57/hQBeQFRjb97jOeAfSpN5BAUjGMCoo8KeDheeM8VMuOfXtjjNAGdrNveXKRpZXH2Yfx/LyRXlPijX9U0nWF064llX5N5bOQw5xj2r2feBnJ47DrXM+MfD0GsWzOYo/tSDCMcAsvpn86APJ38Sb5fMFzMPmOSTjgD+VQnxjf2QNyL53jDAFGHAHvWHrGhSWl2VZH3K3JQ5P/AOquq8GeBTqY3XystsGHA6n2x6UAdh4R1rXNbaOe2YGy3De0oyCO+B3PtXpK52KeSByR3PvWbp1tbWEEcFsiRRIoCogwFArREoYAZGO+KAFzyue4yT0xSvgtnAOegxmkLgkDAzg5xTV8vaV4yeT+tAEFxIkfDE5HYemKhkeBVEjBRkk+lVtW1C3sozNcMBGMkscYryvXfiY0tz5NhCqWikgu3V8en+e9AHqs1pbXcJUqvzDbkAdKyoPC1qjl7lmmbOB/CMds1b8K3o1DRba4ZgfNTOARithtpO0FuRyccCgDOg0u1tWTZBGi9PXn+v19qtCMAkqx7nGP1qVnwv8Asn1quzYzyBxkk0AI52/j0auY8Qa8kIlgtjmXHJHT0wKZ4l11VAtoZOTw7DuPQGuFuZxI/mmXavLFiR+dAD7i8JkJkydudpK9c/5HNVTOZVYEcnsRgYx2qtLcxxkO0gC4PzE9RXGeJPGdnZh4rOQTzgdFPCk0AdDrWtQ6ZC5mITH5nHt2615X4l8VT6g+RIY4wMiNTjB9fesPVtZu9SuS87sQDwW9BzWWztNIQo5PHAoAdeTGTcwfqMnd1J/yagSFFdXc8n7o/wAamjhYZYkcHGemKgurlUTaoUk9wOPpQAst0sasBtaTOaz5JN5J6tnOc0khLMSep/Wp7OwkuQz/AHIVGWduMD29aAI7aJ7iUInOep9BRVme/Edv9msfkjP33KgM34+lFAEYGRkcY/WlXhiMe3NCggkdvXFOVirZG0jpmgDpdG1C3mgW01HcCvypIeQPrTtS0ya0/eg5jc7lKd/eubHLEBhk5+WtvStde0KwTq01qf4G5I/OgCkWIbAYq3X0/SrUNy9s8bgkw9AB1H0rVn06z1GIz6TPvJ5MZX5lP1rAnSa3ZldCHDY+bjHP86ANqCeO4H78EejA9qe0SsEVkBQEjOeQM9vWufBJIIODnt6/WrdtqEsedxO0nGR1H0oAuTWLnJiAYjgr0I+nqKr+ZLEoG/A6HB/z7Vat7oSgFn2YPLdh+XT3q6bJbi3DMFA67weo9vagBNK1+7spAF5UYAT1x2P+fWvRND8WW90yGc+XKwA5HBwB/gf0ryl7N4HZQ+UHG5RgnPb6VcKXNtEHYKoOMHPFAHvWn3azorBztzuB6E/4f1r0Twxq5vLcRuwWVQOvUj1r5h8P+IrqwZFY74+MqxPFes+F9YEc8VxCxAPBAPH4/nQB7WJf3bHOQM9qchxnnI6YxVCyuVmiRwfl6jB/WrkYA27VCkelAGf4oi+1aROjDPy9P1r5r1tpoNUlRklwGwF/hHfI9f8A69fUUyBgemMY+n4V4v8AFfQntLuO6tY9yOCRg8Lz0H+e9AHNaLqVzYPHeRXLK+PmTBxjsOeor2fwh4sttYs4SJljucZaNj8w+leIWdu97apGceYOrDJ7fy/SpopJtHvklj3rgAAbhyM8/wCf5UAfSIuwwITJHPP9KzbzxNY2jtuuY8J1O4CvBvFPxUuvsUlpZsIuAvmAHccdeewrz+bxBdXauskpkJOev8x/X1NAH0lqnxQ0u0KhW3pnBZTkda6fw54kstdsxPZ3CyKRhxXyZNa3b26yzbhG3OP7w9zWr4E8T3Oga1DOrl4clXQE4dfXFAH0xqXhrT7u48yTcjM/Td1PoP8ACtWMQWFvsGIooxk84AX3qtpl/HeWcM8eNjDepzwBjr9e1ePfFTxldXZltbJZYrSMlXfBG/nHX+npQB0Xi/4nR2lw1tpLKzKwBds5/D1rsfCPiJNa0mK4372IwQOCG+lfMelaHd6hm6kkVI8/KM9q2NE8RXnhLVfkkEkGP3inoemf5dfagD6qSXIYhuOgGetZWua5a6bamS5l2hfuqOWb2ry3/hb9l9kDtCQ+3G0Hjp29MZrh9a8Xy6zq6ljiKUDAJ4K0Add468Rz62pjikeCIcgA9QPf/Oa8vvbyUX6w/KyqerAHI9f/AK1dhdJmzKqrFscc8j6+9Z/g/wAOy6p4vtjNFvXeXYn+6OvPY9qAPevh9DJF4ZsDMeWj3EYwCCe9dQ53DbnGOM+nv71TtVMUaqoUIOdoPb1qZ5GZBgAEHsaAAyBlIHH+Ncz4m1X7KnkIQsjjBIbp9K0dVvls7R5ScFeg68147418UR2f72YozMCAoPegC5eXiAtI5AxkFnPB5/SuM1fxnZ2zvHbt5jrkjYeBXBeIvE17qZx5higAx5SHAHYZ9q5wMSWlcER92JH4cetAG/rHim8umZnuHCAYVF4GPeuakmE07MQWjP0B+tRSB7mRdi7V9Ae3/wBapo4VVNzSfKOo7j3oAUxBzwxSIjoeS1OPlQRgllGDnaf4qguL0LGFQdM9+nPasyWRpWyT+HpQBYuLwyDAzsJ+6P8APWqR3Odig89B1q7punSXpPl/Ki9XPQValvbbTP3VgiTTD70zjIB9vWgCC3sooIBc6g+2Mg7IlPzuf6VUv7+S62xgCOBPuxrwBVaaV5nLyku56kmo6ACiiigC/jGByPfrShQcEdc5HanKVzgMfYelI7ANjBHpxxQA1fUjjtTg2WHJ680ivgsPx+tIFHDDgdetAFiyvZbOfzbdyj9sd/r611FrrNpq6LDqCLHP/fUcH6n1rjzgjPU9xS45DL9aAOq1Hw/IkKzWrechJICHJ4rDljK5VhwRkgD04osdUu7EILedhGTyhPFdBZ6lYasBFdDyLpsKD2b8aAOfjldT8pxjjcPar0OoMhyrkyDHTp/+qreqaFNakyIpePH3h6VhlGHfII4oA6aC8hliAfO77wZeB7/hTbgSNEIlZeBu9QB/nt6mueguXU4bDZ5bJzk1civN3DN8p6gev+NAFxZGibDfLgYGRXRaZrUtqwZXYbWBAzwPYiseyuopE2TIjkE7W4Jx65/zxVlbcbQ9oQRnJHUj/GgD6K+GviSG/wBNFvvbzYz91zjj/PevREmG3g9sHNfImjarcWU8TRyyRPGQQQSCvt/TNfRPgfxJHr2lJKWAuVXDgHp7/jxQB2yuArA55Ocjk9axvFViupaTLHtyw+YA+2eKuROScZO85GDUGo3kdrAS5AyPu5/zxQB42LNIJpDsdc5xkY6dcVl6whuGWKNCwOc46AdD07V1Op7JZy2Qcknr1rPuLdSo9W7qf5e360AeT6zHHBciGIDf3J5/yKr6TFG17++UbV/vDjPoa9Hm0S2luA/kI8jHOQeM+ppv/CO2z7iE2MWJwOQT60AZc8gurOSIICqIc8kAj0Pt6Vxdqzte+WGdcNg8c49/8966i6hn0zWPKYD7PjAJzg/XFV9RsVtJE1K2IKsfnQYwuTx/OgD3nQrqay8BW+5iJPKIA79eleT69dnV7j7LDnyo+ZSDgg9T9TivQlmWbwpDHv5eIINrdCfT3rzjW0t9MZhCrvcyggnOSfw/WgC/YeRHahIASoXAVT09x6//AK6qal4fF7DuWXAHzZzz749qpeHJHt1KzxPmQ5BGefQZ/wA967KCdWQMoUvxtI7DHX8PSgDjrLwtDIhZ5PNTHT0PtUraCttdD7MnmAEHa/HHoK6xY1YssalSP7vc9/8APWpPKQoQQWYYO3r+Oe38+KAKtmEmtlXBWQ8MBzn616v4G0mHTtOSVUAklXczEcn2zXl6oYZN38HQgZGPy616R4U1VJLWK3bBdQAcnNAHW5I4y2R2xTJn/dEggsP59qhmYsMqTtPaub8beIodA0lnkO+YjbGueWNAHFfFXxc2nRG2tz+9IIBznB6mvn/XL+4vJTLcSuSxPAySOewrY127n1G8luL24cvIcDnpz71zl28ELBpAvBxtBwf/AK1AFeKBpJMk5x3J6/8A1v8AJrQmuIo4VhuEAULkkYO72NY89+2QsapGmMlV5471UW5BPCctnJPOaALVzeED5PlB9OpFZ8lw78Od2Mc9/wAaeI5LmURRjceuBzWqfDskKB7+eOCIjJyen4UAYYRpHCoGMhOAByTWrbadb2EXnau+wDkQKRvapJNSstPj26ZGJZ8YM7r0+lc/PNJPK0krtIx6ljyaANTVtclvIjb26iC0zxGvU/U1jE0dqT8aAA0lOPWm0AFFFFAF8NuJ9aGOQBuGB1NR8YNLuwMkZPtQA4YI5496kCnb8gOOvv8ApUI5Jp27b3HHpQAAjknJ7Zpxb5B83B5pNxKgMScDv2FMLEcjIoAlByvY+1NXJOMnrQhJxk/5xQ+eAydP1oA2dI1y509tsjeZb90Y5wPb3rZa2sNXG/T5Akp6oxxz9PWuMDcYz7UqOyMrIxVx0IPNAG3eaVd2TspjfGDyAD/k1RCMnzMGwKv6f4lvIOJ9lyhGMSDn659a14NQ0bUQEnT7LITjGP5H+tAGBBOqR5Vsc9B0ArRgv4tyuHYEDAz2/wA/1q7P4dWRfMtp45lJO3YwOfesS7tbizk8uWPBz0H9KAOntb+1lk2XeCchRIDj6V2vgrWf7G1KOaGTzLd/kbg8An/JrxwSNncrfKOgBrZsdRMDIY5JSAMZPTHp9KAPsG01i1uLYPDMmAOucAHHQ1x2uanLcTMryKwHA28cf5FeO6T4vltYcMWKkYwrcDtg+1OuPF8kk+5W564J4z7/ANPwoA9AnkUFCdys/UetAmG0jaSDz+H+RXnI8Ub0LO5UknG3nn396WDxOzyyMtwVON2WHDe/1oA9B80AMfukDOfT0pqGVXy8hwR6Z6/5/WuMi8XLghplypxll647e5/xq2njC1MbbkAVMqNrfyoA39Vs4r0Kx++v3WPY/wCf6VQ1DR/NtEt4yEjVujdPwxz/APrrPPjKzjQbSR2PrWVqfi2K6UAyMibudhwCPr+mfrQB2um6g2z7GpDCHsG6enNC2EEk/nPGxlJDb8k4+n+NefLrFtFEHikyBjLLx+HuO9X7fxr5SFSSwABwR19vp2oA7eKHEqsTlN5Cj0+mPpWiZkiAIAUEZOPp1/rXnbeO487woOMjDduP5daZcePLcqzBXWRTnLdz9KAO9kuVJDA/MM9Oh4qQXAkXJbgc9eo9fwrzCXxcLjAQSKxxwDyfr/n1qv8A8JcyLGyCVuSCxIAx/jQB6wtzH8xMgO38+fbvVzStTezvF3six+vfGPT/AD0rxc+K5JVDEMhj4GeuOnHuaQ+LpInO1iDg4wchf8/4UAfTV34ts7a0Mhl3Y4A7k/5NeHfEDxemq3Mru+4qcKAePp/9euC1TxK91HsyzkdNx7Y6fSsCe8eZmMoU8cgcD/8AV0oAvXuptO43MUQcAKeTWbNOx5P8Xc9qYrTSvtRCWz2HOa07DQLu8O6RfLiHV36UAZKLufK/MfpWrpmjT3Cl5D5cKncztx8vfFWI7jSNKZ2RTeXCnjnCgjoc1naprl1fkruEUPaNe/1oA1brWbHTI2g0eMPNtANwRwPoDXL3NxLcTM80rOxJzuOaY7c56896ax5BoAGx1pOp57npS4LcAZJ7AUOhQlWXawODntQAjD2yMUzPNPOCPc+1IenFADe1GMUUGgBKKKKALWcnoPxp27GBUQddv3h+NSlo9n3xwBwOv/66AEHJ+Xp1pSAecgDOBTDIgxk5GPegzL/eNADiDjJ/WkHB5z+H86b5iZ+8aUSxgjk4+nSgB4bp1z9KAxBHPscUwTKDwSPwpxuEzjJx9OaALEcazBgpUSKD8n972HvUB6gUxZ1ByM565qaS5hmBZiyv9PvH39KAGocYwoNLn5z/AJzUPnKOm7pSGcZzg0AW45XjIKMV91PNbml668UhF9meLHPqPpXMidc8rmlNyOwI9fegD0G3ttAvpA0d4sRcjIc7efx/z0qW58MLhhYypMM53Ajj3+lec/askllzzU0WpzRHMTyIevytigDtLfw5eSSspUovHz46e59B/hUknh3ULc/6rfkDn0965VvFWqlNv2y4AJz9+ksvE2oWT7oLiXG7dh2LD9e9AGnLaXEXmLOjIRnIHHP+f61Vc7WIzknjJ71cPju5kwbixtZGHfGOKgbxZCzK39k2+Vz/ABHnNAFcsUYqCfl+UHqSPSnB2K4JBB6KOBUp8WRhQE0i0UqNoO4k4qP/AISpcMBpVmARt78UARP5hQD5sgkg/wCe9IGLuNxIz2HSpV8VSBmY2FqWIxnBGBTx4rUOXGk2Yc98tj8qAGNuKsOcf3uwPfNQxs244Oc8Z/mKnbxZIzlm0+0IJzgg4/nUZ8TtyP7Ps9p/h2nH86AFkLxqNsYVfX/PbvUaLKTk5IGOSMke1SjxZOCpFlZ/KcjKE/1pf+EuugCFtbRQfRO/rQBGI7jDOEfg9z296RY5SvRtxxyB39PrQ3iq9Z1fyrbK9P3efag+Kr7fuVLdT/1zFAAYrgkkKxLZHQ/5zToNLvJThYjk8L70p8YapjCfZ04xxEOlRN4s1gqwW6CbuSVjUH+VAGuvha+kYCTYg28FmwBV6XRtH01Fe+vULgA7VbcS30A6VxlxrOo3GRNeTOD1BaqRkck5Oc880Adh/wAJHZ2sTJp+mxtu/jmHT6Y6ViahrN5fJ5U0mIx0RBtH41khm9aXe3rQBL16HA756031qMsSck0bj60ASNyBjt39adFG0siomCxOPb61Dk+tOErhWUHAbg8cn8aALcsqwo0NuAQch5Mct9PQVUPQU3c3rRuOetADz0+vemnpTSSe9GT6mgBT1o60lBJPWgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Single axial CT scan of the lower abdomen demonstrates an abscess (arrowheads) extending from the markedly thickened and inflamed terminal ileum (arrow). The presence of contrast material within the abscess confirms a communication with the adjacent ileum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Norman Joffe, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_11_24753=[""].join("\n");
var outline_f24_11_24753=null;
var title_f24_11_24754="Patient information: Age-related macular degeneration (The Basics)";
var content_f24_11_24754=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15846\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/55/42864\">",
"         Amsler grid",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/30/31202\">",
"          How age-related macular degeneration affects vision",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?11/35/11826\">",
"         Patient information: Age-related vision loss (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?5/62/6114\">",
"         Patient information: Cataracts (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?11/34/11810\">",
"         Patient information: Diabetic retinopathy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?2/13/2258\">",
"         Patient information: Glaucoma (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Age-related macular degeneration (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/age-related-macular-degeneration-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H11039572\">",
"      <span class=\"h1\">",
"       What is age-related macular degeneration?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Age-related macular degeneration, often called &ldquo;AMD,&rdquo; is a disease that causes vision loss. It mostly affects your central vision, so that things in the center look blurry (",
"      <a class=\"graphic graphic_picture graphicRef57989 \" href=\"UTD.htm?30/30/31202\">",
"       picture 1",
"      </a>",
"      ). It is most common among people age 65 and older.",
"     </p>",
"     <p>",
"      There are 2 types of AMD, wet and dry:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        <strong>",
"         Dry AMD",
"        </strong>",
"        is the most common type. It affects 85 to 90 percent of people with the condition. It causes gradual vision loss.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        <strong>",
"         Wet AMD",
"        </strong>",
"        is less common. It affects 10 to 15 percent of people with the condition. But it moves more quickly and can cause severe vision loss or even blindness.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Some people can start out with dry macular degeneration and then develop the wet type.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11039579\">",
"      <span class=\"h1\">",
"       What are the symptoms of AMD?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The symptoms are different depending on what type of AMD you have:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        People with",
"        <strong>",
"         dry AMD",
"        </strong>",
"        lose their vision slowly. They might notice a problem with 1 or both eyes when reading or driving. Or they might realize that they now need bright lights or a magnifying glass to see as well as they used to. People with dry AMD sometimes also notice spots that seem blurry.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        People with",
"        <strong>",
"         wet AMD",
"        </strong>",
"        can have sudden changes in vision. When they first notice symptoms, they might have problems in only 1 eye. (Later, both eyes usually develop problems.) When people with wet AMD look at straight lines, the lines actually look bent or wavy. For this reason, doctors often test people&rsquo;s vision by asking them to look at a grid of straight lines (",
"        <a class=\"graphic graphic_figure graphicRef74919 \" href=\"UTD.htm?41/55/42864\">",
"         figure 1",
"        </a>",
"        ). People who say the lines look bent could have wet AMD.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11039586\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you notice vision loss or any of the other symptoms listed above, see an eye doctor as soon as possible.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11039593\">",
"      <span class=\"h1\">",
"       Is there a test for AMD?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. To check for AMD, doctors can use a few different tests:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        <strong>",
"         Dilated eye exam",
"        </strong>",
"        &ndash; For this test, the doctor gives you eye drops to make your pupils open up. Then, he or she uses a special tool to look at the back of your eye, called the retina. That&rsquo;s the part of the eye that gets damaged by AMD. The doctor also looks for clumps called drusen, which form in the eyes of people who have AMD.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29108?source=see_link\">",
"         Fluorescein",
"        </a>",
"        <strong>",
"         angiography",
"        </strong>",
"        &mdash; This test helps doctors see the blood vessels in the retina. The test is useful because people with wet AMD sometime develop abnormal blood vessels in the retina.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        <strong>",
"         Optical coherence tomography (OCT)",
"        </strong>",
"        &mdash; This test creates detailed pictures of the retina. It can show if the retina is damaged.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11039600\">",
"      <span class=\"h1\">",
"       How is macular degeneration treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Both wet and dry AMD can be treated with a special combination of vitamins and minerals, called the &ldquo;AREDS formula.&rdquo; This formula seems to protect the eye from the damage caused by AMD. It is sold without a prescription. But ask your doctor or nurse before you start taking it. Certain vitamins can be harmful if you take them in the wrong amounts. Plus, people who smoke can have serious problems if they take some vitamins.",
"     </p>",
"     <p>",
"      There are no treatments for dry AMD besides the AREDS formula. But there are other treatments for wet AMD.",
"     </p>",
"     <p>",
"      Treatments for wet AMD work by destroying abnormal blood vessels in the retina, or by preventing new blood vessels from forming there. That&rsquo;s important, because much of the damage of wet AMD is caused by abnormal blood vessels in the retina. Treatments include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        <strong>",
"         Medicines called VEGF inhibitors",
"        </strong>",
"        &mdash; These medicines come in shots that go right into the eye. They help keep new blood vessels from forming.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        <strong>",
"         Photodynamic therapy",
"        </strong>",
"        &mdash; For this treatment, you get a shot of a medicine that &ldquo;sticks to&rdquo; abnormal blood vessels. This medicine becomes toxic when it is exposed to light. After you get the shot, a doctor or nurse shines a special light into your eye. When the light hits the medicine in the blood vessels in the back the eye, the medicine destroys the blood vessels.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        <strong>",
"         Laser surgery",
"        </strong>",
"        &mdash; For this treatment, doctors shine lasers into the eye and use them to destroy abnormal blood vessels in the retina.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11039607\">",
"      <span class=\"h1\">",
"       Can AMD be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can reduce your chances of getting AMD by not smoking, or by quitting if you already smoke. If you already have AMD and you smoke, quitting can actually help slow the disease.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H11039704\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/35/11826?source=see_link\">",
"       Patient information: Age-related vision loss (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/34/11810?source=see_link\">",
"       Patient information: Diabetic retinopathy (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?5/62/6114?source=see_link\">",
"       Patient information: Cataracts (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?2/13/2258?source=see_link\">",
"       Patient information: Glaucoma (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?24/11/24754?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15846 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-118.97.94.19-BA627EFD15-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_11_24754=[""].join("\n");
var outline_f24_11_24754=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11039572\">",
"      What is age-related macular degeneration?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11039579\">",
"      What are the symptoms of AMD?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11039586\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11039593\">",
"      Is there a test for AMD?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11039600\">",
"      How is macular degeneration treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11039607\">",
"      Can AMD be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11039704\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15846\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/55/42864\">",
"      Amsler grid",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/30/31202\">",
"       How age-related macular degeneration affects vision",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/35/11826?source=related_link\">",
"      Patient information: Age-related vision loss (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/62/6114?source=related_link\">",
"      Patient information: Cataracts (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/34/11810?source=related_link\">",
"      Patient information: Diabetic retinopathy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?2/13/2258?source=related_link\">",
"      Patient information: Glaucoma (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_11_24755="Patient information: Medicines for chronic obstructive pulmonary disease (COPD) (The Basics)";
var content_f24_11_24755=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/85724\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/17/41237\">",
"         Normal lungs",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/35/37439\">",
"          Metered dose inhaler",
"         </a>",
"         <li>",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/19/306\">",
"           Dry powder inhalers",
"          </a>",
"          <li>",
"           <a class=\"graphic graphic_table\" href=\"UTD.htm?20/57/21405\">",
"            Medicines for COPD",
"           </a>",
"          </li>",
"         </li>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?14/48/15107\">",
"         Patient information: Chronic bronchitis (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?4/59/5043\">",
"         Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?9/47/9970\">",
"         Patient information: How to use your dry powder inhaler (adults) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?40/34/41506\">",
"         Patient information: How to use your metered dose inhaler (adults) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?29/43/30386\">",
"         Patient information: Inhalers (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?13/52/14148\">",
"         Patient information: Chronic obstructive pulmonary disease (COPD) treatments (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?1/13/1236\">",
"         Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Medicines for chronic obstructive pulmonary disease (COPD) (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H73045441\">",
"      <span class=\"h1\">",
"       What do COPD medicines do?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have COPD, the medicines the doctor prescribes can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Help you feel better and more able to do everyday activities",
"       </li>",
"       <li>",
"        Reduce or prevent COPD symptoms, such as coughing or shortness of breath",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H73045456\">",
"      <span class=\"h1\">",
"       Which medicines might I need?",
"      </span>",
"      &nbsp;&mdash;&nbsp;There are a lot of medicines to treat COPD. Most people use inhalers that help open up their airways or decrease swelling in the airways. The airways are the branching tubes that carry air inside the lungs (",
"      <a class=\"graphic graphic_figure graphicRef67527 \" href=\"UTD.htm?40/17/41237\">",
"       figure 1",
"      </a>",
"      ). Depending on your symptoms, you might need more than 1 inhaler at a time. The doses and choices of medicines you need might change as time goes on. &nbsp; &nbsp;",
"     </p>",
"     <p>",
"      It is a good idea to keep a list of all the medicines you take and bring it with you every time you visit a doctor or nurse. You can find an example of this kind of list at the following web site:",
"      <a class=\"external\" href=\"file://www.fda.gov/drugs/resourcesforyou/ucm079489.htm\">",
"       www.fda.gov/Drugs/ResourcesForYou/ucm079489.htm",
"      </a>",
"     </p>",
"     <p>",
"      The list below gives basic information on COPD medicines, and the table lists the names of some common COPD medicines (",
"      <a class=\"graphic graphic_table graphicRef84043 \" href=\"UTD.htm?20/57/21405\">",
"       table 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      For more detailed information about your medicines, ask your doctor or nurse for information from Lexicomp available through UpToDate. The Lexicomp handouts explain how to use and store your medicines. They also list possible side effects and warn you if your medicines should not be taken with certain other medicines or foods.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H73045471\">",
"      <span class=\"h1\">",
"       Medicines to treat COPD",
"      </span>",
"     </p>",
"     <p>",
"      <strong>",
"       Bronchodilator medicines",
"      </strong>",
"      &ndash; Bronchodilator medicines (also called &ldquo;bronchodilators&rdquo;) are the main medicines used to treat COPD. They help open the airways. They might also help lower the amount of mucus in the lungs.",
"     </p>",
"     <p>",
"      Bronchodilators come in &ldquo;short-acting&rdquo; forms that relieve symptoms quickly and &ldquo;long-acting&rdquo; forms that control symptoms over time.",
"     </p>",
"     <p>",
"      Short-acting bronchodilators include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Short-acting beta agonists &ndash;",
"        </strong>",
"        Short-acting beta agonists (called &ldquo;SABAs&rdquo;) relieve shortness of breath quickly by relaxing tight muscles around the airways. SABAs usually come in a &ldquo;metered dose&rdquo; inhaler (",
"        <a class=\"graphic graphic_picture graphicRef61575 \" href=\"UTD.htm?36/35/37439\">",
"         picture 1",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        <strong>",
"         Short-acting anticholinergics",
"        </strong>",
"        &ndash; Short-acting anticholinergics help the lungs work better and reduce symptoms. If you have mild COPD, you might take a short-acting anticholinergic only when you have symptoms. If symptoms are more severe or happen often, you might take it every day to help keep symptoms from happening. These medicines come in a metered dose inhaler.",
"       </li>",
"       <li>",
"        <strong>",
"         Short-acting combination medicine &ndash;",
"        </strong>",
"        A combination medicine has 2 medicines in 1 inhaler. Taking them together can work better than taking them alone. These medicines come in a metered dose inhaler.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Long-acting bronchodilators include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Long-acting beta agonists -",
"        </strong>",
"        Long-acting beta agonists (called &ldquo;LABAs&rdquo;) relax the muscles around the airways like short-acting beta agonists do. But the effects last much longer. LABAs help control symptoms over time.",
"       </li>",
"       <li>",
"        <strong>",
"         Long-acting anticholinergics &ndash;",
"        </strong>",
"        Long-acting anticholinergics help the lungs work better and decrease symptoms over time. They also reduce the risk of COPD attacks, called &ldquo;flares.&rdquo; (A flare is when symptoms suddenly get worse.) This medication comes in single-dose inhaler. You put a pill in the inhaler and then push buttons on the inhaler that poke holes in the pill (",
"        <a class=\"graphic graphic_picture graphicRef67084 \" href=\"UTD.htm?0/19/306\">",
"         picture 2",
"        </a>",
"        ).",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Other COPD medicines include:",
"     </p>",
"     <p>",
"      <strong>",
"       Inhaled steroid medicines &ndash;",
"      </strong>",
"      Steroid medicines in an inhaler can help if other medicines can&rsquo;t completely control COPD. They are taken along with other medicines. Some steroids come in metered dose inhalers and some come in dry powder inhalers. Each time you use steroids from an inhaler, you need to rinse your mouth out and gargle with water afterwards.",
"     </p>",
"     <p>",
"      Inhaled steroid medicines are not the same as the steroids athletes use to build muscle.",
"     </p>",
"     <p>",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?42/11/43188?source=see_link\">",
"       Roflumilast",
"      </a>",
"      <strong>",
"       &ndash;",
"      </strong>",
"      Roflumilast comes in a pill you take by mouth. Doctors don&rsquo;t prescribe this often. That&rsquo;s because it does not work as well as other bronchodilators and causes more side effects. But it might be used if other medicines do not work well.",
"     </p>",
"     <p>",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?1/7/1141?source=see_link\">",
"       Theophylline",
"      </a>",
"      <strong>",
"       &ndash;",
"      </strong>",
"      Theophylline comes in a pill you take by mouth. Doctors don&rsquo;t prescribe this often. That&rsquo;s because it does not work as well as other bronchodilators and causes more side effects. But it might be used if other medicines do not work well. People who take theophylline need regular blood tests to check for side effects.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H73045487\">",
"      <span class=\"h1\">",
"       What else should I know about COPD medicines?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It is very important to use your inhalers correctly. Medicines for COPD come in different kinds of inhalers, and each kind has its own directions. You need to get some metered dose inhalers ready before you use them for the first time, or if you haven&rsquo;t used them in more than 2 weeks. You get them ready by shaking them for 5 seconds, then spraying medicine into the air (away from your face). Repeat these steps 3 times before using the inhaler.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H73045504\">",
"      <span class=\"h1\">",
"       What if I have a COPD flare?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have a COPD flare, you might need some new medicines. Or you might need to take medicine in a different way than through an inhaler for a while.",
"     </p>",
"     <p>",
"      Medicines for COPD flares include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Short-acting beta agonists and anticholinergics",
"        </strong>",
"        &ndash; You might need to take these medications from a machine called a &ldquo;nebulizer.&rdquo; This is a machine that helps you breathe in the medicine. A nebulizer might work better than an inhaler when you have a COPD flare.",
"       </li>",
"       <li>",
"        <strong>",
"         Steroids that come in pills &ndash;",
"        </strong>",
"        If inhaled medicines for COPD do not work well, you might need to take steroid pills for a few days or weeks.",
"       </li>",
"       <li>",
"        <strong>",
"         Steroids that come in an &ldquo;IV",
"        </strong>",
"        &rdquo; &ndash; An &ldquo;IV&rdquo; is a thin tube that goes into a vein. It is usually given in the hospital. A person who has a severe COPD flare might need treatment in the hospital.",
"       </li>",
"       <li>",
"        <strong>",
"         Antibiotic medicines",
"        </strong>",
"        - You might need to take an antibiotic to help you cough up less mucus. If you are in the hospital, you might get antibiotics in an IV. If you are able to stay at home, you can take antibiotic pills by mouth.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H73045521\">",
"      <span class=\"h1\">",
"       How can I prevent flares of my COPD?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have COPD, you need a flu shot every fall and the pneumonia vaccine at least once. This is because infections like flu and pneumonia can be very hard on your lungs. It is important to try to prevent them.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H73045536\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?14/48/15107?source=see_link\">",
"       Patient information: Chronic bronchitis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/59/5043?source=see_link\">",
"       Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?29/43/30386?source=see_link\">",
"       Patient information: Inhalers (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/47/9970?source=see_link\">",
"       Patient information: How to use your dry powder inhaler (adults) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?40/34/41506?source=see_link\">",
"       Patient information: How to use your metered dose inhaler (adults) (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?1/13/1236?source=see_link\">",
"       Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?13/52/14148?source=see_link\">",
"       Patient information: Chronic obstructive pulmonary disease (COPD) treatments (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?24/11/24755?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 85724 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.66.252.144-564C5304BD-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_11_24755=[""].join("\n");
var outline_f24_11_24755=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H73045441\">",
"      What do COPD medicines do?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H73045456\">",
"      Which medicines might I need?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H73045471\">",
"      Medicines to treat COPD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H73045487\">",
"      What else should I know about COPD medicines?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H73045504\">",
"      What if I have a COPD flare?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H73045521\">",
"      How can I prevent flares of my COPD?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H73045536\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/85724\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/17/41237\">",
"      Normal lungs",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/35/37439\">",
"       Metered dose inhaler",
"      </a>",
"      <li>",
"       <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/19/306\">",
"        Dry powder inhalers",
"       </a>",
"       <li>",
"        <a class=\"graphic graphic_table\" href=\"UTD.htm?20/57/21405\">",
"         Medicines for COPD",
"        </a>",
"       </li>",
"      </li>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?14/48/15107?source=related_link\">",
"      Patient information: Chronic bronchitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/52/14148?source=related_link\">",
"      Patient information: Chronic obstructive pulmonary disease (COPD) treatments (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/13/1236?source=related_link\">",
"      Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/59/5043?source=related_link\">",
"      Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/47/9970?source=related_link\">",
"      Patient information: How to use your dry powder inhaler (adults) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/34/41506?source=related_link\">",
"      Patient information: How to use your metered dose inhaler (adults) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/43/30386?source=related_link\">",
"      Patient information: Inhalers (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_11_24756="U-S choriocarcinoma and AVM A";
var content_f24_11_24756=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F56972&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F56972&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Ultrasound choriocarcinoma and AVM",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 507px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Choriocarcinoma: with associated arteriovenous malformation: Patient with choriocarcinoma after a molar pregnancy. Ultrasound shows a solid and cystic lesion in the myometrium adjacent to the endometrial cavity and measuring 3.0 x 2.5 cm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Department of Radiology, Santa Clara Valley Medical Center.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_11_24756=[""].join("\n");
var outline_f24_11_24756=null;
var title_f24_11_24757="Intralesional steroid injection";
var content_f24_11_24757=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F80429&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F80429&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Intralesional corticosteroids",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 343px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Triamcinolone is injected into the upper subcutis&nbsp;of the scalp in areas affected by alopecia areata.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Andrew G Messenger, MD, FRCP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_11_24757=[""].join("\n");
var outline_f24_11_24757=null;
var title_f24_11_24758="Chordoma Light";
var content_f24_11_24758=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F76084&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F76084&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 535px\">",
"   <div class=\"ttl\">",
"    Chordoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 515px; height: 231px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low and high power light micrographs of a skull base chordoma. The tumor cells have vesicular nuclei and abundant vacuolated, soap bubble-like cytoplasm (physaliphorous cells) that contains glycogen (PAS positive) or mucin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Silloo B Kapadia, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_11_24758=[""].join("\n");
var outline_f24_11_24758=null;
var title_f24_11_24759="Overview of nontuberculous mycobacterial infections in HIV-negative patients";
var content_f24_11_24759=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of nontuberculous mycobacterial infections in HIV-negative patients",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/11/24759/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/11/24759/contributors\">",
"     David E Griffith, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/11/24759/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/11/24759/contributors\">",
"     C Fordham von Reyn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/11/24759/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/11/24759/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/11/24759/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nontuberculous mycobacterial (NTM) species are mycobacterial species other than those belonging to the Mycobacterium tuberculosis complex (eg, M. tuberculosis, M. bovis, M. africanum, and M. microti) and M. leprae. NTM are generally free-living organisms that are ubiquitous in the environment. There have been more than 140 NTM species identified.",
"   </p>",
"   <p>",
"    In broad terms, NTM can cause four clinical syndromes in humans [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pulmonary disease, especially in older persons with or without underlying lung disease and patients with cystic fibrosis, caused primarily by M. avium complex (MAC) and M. kansasii.",
"      <br/>",
"      <br/>",
"      Other species that cause lung disease include M. abscessus, M. fortuitum, M. xenopi, M. malmoense, M. szulgai, and M. simiae (",
"      <a class=\"graphic graphic_table graphicRef61936 \" href=\"UTD.htm?3/0/3085\">",
"       table 1",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/3\">",
"       3",
"      </a>",
"      ]. Geography plays a prominent role in the epidemiology of NTM pulmonary disease. M. xenopi is relatively more common in Europe, Great Britain, and Canada, while M. malmoense is relatively more common in Scandinavia and Northern Europe [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/1,4\">",
"       1,4",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/33/24089?source=see_link\">",
"       \"Epidemiology of nontuberculous mycobacterial infections\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Superficial lymphadenitis, especially cervical lymphadenitis, in children caused mostly by MAC, M. scrofulaceum, and, in northern Europe, M. malmoense and M. haemophilum. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/24/37257?source=see_link\">",
"       \"Overview of disseminated nontuberculous mycobacterial (NTM) infections and NTM bacteremia in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/42/13994?source=see_link\">",
"       \"Overview of nontuberculous mycobacterial lymphadenitis in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Disseminated disease in severely immunocompromised patients (most commonly caused by MAC and less commonly by the rapidly growing mycobacteria [RGM], eg, M. abscessus, M. fortuitum, and M. chelonae). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/55/38777?source=see_link\">",
"       \"Mycobacterium avium complex (MAC) infections in HIV-infected patients\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/25/5530?source=see_link\">",
"       \"Rapidly growing mycobacterial infections in HIV-negative patients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Skin and soft tissue infection usually as a consequence of direct inoculation, caused primarily by M. marinum and M. ulcerans and the RGM spp. RGM infections in this category may be nosocomial, including surgical site infections [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/5\">",
"       5",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/25/5530?source=see_link\">",
"       \"Rapidly growing mycobacterial infections in HIV-negative patients\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An overview of NTM infection in HIV-negative patients, with emphasis on chronic lung infections that account for up to 90 percent of patient encounters due to NTM, will be reviewed here. The epidemiology, microbiology, pathogenesis, diagnosis, and treatment of NTM infection, as well as infection due to rapidly growing mycobacteria and M. ulcerans, are discussed separately (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/33/24089?source=see_link\">",
"     \"Epidemiology of nontuberculous mycobacterial infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5687?source=see_link\">",
"     \"Microbiology of nontuberculous mycobacteria\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/44/25288?source=see_link\">",
"     \"Pathogenesis of nontuberculous mycobacterial infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11045?source=see_link\">",
"     \"Diagnosis of nontuberculous mycobacterial infections of the lungs in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/24/2441?source=see_link\">",
"     \"Treatment of nontuberculous mycobacterial infections of the lung in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/25/5530?source=see_link\">",
"     \"Rapidly growing mycobacterial infections in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39033?source=see_link\">",
"     \"Buruli ulcer (Mycobacterium ulcerans infection)\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    NTM infections in HIV-infected patients and lung transplant candidates and recipients are also reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/55/38777?source=see_link\">",
"     \"Mycobacterium avium complex (MAC) infections in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/9/15512?source=see_link\">",
"     \"Overview of nontuberculous mycobacteria (excluding MAC) in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31207?source=see_link\">",
"     \"Nontuberculous mycobacterial infections in solid organ transplant candidates and recipients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MYCOBACTERIUM AVIUM COMPLEX",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mycobacterium avium complex (MAC) includes the two species M. avium and M. intracellulare. These organisms are genetically similar and generally not differentiated in the clinical microbiology laboratory. Among NTM, MAC is the most common cause of pulmonary disease worldwide. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5687?source=see_link\">",
"     \"Microbiology of nontuberculous mycobacteria\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is generally felt that these organisms are acquired from the environment. Unlike M. tuberculosis, there are no convincing data demonstrating human-to-human or animal-to-human transmission of MAC. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/33/24089?source=see_link\">",
"     \"Epidemiology of nontuberculous mycobacterial infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The symptoms and signs of MAC lung disease are variable, not specific, and are influenced by whether the patient has pre-existing symptomatic lung disease. They include cough (productive or dry), fatigue, malaise, weakness, dyspnea, chest discomfort, and occasionally hemoptysis. Fever and weight loss occur less frequently than in patients with typical tuberculosis. Examination of the lungs is often normal but, since these infections frequently coexist with underlying lung disease such as chronic obstructive pulmonary disease (COPD) or bronchiectasis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/6\">",
"     6",
"    </a>",
"    ], physical findings of the latter diseases may predominate.",
"   </p>",
"   <p>",
"    Two major clinical presentations have been described:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Disease in those with known underlying lung disease, primarily white, middle-aged, or elderly men, often alcoholics",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      smokers with underlying chronic obstructive pulmonary disease. The disease resembles typical tuberculosis clinically and radiographically, with cough, weight loss, upper lobe infiltrates, and cavities [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/7,8\">",
"       7,8",
"      </a>",
"      ]. Symptoms are generally less severe than those associated with tuberculosis. Additionally, due to the relatively indolent nature of MAC lung disease, lung destruction may be quite extensive at the time of diagnosis with very large cavities on chest radiograph. Another presentation is seen in patients in whom MAC develops in areas of prior bronchiectasis, such as patients with prior tuberculosis. Older adults are also affected, but there is no association with male sex or smoking-related pulmonary disease. Most commonly, patients with prior treated tuberculosis develop symptoms, such as cough, sputum production, fatigue and weight loss, and a new infiltrate in the previously affected lung zone suggesting a relapse of tuberculosis. This pattern is also seen with other types of bronchiectasis including cystic fibrosis [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/8,9\">",
"       8,9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Disease in those without known underlying lung disease predominantly in nonsmoking women over age 50 who have interstitial patterns on chest radiography [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/6,10\">",
"       6,10",
"      </a>",
"      ]. For many clinicians, this is the form of MAC lung disease that is most commonly encountered. The typical presenting symptoms were persistent cough and purulent sputum, usually without fever or weight loss; the mean duration of cough was 25 weeks before the diagnosis was made [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/6\">",
"       6",
"      </a>",
"      ]. Previously thought to represent airway colonization, the serious nature of this disease has become increasingly evident. One report, for example, noted a 19 percent mortality rate from respiratory failure during longitudinal follow-up in 21 such patients [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/6\">",
"       6",
"      </a>",
"      ]. A syndrome of right middle lobe or lingular infiltrates, sometimes called the Lady Windermere syndrome, has been noted in elderly women without predisposing lung disease, volume loss, adenopathy, or cavitation [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/10\">",
"       10",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Radiographically, this form of MAC lung disease is almost invariably associated with nodules and bronchiectasis and is sometimes referred to as",
"      <span class=\"nowrap\">",
"       nodular/bronchiectatic",
"      </span>",
"      MAC lung disease. In a series of selected patients with this form of MAC lung disease, it was noted that patients with NTM tend to be taller and leaner than control subjects and have increased likelihood of pectus excavatum, scoliosis, and mitral valve prolapse [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/11,12\">",
"       11,12",
"      </a>",
"      ]. These patients are also more likely to have cystic fibrosis transmembrane conductance regulator mutations in the absence of recognized immune defects [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/12\">",
"       12",
"      </a>",
"      ]. There were no recognized immune defects such as cell-mediated immune dysfunction or cytokine pathway abnormalities identified in these patients. The pathophysiologic consequences of the morphologic abnormalities and their potential contribution(s) to the predisposition for MAC infection are not yet known.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Two other less common forms of MAC lung disease have been described:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One report noted an unexpectedly high frequency (78 of 244 patients) of MAC pulmonary infections presenting as solitary pulmonary nodules, which resembled lung cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/8\">",
"       8",
"      </a>",
"      ]. Solitary pulmonary nodules caused by MAC were observed in 11 patients in South Korea in a retrospective study [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      MAC exposure in immunocompetent hosts without underlying lung disease has been linked to the development of hypersensitivity pneumonitis, particularly following hot tub use [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/14-17\">",
"       14-17",
"      </a>",
"      ]. The resulting hypersensitivity reaction (\"hot tub lung\") generally responds to avoidance of the offending environment, and the role of antibiotic therapy appears limited. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/18/34087?source=see_link&amp;anchor=H8#H8\">",
"       \"Epidemiology and causes of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\", section on 'Ventilation and water-related contamination'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, thus far, no severe or consistent predisposition or immune deficiency has been identified to explain MAC infection in HIV-negative patients. Six familial clusters of NTM disease, mostly caused by MAC, have been identified, although no specific immune defect was identified [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One study that included patients with both cavitary and noncavitary MAC lung disease found that mycobacterium-stimulated peripheral blood monocytes (PBMC) produced higher concentrations of interleukin 10 (IL-10) but lower concentrations of interferon (IFN)-gamma, IL-12 and tumor necrosis factor alpha (TNF-alpha), compared with PBMC from control subjects with a delayed hypersensitivity skin test response to M. avium sensitin. The authors concluded that IFN-gamma, TNF-alpha, and IL-12 contributed to protection against MAC lung disease whereas IL-10 was immunosuppressive [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another small case series noted a decreased interferon gamma response to mitogen stimulation in five such patients, which did not improve in two of the patients despite successful therapy with antimycobacterial agents [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/20\">",
"     20",
"    </a>",
"    ]. The study cited above in patients with",
"    <span class=\"nowrap\">",
"     nodular/bronchiectatic",
"    </span>",
"    disease found no cytokine pathway abnormalities to explain the apparent susceptibility for acquiring MAC lung disease in these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/12\">",
"     12",
"    </a>",
"    ]. There is clearly a great deal more that must be learned about these patients and their predisposition for MAC lung disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Diagnostic criteria for pulmonary disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Thoracic Society and Infectious Disease Society of America's diagnostic criteria for nontuberculous mycobacterial pulmonary infections include both imaging studies consistent with pulmonary disease and recurrent isolation of mycobacteria from sputum or isolated from at least one bronchial wash in a symptomatic patient (",
"    <a class=\"graphic graphic_table graphicRef61404 \" href=\"UTD.htm?10/48/11020\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11045?source=see_link\">",
"     \"Diagnosis of nontuberculous mycobacterial infections of the lungs in HIV-negative patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Disseminated disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disseminated MAC disease may complicate MAC pulmonary disease through local multiplication and entry into the bloodstream with seeding of other organs and tissues. The disease primarily occurs in severely immunocompromised patients, such as those with advanced AIDS, hematologic malignancy, or a history of immunosuppressive therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/33/24089?source=see_link&amp;anchor=H6#H6\">",
"     \"Epidemiology of nontuberculous mycobacterial infections\", section on 'Disseminated disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Clinical symptoms and signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinically, disseminated MAC manifests as intermittent or persistent fever (&gt;80 percent), night sweats (&gt;35 percent), weight loss (&gt;25 percent), with additional symptoms including fatigue, malaise, and anorexia [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/22\">",
"     22",
"    </a>",
"    ]. Organ-specific symptoms and signs reflect the major sites of involvement including anemia and neutropenia from bone marrow involvement; adenopathy or hepatosplenomegaly from lymphoreticular involvement; diarrhea, abdominal pain, hepatomegaly, and elevations of liver enzymes from involvement of the gastrointestinal tract; and cough and lung infiltrates from pulmonary involvement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Diagnostic cultures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis is most readily established by culture of blood for mycobacteria. It is important to note that mycobacterial blood cultures are collected in special media, different from the media used in standard bacterial blood cultures, and must be specifically requested. Culture of bone marrow, or fluid or tissue specimens from suspected sites of involvement may also be considered. The major differential diagnosis includes tuberculosis and disease due to other NTM.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     MYCOBACTERIUM KANSASII",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unlike other NTM, M. kansasii has never been found in soil or natural water supplies, but has been recovered consistently from tap water in cities where M. kansasii is endemic. Thus, there may be an association between clinical disease and potable water supplies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/33/24089?source=see_link&amp;anchor=H7#H7\">",
"     \"Epidemiology of nontuberculous mycobacterial infections\", section on 'Mycobacterium kansasii'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/24/2441?source=see_link&amp;anchor=H10#H10\">",
"     \"Treatment of nontuberculous mycobacterial infections of the lung in HIV-negative patients\", section on 'Mycobacterium kansasii'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;M. kansasii usually presents as lung disease that is nearly identical to tuberculosis, although fever may be less common [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/10\">",
"     10",
"    </a>",
"    ]. In older studies, cavitation occurred in 85 to 95 percent of cases, being bilateral in 20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/7,23,24\">",
"     7,23,24",
"    </a>",
"    ]. In some cases, the cavities tended to have thinner walls and less surrounding parenchymal infiltration than in tuberculosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/7,24\">",
"     7,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A survey of 56 adults with M. kansasii pulmonary infection in Israel diagnosed in the time period 1999 to 2004 noted the following findings [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/25\">",
"     25",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The most common clinical presentations were chest pain (82 percent), cough (84 percent), hemoptysis (38 percent), fever, and night sweats (39 percent)",
"     </li>",
"     <li>",
"      Cavitation occurred in 54 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The explanation for the difference in prevalence of cavitation in the studies is unclear, although patients in older studies may have had more advanced disease prior to diagnosis.",
"   </p>",
"   <p>",
"    Disseminated infection is a rare complication that occurs in immunocompromised hosts such as those with HIV infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/9/15512?source=see_link&amp;anchor=H3#H3\">",
"     \"Overview of nontuberculous mycobacteria (excluding MAC) in HIV-infected patients\", section on 'Mycobacterium kansasii'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The same diagnostic criteria apply to the diagnosis of pulmonary infection with M. kansasii as to MAC infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11045?source=see_link\">",
"     \"Diagnosis of nontuberculous mycobacterial infections of the lungs in HIV-negative patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     RAPIDLY GROWING MYCOBACTERIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rapidly growing mycobacteria (RGM) include three clinically relevant species: M. fortuitum, M. chelonae, and M. abscessus (",
"    <a class=\"graphic graphic_table graphicRef61936 \" href=\"UTD.htm?3/0/3085\">",
"     table 1",
"    </a>",
"    ). The RGM are environmental organisms found worldwide that usually grow in culture in less than one week following initial isolation, and may sometimes grow on standard microbiologic media (rather than requiring special mycobacterial media). Pulmonary disease due to rapidly growing mycobacteria (RGM) is predominantly due to M. abscessus (80 percent of cases) and M. fortuitum (15 percent of cases). This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/25/5530?source=see_link&amp;anchor=H4#H4\">",
"     \"Rapidly growing mycobacterial infections in HIV-negative patients\", section on 'Pulmonary infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As noted above, disseminated NTM disease usually occurs in the immunosuppressed host. Perhaps surprisingly, M. abscessus is not an important pathogen in HIV-seropositive patients. However, in 2000, a previously unrecognized clinical entity of disseminated infection following lymphadenitis was reported in a group of 19 HIV-seronegative patients from northeast Thailand [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/26\">",
"     26",
"    </a>",
"    ]. A follow-up report from this region in 2007 described 129 patients with chronic lymphadenitis and subsequent progressive involvement of other organs (eg, skin and soft tissue, lung, bone and joint, liver); 99 of 129 cases involved RGM [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/27\">",
"     27",
"    </a>",
"    ]. Almost half of the patients also had other opportunistic infections, consistent with an underlying T-cell defect. However, all were HIV-seronegative.",
"   </p>",
"   <p>",
"    A natural history study of this cohort is underway to determine which host factors lead to susceptibility to mycobacteria and other intracellular pathogens. To date, there has not been a similar syndrome reported in the US or western Europe.",
"   </p>",
"   <p>",
"    RGM occasionally cause skin and soft tissue infections. This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/25/5530?source=see_link&amp;anchor=H7#H7\">",
"     \"Rapidly growing mycobacterial infections in HIV-negative patients\", section on 'Skin and soft tissue infection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     OTHER NONTUBERCULOUS MYCOBACTERIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other pathogens including M. xenopi, M. simiae, M. szulgai, and M. malmoense can also cause chronic lung disease (",
"    <a class=\"graphic graphic_table graphicRef61936 \" href=\"UTD.htm?3/0/3085\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24759/abstract/3,28\">",
"     3,28",
"    </a>",
"    ]. The clinical manifestations and diagnostic criteria for infection are as discussed above for MAC. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Mycobacterium avium complex'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nontuberculous mycobacterium (NTM) species are mycobacterial species other than those belonging to the Mycobacterium tuberculosis complex and M. leprae. NTM are generally free-living organisms that are ubiquitous in the environment. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pulmonary disease, especially in older persons with or without underlying lung disease, is caused primarily by M. avium complex (MAC) and M. kansasii. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Among NTM, MAC is the most common cause of pulmonary disease worldwide. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Mycobacterium avium complex'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The symptoms and signs of MAC lung disease are variable and not specific, but include cough (productive or dry), fatigue, malaise, weakness, dyspnea, chest discomfort, and occasionally hemoptysis. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Two major clinical presentations of MAC pulmonary disease include disease in:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Those with underlying lung disease, primarily white, middle-aged or elderly men (often, alcoholics",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      smokers with underlying chronic obstructive lung disease), patients in whom MAC develops in areas of prior bronchiectasis, and patients with cystic fibrosis; and",
"     </li>",
"     <li>",
"      Those without known underlying lung disease, including nonsmoking women over age 50 who have interstitial patterns on chest radiography. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The American Thoracic Society and Infectious Disease Society of America's diagnostic criteria for nontuberculous mycobacterial pulmonary infections include both imaging studies consistent with pulmonary disease and recurrent isolation of mycobacteria from sputum or isolated from at least one bronchial wash in a symptomatic patient. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11045?source=see_link\">",
"       \"Diagnosis of nontuberculous mycobacterial infections of the lungs in HIV-negative patients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Unlike other NTM, M. kansasii has never been found in soil or natural water supplies, but has been recovered consistently from tap water in cities where M. kansasii is endemic. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Mycobacterium kansasii'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      M. kansasii usually presents as lung disease that is nearly identical to tuberculosis. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pulmonary disease due to rapidly growing mycobacteria (RGM) is predominantly due to M. abscessus (80 percent of cases) and M. fortuitum (15 percent of cases). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Rapidly growing mycobacteria'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/1\">",
"      Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979; 119:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/2\">",
"      Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/3\">",
"      Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 1997; 156:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/4\">",
"      Wolinsky E, Rynearson TK. Mycobacteria in soil and their relation to disease-associated strains. Am Rev Respir Dis 1968; 97:1032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/5\">",
"      Phillips MS, von Reyn CF. Nosocomial infections due to nontuberculous mycobacteria. Clin Infect Dis 2001; 33:1363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/6\">",
"      Prince DS, Peterson DD, Steiner RM, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989; 321:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/7\">",
"      Ahn CH, McLarty JW, Ahn SS, et al. Diagnostic criteria for pulmonary disease caused by Mycobacterium kansasii and Mycobacterium intracellulare. Am Rev Respir Dis 1982; 125:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/8\">",
"      Teirstein AS, Damsker B, Kirschner PA, et al. Pulmonary infection with Mycobacterium avium-intracellulare: diagnosis, clinical patterns, treatment. Mt Sinai J Med 1990; 57:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/9\">",
"      Kilby JM, Gilligan PH, Yankaskas JR, et al. Nontuberculous mycobacteria in adult patients with cystic fibrosis. Chest 1992; 102:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/10\">",
"      Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome. Chest 1992; 101:1605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/11\">",
"      Iseman MD, Buschman DL, Ackerson LM. Pectus excavatum and scoliosis. Thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex. Am Rev Respir Dis 1991; 144:914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/12\">",
"      Kim RD, Greenberg DE, Ehrmantraut ME, et al. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med 2008; 178:1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/13\">",
"      Lim J, Lyu J, Choi CM, et al. Non-tuberculous mycobacterial diseases presenting as solitary pulmonary nodules. Int J Tuberc Lung Dis 2010; 14:1635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/14\">",
"      Cappelluti E, Fraire AE, Schaefer OP. A case of \"hot tub lung\" due to Mycobacterium avium complex in an immunocompetent host. Arch Intern Med 2003; 163:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/15\">",
"      Khoor A, Leslie KO, Tazelaar HD, et al. Diffuse pulmonary disease caused by nontuberculous mycobacteria in immunocompetent people (hot tub lung). Am J Clin Pathol 2001; 115:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/16\">",
"      Kahana LM, Kay JM, Yakrus MA, Waserman S. Mycobacterium avium complex infection in an immunocompetent young adult related to hot tub exposure. Chest 1997; 111:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/17\">",
"      Embil J, Warren P, Yakrus M, et al. Pulmonary illness associated with exposure to Mycobacterium-avium complex in hot tub water. Hypersensitivity pneumonitis or infection? Chest 1997; 111:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/18\">",
"      Colombo RE, Hill SC, Claypool RJ, et al. Familial clustering of pulmonary nontuberculous mycobacterial disease. Chest 2010; 137:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/19\">",
"      Vankayalapati R, Wizel B, Samten B, et al. Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex. J Infect Dis 2001; 183:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/20\">",
"      Safdar A, White DA, Stover D, et al. Profound interferon gamma deficiency in patients with chronic pulmonary nontuberculous mycobacteriosis. Am J Med 2002; 113:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/21\">",
"      Horsburgh CR Jr, Mason UG 3rd, Farhi DC, Iseman MD. Disseminated infection with Mycobacterium avium-intracellulare. A report of 13 cases and a review of the literature. Medicine (Baltimore) 1985; 64:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/22\">",
"      Nightingale SD, Byrd LT, Southern PM, et al. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis 1992; 165:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/23\">",
"      Johanson WG Jr, Nicholson DP. Pulmonary disease due to Mycobacterium Kansasii. An analysis of some factors affecting prognosis. Am Rev Respir Dis 1969; 99:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/24\">",
"      Christensen EE, Dietz GW, Ahn CH, et al. Radiographic manifestations of pulmonary Mycobacterium kansasii infections. AJR Am J Roentgenol 1978; 131:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/25\">",
"      Shitrit D, Baum GL, Priess R, et al. Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome. Chest 2006; 129:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/26\">",
"      Chetchotisakd P, Mootsikapun P, Anunnatsiri S, et al. Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity. Clin Infect Dis 2000; 30:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/27\">",
"      Chetchotisakd P, Kiertiburanakul S, Mootsikapun P, et al. Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. Clin Infect Dis 2007; 45:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24759/abstract/28\">",
"      Majoor CJ, Schreurs AJ, Weers-Pothoff G. Mycobacterium xenopi infection in an immunosuppressed patient with Crohn's disease. Thorax 2004; 59:631.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5342 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-CAE323FBD7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_11_24759=[""].join("\n");
var outline_f24_11_24759=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MYCOBACTERIUM AVIUM COMPLEX",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Diagnostic criteria for pulmonary disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Disseminated disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Clinical symptoms and signs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Diagnostic cultures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      MYCOBACTERIUM KANSASII",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      RAPIDLY GROWING MYCOBACTERIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      OTHER NONTUBERCULOUS MYCOBACTERIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/5342\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5342|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/0/3085\" title=\"table 1\">",
"      Mycobacteria classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/48/11020\" title=\"table 2\">",
"      Criteria for NTM diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39033?source=related_link\">",
"      Buruli ulcer (Mycobacterium ulcerans infection)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11045?source=related_link\">",
"      Diagnosis of nontuberculous mycobacterial infections of the lungs in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/18/34087?source=related_link\">",
"      Epidemiology and causes of hypersensitivity pneumonitis (extrinsic allergic alveolitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/33/24089?source=related_link\">",
"      Epidemiology of nontuberculous mycobacterial infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5687?source=related_link\">",
"      Microbiology of nontuberculous mycobacteria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/55/38777?source=related_link\">",
"      Mycobacterium avium complex (MAC) infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31207?source=related_link\">",
"      Nontuberculous mycobacterial infections in solid organ transplant candidates and recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/24/37257?source=related_link\">",
"      Overview of disseminated nontuberculous mycobacterial (NTM) infections and NTM bacteremia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/9/15512?source=related_link\">",
"      Overview of nontuberculous mycobacteria (excluding MAC) in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/42/13994?source=related_link\">",
"      Overview of nontuberculous mycobacterial lymphadenitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/44/25288?source=related_link\">",
"      Pathogenesis of nontuberculous mycobacterial infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/25/5530?source=related_link\">",
"      Rapidly growing mycobacterial infections in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/24/2441?source=related_link\">",
"      Treatment of nontuberculous mycobacterial infections of the lung in HIV-negative patients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_11_24760="Epidemiology and toxicity of cadmium";
var content_f24_11_24760=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology and toxicity of cadmium",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/11/24760/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/11/24760/contributors\">",
"     Carl-Gustaf Elinder, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/11/24760/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/11/24760/contributors\">",
"     Gary C Curhan, MD, ScD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/11/24760/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/11/24760/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/11/24760/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cadmium (Cd) is a metal that can cause severe toxicity in humans. Prolonged cadmium exposure can affect a variety of organs, with the kidneys and bones being the principal targets [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cadmium is a relatively rare heavy metal that occurs naturally in combination with zinc. Major industrial applications for cadmium are in the production of alloys, galvanizing, pigments, and batteries. Evidence strongly suggests that environmental contamination and human exposure have dramatically increased during the past one hundred years [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cadmium commonly contaminates the environment due to the presence of cadmium-containing material in household waste, industrial emissions, and soil.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cadmium-containing products are frequently thrown out with the household garbage; the metal is then released into the atmosphere if the waste is burned.",
"     </li>",
"     <li>",
"      Considerable cadmium emissions result from mining and nonferrous smelters.",
"     </li>",
"     <li>",
"      Soil is commonly contaminated via atmospheric emissions and sewage sludge. Land used for farming can also contain cadmium due to the use of phosphate fertilizers containing the metal. Cadmium is readily absorbed by plants grown in cadmium-containing soil, particularly grain, rice, and vegetables.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HUMAN EXPOSURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exposure to cadmium principally results from eating contaminated food, smoking cigarettes, and working in cadmium-contaminated work places. Exposure to cadmium is commonly determined by measuring cadmium levels in blood or urine. Blood cadmium reflects recent cadmium exposure (from smoking, for example). Cadmium in urine (usually adjusted for dilution by calculating the",
"    <span class=\"nowrap\">",
"     cadmium/creatinine",
"    </span>",
"    ratio) indicates accumulation, or kidney burden, of cadmium [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Food intake",
"    </span>",
"    &nbsp;&mdash;&nbsp;The daily intake of cadmium through food varies in part by geographic region. As an example, intake is reported to be approximately 8 to 30 mcg in Europe and the United States, versus 59 to 113 mcg in various areas of Japan [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/8\">",
"     8",
"    </a>",
"    ]. There is also a wide individual variation in cadmium intake based upon the type and amount of food consumed. Since this variation follows a log-normal distribution, most individuals ingest between 4 and 60 mcg per day (eg, &plusmn;2 SD) if the average individual intake is 15 mcg per day [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/6,9\">",
"     6,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since the average gastrointestinal absorption is five percent, the net absorbed amount of cadmium is approximately 1 to 2 mcg per day in Europe and the United States, and up to 5 mcg in \"non-polluted\" areas in Japan. A slight degree of iron deficiency markedly enhances the absorption of dietary cadmium (and iron) from the gastrointestinal tract; this phenomenon is one reason why women constitute a risk group for environmental cadmium exposure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Smoking",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoking is a potentially important route of cadmium exposure. Individuals who smoke 20 cigarettes a day absorb nearly 1 mcg of cadmium, an amount similar to the quantity absorbed via food in Europe and the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Occupational exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The workplace constitutes the most important source of cadmium exposure among individuals engaged in cadmium production and the industrial use of cadmium (eg, nickel-cadmium batteries). The number of workers occupationally exposed to cadmium is considered to exceed one million individuals worldwide.",
"   </p>",
"   <p>",
"    Occupational threshold limit values (TLVs) range from .01 to .05 mg",
"    <span class=\"nowrap\">",
"     Cd/m3",
"    </span>",
"    in various countries. To protect workers from kidney dysfunction and lung cancer over a working lifetime, the Occupational Safety and Health Administration (OSHA) of the United States has proposed a revised TLV for cadmium in air of .001 to .005 mg",
"    <span class=\"nowrap\">",
"     Cd/m3",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/1,10\">",
"     1,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     METABOLISM OF CADMIUM AND METALLOTHIONEIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;After ingestion or inhalation, cadmium is transported to the liver where metallothionein, a cadmium- and zinc-binding protein, is synthesized [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/9\">",
"     9",
"    </a>",
"    ]. Metallothionein serves as a detoxifying protein by binding cadmium and preventing \"free\" cadmium ions from disturbing normal cellular functions. It is also responsible for the pronounced accumulation of cadmium in the liver and kidneys.",
"   </p>",
"   <p>",
"    Metallothionein, which has a molecular weight around 7000, migrates slowly from the liver cells into the blood stream where it is transported to the kidneys. As with other small proteins it is freely filtered across the glomerulus and then reabsorbed by the proximal tubular cells via pinocytosis. In the tubular cells, metallothionein enters the lysosomes where it is degraded by lysozymes, releasing free cadmium ions into the tubular cell cytoplasm.",
"   </p>",
"   <p>",
"    The renal tubular cells have a considerable capacity to synthesize metallothionein, thereby binding the toxic cadmium ions. At some point, however, the kidneys' detoxifying capacity is surpassed and tubular damage can ensue. Later changes include interstitial inflammation and fibrosis, and glomerular injury [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/1,10\">",
"     1,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     RENAL TOXICITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is well established that cadmium exposure can cause kidney injury:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In several areas of Japan, cadmium pollution of soil and subsequent human exposure via rice has caused endemic outbreaks of renal tubular disease [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/1,10,11\">",
"       1,10,11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Individuals in certain areas of Belgium, China, Japan, and Sweden have high cadmium body burdens and resultant kidney dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/11-14\">",
"       11-14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The first sign of cadmium nephrotoxicity is tubular dysfunction, which is characterized by an increased excretion of low molecular weight proteins (such as &szlig;2-microglobulin) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/10\">",
"     10",
"    </a>",
"    ]. In almost all cases, tubular proteinuria is irreversible even if exposure has ceased [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/15-17\">",
"     15-17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the finding of initial tubular damage does not necessarily portend progression. In a five-year follow-up study of nearly 600 Belgian individuals with initially mild evidence of tubular damage and decreasing exposure to cadmium, there was no evidence of progressive renal damage [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although research on the renal effects of cadmium has focused on tubular injury, such toxicity rarely gives rise to symptoms or clinical disease. More important is glomerular injury, which can eventually lead to a fall in glomerular filtration rate (GFR) and end-stage renal disease [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/10,19,20\">",
"     10,19,20",
"    </a>",
"    ]. Data from Japan, for example, show that individuals environmentally exposed to cadmium may have a decreased GFR [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/21\">",
"     21",
"    </a>",
"    ]. Uremia was a common cause of death among Japanese farmers suffering from Itai-Itai disease (see below) and has been observed in workers previously heavily exposed to cadmium [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, in a large cohort study from a cadmium polluted area of Sweden, the age standardized incidence rate ratio (SRR) of requiring renal replacement therapy over a 18 year period was significantly higher among those with increased exposure to cadmium [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/20\">",
"     20",
"    </a>",
"    ]. The SRR among those with low, moderate, and high cadmium exposure was 1.4, 1.9, and 2.3, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Tubular damage and dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The recognition that cadmium may result in tubular proteinuria first occurred in the 1950s [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. In severe cases of cadmium toxicity, tubular injury can also lead to one or more of the following [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/1,10,24,25\">",
"     1,10,24,25",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Renal glucosuria",
"     </li>",
"     <li>",
"      Aminoaciduria",
"     </li>",
"     <li>",
"      Renal phosphate wasting",
"     </li>",
"     <li>",
"      Hypercalciuria",
"     </li>",
"     <li>",
"      Polyuria due to decreased concentration capacity",
"     </li>",
"     <li>",
"      Diminished ability to handle an acid (NH4Cl) load",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is clearly desirable to detect the more subtle signs of cadmium nephrotoxicity to prevent progressive disease. Several highly sensitive indicators of tubular damage have been developed and used in cross-sectional and epidemiologic studies in cadmium exposed groups. The urinary excretion of &szlig;2-microglobulin, a low-molecular plasma protein having a molecular weight of 12,000 and easily detected using radioimmunoassays, has proven to be particularly useful in this setting.",
"   </p>",
"   <p>",
"    In order to appreciate the utility of urinary measurements of &szlig;2-microglobulin in detecting tubular damage due to cadmium, it is helpful to review briefly the renal handling of this protein. The concentration of &szlig;2-microglobulin in plasma is usually around 2",
"    <span class=\"nowrap\">",
"     mg/L",
"    </span>",
"    and, because of its small size, this protein is freely filtered through the glomerulus. The daily filtered load in a 70 kg man with a GFR of 180",
"    <span class=\"nowrap\">",
"     L/day",
"    </span>",
"    (125",
"    <span class=\"nowrap\">",
"     mL/min)",
"    </span>",
"    is approximately 360 mg (2",
"    <span class=\"nowrap\">",
"     mg/L",
"    </span>",
"    x 180 L). Almost all (more than 99.9 percent) of the filtered &szlig;2-microglobulin is reabsorbed, with the normal rate of urinary excretion being less than 0.3",
"    <span class=\"nowrap\">",
"     mg/day.",
"    </span>",
"    As a result, a relatively small decrease in tubular reabsorptive capacity will result in a marked increase in urinary &szlig;2-microglobulin excretion. As an example, a decrease in reabsorption from 99.95 to 99.0 percent will result in a twenty-fold increase in urinary &szlig;2-microglobulin excretion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other equally sensitive but less widely used indicators of cadmium induced tubular damage are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Retinol binding protein",
"     </li>",
"     <li>",
"      Apolipoprotein",
"     </li>",
"     <li>",
"      Human complex-forming glycoprotein (protein HC or alpha-1-microglobulin)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These plasma proteins are all filtered through the glomerulus. Other urinary markers indicative of a subtle tubulotoxic effect are increased excretion N-acetyl-&szlig;-D-glucosaminidase (NAG), an enzyme localized in lysosomes of the tubular cells, and kidney injury molecule-1 (KIM-1), a transmembrane protein expressed in proximal tubule cells after injury [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/26,27\">",
"     26,27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Glomerular damage",
"    </span>",
"    &nbsp;&mdash;&nbsp;It was observed in 1950 that cadmium exposed workers with tubular proteinuria also had a decreased GFR as measured by inulin clearance [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/22\">",
"     22",
"    </a>",
"    ]. This finding was later confirmed in additional studies of occupationally exposed workers and of environmentally exposed Japanese farmers. There is an association between the degree of tubular dysfunction, the cadmium dose, and a decrease in GFR (",
"    <a class=\"graphic graphic_figure graphicRef69587 \" href=\"UTD.htm?20/19/20797\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Some workers exposed to cadmium also have a slightly increased urinary excretion of albumin. The cause of this finding remains unclear and has been the source of debate. It could result from primary glomerular damage or decreased tubular reabsorption of the small amount of albumin that is normally filtered through the glomerulus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Nephrolithiasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies have demonstrated an increased prevalence of kidney stones among individuals occupationally exposed to cadmium [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/1,10,28\">",
"     1,10,28",
"    </a>",
"    ]. In one report, for example, a dose-response relationship was demonstrated between cumulative cadmium exposure among a group of battery workers and the age-adjusted cumulative incidence of renal calculi (",
"    <a class=\"graphic graphic_figure graphicRef74139 \" href=\"UTD.htm?1/11/1215\">",
"     figure 2",
"    </a>",
"    ). Increased urinary excretion of calcium, resulting from tubular damage, is thought to be a primary determinant of stone formation in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Dose response and renal toxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relationship between the urinary excretion of cadmium and the prevalence of renal effects has been examined in several studies. Based upon cross-sectional studies of occupationally exposed workers, it was previously suggested that 10 mcg",
"    <span class=\"nowrap\">",
"     Cd/g",
"    </span>",
"    creatinine (equal to 10 nmol",
"    <span class=\"nowrap\">",
"     Cd/mmol",
"    </span>",
"    creatinine) would be a safe level below which kidney dysfunction would rarely develop [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/31\">",
"     31",
"    </a>",
"    ]. A urinary cadmium concentration of 10",
"    <span class=\"nowrap\">",
"     mcg/g",
"    </span>",
"    creatinine roughly corresponds to a kidney cortex concentration of 200 mg",
"    <span class=\"nowrap\">",
"     Cd/kg,",
"    </span>",
"    a level long considered to be the \"critical level\" above which kidney damage may first be seen. Realizing the variation in individual susceptibility to cadmium, a document from the World Health Organization stated that renal tubular proteinuria would develop in about 10 and 50 percent of individuals with kidney cortex cadmium concentrations of 200 and 300",
"    <span class=\"nowrap\">",
"     mg/kg,",
"    </span>",
"    respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Subsequent reports however, indicate that this approach represents a serious",
"    <strong>",
"     underestimation",
"    </strong>",
"    of the risk and an overestimate of the critical concentration of cadmium in the kidney [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/5,6,14\">",
"     5,6,14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An important and frequently cited study of the general population in Belgium revealed that a significant (up to 10 percent) proportion of the environmentally-exposed population displayed evidence of cadmium induced renal dysfunction at urine cadmium concentrations exceeding a level of only 2 to 3 mcg",
"      <span class=\"nowrap\">",
"       cadmium/g",
"      </span>",
"      creatinine (or 2 to 3 nmol",
"      <span class=\"nowrap\">",
"       cadmium/mmol",
"      </span>",
"      creatinine) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      An American study of workers occupationally exposed to cadmium reported a 10 percent prevalence of tubular proteinuria among patients with urinary cadmium concentrations of 5 to 7",
"      <span class=\"nowrap\">",
"       nanomol/mmol",
"      </span>",
"      creatinine [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Results from Swedish battery workers support the findings of the American study and suggest that significant renal effects (eg, tubular proteinuria) are detected if cadmium levels are above a critical level of approximately 3",
"      <span class=\"nowrap\">",
"       nanomol/mmol",
"      </span>",
"      creatinine [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/14\">",
"       14",
"      </a>",
"      ]. Depending upon age, the prevalence of &szlig;2-microglobulinuria was 5 to 15 percent at urinary cadmium concentrations of 3",
"      <span class=\"nowrap\">",
"       nanomol/mmol",
"      </span>",
"      creatinine (",
"      <a class=\"graphic graphic_figure graphicRef74549 \" href=\"UTD.htm?0/44/719\">",
"       figure 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      In a survey of occupational and environmentally exposed individuals, the prevalence of tubular proteinuria increased at urinary cadmium concentrations of greater than 1.0",
"      <span class=\"nowrap\">",
"       nanomol/mmol",
"      </span>",
"      creatinine [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Among 820 environmentally exposed post-menopausal women (aged 53 to 64 years), cadmium levels in blood and urine were significantly associated with reduced glomerular filtration rate (estimated from serum creatinine and cystatin C) and increased markers of tubular injury; these associations were seen at a mean urinary cadmium level as low as 0.8",
"      <span class=\"nowrap\">",
"       nanomol/mmol",
"      </span>",
"      creatinine [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/33\">",
"       33",
"      </a>",
"      ]. However, associations between estimated GFR and cadmium were only recorded when smokers were included in the multiple regression analysis, which suggests that confounding from smoking may be a problem in the interpretation of the findings.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A review of the literature combined with an analysis of the risks from environmental cadmium exposure concluded that there is an extremely low margin of safety between current levels of exposure to cadmium and that which may cause renal toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/6\">",
"     6",
"    </a>",
"    ]. If the average daily intake of cadmium is increased from 15 to 30 mcg, approximately 1 percent of the adult population would be expected to develop renal tubular damage (as detected by tubular proteinuria). In certain high risk groups, such as women with poor iron stores, the percentage affected would be even higher.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Effect of age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Age influences the dose-response relationship between renal cadmium levels and renal dysfunction; older individuals are more likely to suffer from renal toxicity at a given level of cadmium exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/14\">",
"     14",
"    </a>",
"    ]. In an examination of Swedish battery workers, for example, a 10 percent prevalence of tubular proteinuria associated with a cadmium level of 1.5",
"    <span class=\"nowrap\">",
"     nanomol/mmol",
"    </span>",
"    creatinine was found in the older age group versus 5",
"    <span class=\"nowrap\">",
"     nanomol/mmol",
"    </span>",
"    creatinine in the younger subjects (",
"    <a class=\"graphic graphic_figure graphicRef74549 \" href=\"UTD.htm?0/44/719\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A number of possible reasons have been advanced as to why older individuals have a higher prevalence of renal dysfunction when exposed to cadmium:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Older individuals may have an increased cadmium body burden with age due to higher amounts of cadmium accumulated in the kidney from both occupational exposure and environmental sources (food, tobacco).",
"     </li>",
"     <li>",
"      Degenerative changes in the renal tubules with age may predispose to cadmium-induced tubular injury and accelerate the rate of cadmium-induced renal dysfunction.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Results from Belgium suggest that individuals with diabetes mellitus also have a higher risk to develop kidney dysfunction from cadmium exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     OTHER MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cadmium exposure has also been observed to cause significant toxicity of bone and the lungs, including lung cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Bone disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone disease due to prolonged exposure to cadmium was first noticed and reported among exposed individuals living in the Jinzu river basin in Japan, an area in which 150 cases have been recognized. Exposure to cadmium was caused by the use of contaminated river water for irrigation of rice fields. Cadmium toxicity resulted in Itai-Itai disease, meaning \"Ouch-ouch\" disease, an illness characterized by multiple fractures, a mixed pattern of osteoporosis and osteomalacia, and kidney damage [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/1,10,34\">",
"     1,10,34",
"    </a>",
"    ]. A few reports have described similar bone disorders in workers with kidney damage and a history of heavy exposure to cadmium [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/1,10\">",
"     1,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H53299943\">",
"    <span class=\"h3\">",
"     Association with bone mineral density and fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;A dose dependent association of cadmium exposure with osteoporosis and bone fractures has been described in numerous observational studies [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/2,3,35-42\">",
"     2,3,35-42",
"    </a>",
"    ]. These studies, which included individuals who had lower intensity cadmium exposure than those in the original case series, ascertained cadmium exposure using plasma",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    urine levels, or an estimation of dietary intake.",
"   </p>",
"   <p>",
"    The following examples illustrate the range of findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A prospective cohort of 506 individuals living in proximity to zinc smelters in Belgium underwent baseline measurement of urinary cadmium excretion with assessments of forearm bone mineral density and fracture incidence a mean of 6.6 years later [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/36\">",
"       36",
"      </a>",
"      ]. Urinary cadmium excretion was inversely correlated with future bone mineral density. In addition, a twofold higher urinary cadmium excretion was significantly associated with a 73 percent increased risk of fracture in women after controlling for other variables, and a 60 percent increased risk of height loss in men.",
"     </li>",
"     <li>",
"      A cross-sectional study of 1021 men and women who resided near or worked in two battery plants in Sweden had measurements of blood cadmium and forearm bone mineral density [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/38\">",
"       38",
"      </a>",
"      ]. Among those aged 60 years and older, blood cadmium was independently and inversely correlated with bone mineral density in women. In both men and women 60 years or older, a blood cadmium of 10",
"      <span class=\"nowrap\">",
"       nanomol/L",
"      </span>",
"      or higher was significantly associated with a threefold higher prevalence of osteomalacia (defined as a z-score less than -1) compared with those who had a blood cadmium less than 5",
"      <span class=\"nowrap\">",
"       nanomol/L.",
"      </span>",
"     </li>",
"     <li>",
"      Another cross-sectional study of 2688 women examined the association of the urine cadmium to creatinine ratio with bone mineral density and the prevalence of fractures [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/41\">",
"       41",
"      </a>",
"      ]. After controlling for potential confounders, a higher urine cadmium to creatinine ratio was significantly and inversely correlated with bone mineral density, and positively associated with the prevalence of osteoporosis. This relationship was stronger in women who had never smoked compared with women who smoked. In addition, the prevalence of fractures was twofold higher in nonsmoking women whose cadmium to creatinine ratio was greater than 0.75",
"      <span class=\"nowrap\">",
"       microg/g",
"      </span>",
"      compared with nonsmoking women whose ratio was less than 0.5",
"      <span class=\"nowrap\">",
"       microg/g.",
"      </span>",
"      By coincidence 1 nmol",
"      <span class=\"nowrap\">",
"       cadmium/mmol",
"      </span>",
"      creatinine equals 1 microg",
"      <span class=\"nowrap\">",
"       cadmium/g",
"      </span>",
"      creatinine.",
"     </li>",
"     <li>",
"      The association of estimated dietary cadmium intake and incidence of fractures was analyzed in a prospective population based cohort of Swedish men followed for 10 years [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/42\">",
"       42",
"      </a>",
"      ]. Men in the highest compared with lowest tertile of cadmium intake had an increased risk of developing a fracture (hazard ratio 1.19, 95% CI 1.06-1.34) after controlling for potential confounders.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Not all studies have found such an association. As an example, a Japanese cross-sectional study of more than 1300 individuals with long-term cadmium exposure from food reported no significant association of cadmium with bone density; however, the assessment of dietary cadmium intake in this study was potentially biased, since it did not correlate with urinary calcium excretion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H53299950\">",
"    <span class=\"h3\">",
"     Potential mechanisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although still not fully understood, the following sequential steps may result in cadmium-induced osteoporosis or osteomalacia [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/44\">",
"     44",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Cadmium initially accumulates in the kidney cortex, particularly in the tubular cells.",
"     </li>",
"     <li>",
"      Increasing accumulation of cadmium causes increasingly impaired tubular function.",
"     </li>",
"     <li>",
"      Normal activation of calcidiol to calcitriol in tubular cells is reduced.",
"     </li>",
"     <li>",
"      Lower levels of calcitriol result in decreased calcium absorption from the gut and impaired bone mineralization.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other mechanisms, however, may also be involved. A direct toxic effect from cadmium on the bone is suggested by several epidemiological studies that documented associations between cadmium exposure and lower bone mineral density in the absence of any evidence for renal tubular injury [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Lung toxicity and cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inhalation of high concentrations of cadmium-containing smoke and dusts is immediately dangerous. Shortly after exposure, a severe and (not rare) fatal chemical pneumonitis may develop. In turn, continued inhalative exposure to cadmium can give rise to obstructive lung disease and emphysema [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/1,9\">",
"     1,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are experimental and epidemiologic evidence linking exposure to cadmium to respiratory cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/45\">",
"     45",
"    </a>",
"    ]. In 1993, The International Agency for Research on Cancer concluded that inhalative cadmium should be considered a human carcinogen [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/46\">",
"     46",
"    </a>",
"    ]; this interpretation, however, has been challenged [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. Nevertheless, a summary evaluation of existing studies found that both lung cancer and kidney dysfunction should be considered \"critical effects\" from exposure to cadmium [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In an attempt to further examine the relationship between cadmium and lung cancer, an epidemiologic study was carried out in Belgium. Lung cancer incidence among 521 individuals residing in a zinc smelter area contaminated with cadmium was compared to that in 473 individuals with low environmental exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/49\">",
"     49",
"    </a>",
"    ]. Environmental contamination was confirmed by measuring cadmium concentration in the soil. During a median follow-up of 17 years, 3 and 16 lung cancers occurred in the low and high exposure areas, respectively, for an incidence of 0.4 versus 1.8 per 1000 patient years at risk, respectively. In multivariate analyses adjusted for smoking, age, and gender, the hazard ratio was 4.2 (95% CI 1.2-14) for high versus low exposure areas, respectively, and 1.7 (95% CI 1.1-2.6) for doubling of 24-hour urinary cadmium excretion. However, concomitant exposure to arsenic, a well-known human carcinogen, occurred in the exposed area. This was adjusted for in the epidemiological analyses, but the possibility for residual confounding from arsenic, or some other contaminant in the zinc smelter area, cannot be ruled out completely [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Minimizing exposure to cadmium is the most important therapeutic measure. Occupational exposure should be kept as low as technically feasible, preferably below 0.005",
"    <span class=\"nowrap\">",
"     mg/m3.",
"    </span>",
"    Exposure via food should be kept well below 30 mcg",
"    <span class=\"nowrap\">",
"     Cd/day",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is hardly any margin of safety between current levels of cadmium found in human kidneys and the levels in which early kidney dysfunction can occur in susceptible individuals. Subtle renal and bone effects are possibly already occurring in certain areas where cadmium pollution is somewhat more severe. As a result, actions aimed at decreasing pollution and human exposure from cadmium are well founded.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other than general supportive therapy, there are no specific methods available for treating acute cadmium poisoning. Although various chelating agents have been tried in animals, none has been shown to be efficient in humans. To the contrary, chelators may actually increase cadmium nephrotoxicity.",
"   </p>",
"   <p>",
"    There is also no specific therapy for the chronic kidney disease [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/10\">",
"     10",
"    </a>",
"    ]. Cadmium-induced osteomalacia has been treated with large doses of vitamin D [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     MORTALITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased mortality among Japanese farmers with proteinuria due to environmental exposure to cadmium has been observed in several epidemiologic studies [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/6,52-54\">",
"     6,52-54",
"    </a>",
"    ]. A 15-year follow-up of 3,178 inhabitants in a cadmium polluted area of Japan revealed a dose-related increase in the overall age adjusted mortality with increasing urinary excretion of &szlig;2-microglobulin [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/55\">",
"     55",
"    </a>",
"    ]. Persons with an initial examination showing urine &szlig;2-microglobulin exceeding 1 to 10",
"    <span class=\"nowrap\">",
"     mg/g",
"    </span>",
"    creatinine had more than twice the mortality compared to those with normal values (&lt;0.3",
"    <span class=\"nowrap\">",
"     mg/g",
"    </span>",
"    creatinine) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. The elevated mortality rate, in particular, is associated with cardiovascular and renal diseases [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/56,57\">",
"     56,57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Taken together, available epidemiological evidence indicate that the initial rather subtle renal effects from cadmium in the form of a tubular proteinuria eventually may develop, or at least contribute, to more severe renal diseases and increased mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24760/abstract/20,56\">",
"     20,56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/37/16978?source=see_link\">",
"       \"Patient information: Cadmium toxicity (Cadmium poisoning) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20840495\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cadmium (Cd) is a metal that can cause severe toxicity in humans. Prolonged cadmium exposure can affect a variety of organs, with the kidneys and bones being the principal targets. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Environmental cadmium contamination comes from its presence in household waste, industrial emissions, and the soil via atmospheric emissions and sewage. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Exposure to cadmium principally results from eating contaminated food, smoking cigarettes, and working in cadmium-contaminated work places. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Human exposure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      After ingestion or inhalation, cadmium is transported to the liver and binds metallothionein, a cadmium- and zinc-binding protein, preventing \"free\" cadmium ions from disturbing normal cellular functions. Metallothionein is transported to the kidneys, where it is freely filtered across the glomerulus and then reabsorbed by the proximal tubular cells. In the tubular lysosomes, metallothionein is degraded, releasing free cadmium ions into the tubular cell cytoplasm. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Metabolism of cadmium and metallothionein'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cadmium is a well established tubular toxin. The earliest sign of cadmium nephrotoxicity is tubular proteinuria. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Renal toxicity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An elevated urinary measurement of &szlig;2-microglobulin is a useful means of detecting subtle tubular damage due to cadmium. Other urinary proteins, ie, retinol binding protein, human complex-forming glycoprotein (protein HC or alpha-1-microglobulin), and enzymes such as N-acetyl-&szlig;-D-glucosaminidase (NAG) may also be used to detect early cadmium-induced tubular dysfunction. In more severe tubular injury, signs of more generalized tubular dysfunction may be apparent, such as renal glycosuria, aminoaciduria, and phosphate wasting. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Tubular damage and dysfunction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cadmium nephrotoxicity may also be characterized by a decline in glomerular filtration rate (GFR), and the severity of the GFR impairment is associated with the degree of tubular toxicity and the dose of cadmium exposure. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Glomerular damage'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cadmium exposure is associated with an increased prevalence of kidney stones, possibly due to hypercalciuria resulting from tubular damage. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Nephrolithiasis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A urinary cadmium concentration of 10",
"      <span class=\"nowrap\">",
"       microg/g",
"      </span>",
"      creatinine roughly corresponds to a concentration of cadmium in the renal cortex of 200",
"      <span class=\"nowrap\">",
"       mg/kg,",
"      </span>",
"      a level long considered to be the \"critical level\" above which kidney damage may first be seen. However, various studies have demonstrated associations of urinary cadmium concentrations of 1",
"      <span class=\"nowrap\">",
"       microg/g",
"      </span>",
"      creatinine or lower with markers of tubular injury. Older individuals may display more renal toxicity than younger individuals with similar urinary cadmium concentrations. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Dose response and renal toxicity'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Effect of age'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A dose dependent association of cadmium exposure with osteoporosis and bone fractures has been described in numerous observational studies. Cadmium exposure may also cause significant toxicity of the lungs, including lung cancer. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Bone disease'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Lung toxicity and cancer'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Since there is no specific therapy for cadmium poisoning or cadmium nephrotoxicity, prevention via minimization of cadmium exposure is of paramount importance. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Prevention'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     WHO. Cadmium. Environmental Health Criteria. WHO, Geneva, 1992, p. 280.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/2\">",
"      Schutte R, Nawrot TS, Richart T, et al. Bone resorption and environmental exposure to cadmium in women: a population study. Environ Health Perspect 2008; 116:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/3\">",
"      Nawrot T, Geusens P, Nulens TS, Nemery B. Occupational cadmium exposure and calcium excretion, bone density, and osteoporosis in men. J Bone Miner Res 2010; 25:1441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/4\">",
"      Nriagu JO, Pacyna JM. Quantitative assessment of worldwide contamination of air, water and soils by trace metals. Nature 1988; 333:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/5\">",
"      Elinder, CG, J&auml;rup, L. Cadmium exposure and health risks: Recent findings. Ambio 1996; 25:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/6\">",
"      J&auml;rup L, Berglund M, Elinder CG, et al. Health effects of cadmium exposure--a review of the literature and a risk estimate. Scand J Work Environ Health 1998; 24 Suppl 1:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/7\">",
"      Wittman R, Hu H. Cadmium exposure and nephropathy in a 28-year-old female metals worker. Environ Health Perspect 2002; 110:1261.",
"     </a>",
"    </li>",
"    <li>",
"     Elinder, CG. Uses, occurrence and intake. In: Cadmium and Health: An Epidemiologic and Toxicological Appraisal, Volume l, Friberg, L, Elinder CG, Nordberg, GF, et al (Eds), CRC Press, Florida 1985. p. 23.",
"    </li>",
"    <li>",
"     Friberg, L, Elinder, CG, Kjellstr&ouml;m, T, et al. Cadmium and health: A toxicological and epidemiologic appraisal (Vol I &mdash; Exposure, dose, and metabolism). Boca Raton, 1985, p. 209.",
"    </li>",
"    <li>",
"     Friberg, L, Elinder, CG, Kjellstr&ouml;m, T, et al. Cadmium and health: A toxicological and epidemiologic appraisal (Vol II &mdash; Effects and response). Boca Raton, 1986, p. 307.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/11\">",
"      Nogawa K, Kobayashi E, Okubo Y, Suwazono Y. Environmental cadmium exposure, adverse effects and preventive measures in Japan. Biometals 2004; 17:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/12\">",
"      Buchet JP, Lauwerys R, Roels H, et al. Renal effects of cadmium body burden of the general population. Lancet 1990; 336:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/13\">",
"      Cai SW, Yue L, Hu ZN, et al. Cadmium exposure and health effects among residents in an irrigation area with ore dressing wastewater. Sci Total Environ 1990; 90:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/14\">",
"      J&auml;rup L, Elinder CG. Dose-response relations between urinary cadmium and tubular proteinuria in cadmium-exposed workers. Am J Ind Med 1994; 26:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/15\">",
"      Roels H, Djubgang J, Buchet JP, et al. Evolution of cadmium-induced renal dysfunction in workers removed from exposure. Scand J Work Environ Health 1982; 8:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/16\">",
"      Elinder CG, Edling C, Lindberg E, et al. beta 2-Microglobulinuria among workers previously exposed to cadmium: follow-up and dose-response analyses. Am J Ind Med 1985; 8:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/17\">",
"      Mason HJ, Williams N, Armitage S, et al. Follow up of workers previously exposed to silver solder containing cadmium. Occup Environ Med 1999; 56:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/18\">",
"      Hotz P, Buchet JP, Bernard A, et al. Renal effects of low-level environmental cadmium exposure: 5-year follow-up of a subcohort from the Cadmibel study. Lancet 1999; 354:1508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/19\">",
"      J&auml;rup L, Persson B, Elinder CG. Decreased glomerular filtration rate in solderers exposed to cadmium. Occup Environ Med 1995; 52:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/20\">",
"      Hellstr&ouml;m L, Elinder CG, Dahlberg B, et al. Cadmium exposure and end-stage renal disease. Am J Kidney Dis 2001; 38:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/21\">",
"      Nogawa K. Biologic indicators of cadmium nephrotoxicity in persons with low-level cadmium exposure. Environ Health Perspect 1984; 54:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/22\">",
"      FRIBERG L. Health hazards in the manufacture of alkaline accumulators with special reference to chronic cadmium poisoning; a clinical and experimental study. Acta Med Scand Suppl 1950; 240:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/23\">",
"      BUTLER EA, FLYNN FV. The proteinuria of renal tubular disorders. Lancet 1958; 2:978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/24\">",
"      Van Vleet TR, Schnellmann RG. Toxic nephropathy: environmental chemicals. Semin Nephrol 2003; 23:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/25\">",
"      Xia X, Wang G, Peng Y, et al. The endogenous CXXC motif governs the cadmium sensitivity of the renal Na+/glucose co-transporter. J Am Soc Nephrol 2005; 16:1257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/26\">",
"      Mueller PW, Smith SJ, Steinberg KK, Thun MJ. Chronic renal tubular effects in relation to urine cadmium levels. Nephron 1989; 52:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/27\">",
"      Prozialeck WC, Vaidya VS, Liu J, et al. Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity. Kidney Int 2007; 72:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/28\">",
"      J&auml;rup L, Elinder CG. Incidence of renal stones among cadmium exposed battery workers. Br J Ind Med 1993; 50:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/29\">",
"      Scott R, Patterson PJ, Burns R, et al. Hypercalciuria related to cadmium exposure. Urology 1978; 11:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/30\">",
"      Wu X, Jin T, Wang Z, et al. Urinary calcium as a biomarker of renal dysfunction in a general population exposed to cadmium. J Occup Environ Med 2001; 43:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/31\">",
"      Bernard A, Buchet JP, Roels H, et al. Renal excretion of proteins and enzymes in workers exposed to cadmium. Eur J Clin Invest 1979; 9:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/32\">",
"      J&auml;rup L, Hellstr&ouml;m L, Alfv&eacute;n T, et al. Low level exposure to cadmium and early kidney damage: the OSCAR study. Occup Environ Med 2000; 57:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/33\">",
"      Akesson A, Lundh T, Vahter M, et al. Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ Health Perspect 2005; 113:1627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/34\">",
"      Kido T, Nogawa K, Yamada Y, et al. Osteopenia in inhabitants with renal dysfunction induced by exposure to environmental cadmium. Int Arch Occup Environ Health 1989; 61:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/35\">",
"      J&auml;rup L, Alfv&eacute;n T, Persson B, et al. Cadmium may be a risk factor for osteoporosis. Occup Environ Med 1998; 55:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/36\">",
"      Staessen JA, Roels HA, Emelianov D, et al. Environmental exposure to cadmium, forearm bone density, and risk of fractures: prospective population study. Public Health and Environmental Exposure to Cadmium (PheeCad) Study Group. Lancet 1999; 353:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/37\">",
"      Alfv&eacute;n T, Elinder CG, Carlsson MD, et al. Low-level cadmium exposure and osteoporosis. J Bone Miner Res 2000; 15:1579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/38\">",
"      Alfv&eacute;n T, J&auml;rup L, Elinder CG. Cadmium and lead in blood in relation to low bone mineral density and tubular proteinuria. Environ Health Perspect 2002; 110:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/39\">",
"      Akesson A, Bjellerup P, Lundh T, et al. Cadmium-induced effects on bone in a population-based study of women. Environ Health Perspect 2006; 114:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/40\">",
"      Alfv&eacute;n T, Elinder CG, Hellstr&ouml;m L, et al. Cadmium exposure and distal forearm fractures. J Bone Miner Res 2004; 19:900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/41\">",
"      Engstr&ouml;m A, Micha&euml;lsson K, Suwazono Y, et al. Long-term cadmium exposure and the association with bone mineral density and fractures in a population-based study among women. J Bone Miner Res 2011; 26:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/42\">",
"      Thomas LD, Micha&euml;lsson K, Julin B, et al. Dietary cadmium exposure and fracture incidence among men: a population-based prospective cohort study. J Bone Miner Res 2011; 26:1601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/43\">",
"      Horiguchi H, Oguma E, Sasaki S, et al. Environmental exposure to cadmium at a level insufficient to induce renal tubular dysfunction does not affect bone density among female Japanese farmers. Environ Res 2005; 97:83.",
"     </a>",
"    </li>",
"    <li>",
"     Kjellstr&ouml;m, T. Mechanism and epidemiology of bone effects of cadmium. In: Toxicity and Carcinogenicity of Cadmium in the Human Environment - an International Symposium, Nordberg, GF, Herber, RFM, Alessio, L (Eds), 1992, p. 301.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/45\">",
"      Takenaka S, Oldiges H, K&ouml;nig H, et al. Carcinogenicity of cadmium chloride aerosols in W rats. J Natl Cancer Inst 1983; 70:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/46\">",
"      IARC. Monographs. Cadmium and cadmium compounds. IARC Monogr Eval Carcinog Risks Hum 1993; 58:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/47\">",
"      Doll R. Is cadmium a human carcinogen? Ann Epidemiol 1992; 2:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/48\">",
"      J&auml;rup L, Bellander T, Hogstedt C, Sp&aring;ng G. Mortality and cancer incidence in Swedish battery workers exposed to cadmium and nickel. Occup Environ Med 1998; 55:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/49\">",
"      Nawrot T, Plusquin M, Hogervorst J, et al. Environmental exposure to cadmium and risk of cancer: a prospective population-based study. Lancet Oncol 2006; 7:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/50\">",
"      Nordberg GF. Lung cancer and exposure to environmental cadmium. Lancet Oncol 2006; 7:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/51\">",
"      Satarug S, Haswell-Elkins MR, Moore MR. Safe levels of cadmium intake to prevent renal toxicity in human subjects. Br J Nutr 2000; 84:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/52\">",
"      Nishijo M, Nakagawa H, Morikawa Y, et al. Prognostic factors of renal dysfunction induced by environmental cadmium pollution. Environ Res 1994; 64:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/53\">",
"      Iwata K, Saito H, Moriyama M, Nakano A. Follow up study of renal tubular dysfunction and mortality in residents of an area polluted with cadmium. Br J Ind Med 1992; 49:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/54\">",
"      Nishijo M, Nakagawa H, Morikawa M, et al. Relationship between urinary cadmium and mortality among inhabitants living in a cadmium polluted area in Japan. Toxicol Lett 1999; 108:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/55\">",
"      Nishijo M, Nakagawa H, Morikawa Y, et al. Mortality in a cadmium polluted area in Japan. Biometals 2004; 17:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/56\">",
"      Nishijo M, Morikawa Y, Nakagawa H, et al. Causes of death and renal tubular dysfunction in residents exposed to cadmium in the environment. Occup Environ Med 2006; 63:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24760/abstract/57\">",
"      Nishijo M, Nakagawa H, Morikawa Y, et al. Mortality of inhabitants in an area polluted by cadmium: 15 year follow up. Occup Environ Med 1995; 52:181.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7202 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.25.216.6-3A7D25EF8E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_11_24760=[""].join("\n");
var outline_f24_11_24760=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20840495\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HUMAN EXPOSURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Food intake",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Smoking",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Occupational exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      METABOLISM OF CADMIUM AND METALLOTHIONEIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      RENAL TOXICITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Tubular damage and dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Glomerular damage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Nephrolithiasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Dose response and renal toxicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Effect of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      OTHER MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Bone disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H53299943\">",
"      - Association with bone mineral density and fractures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H53299950\">",
"      - Potential mechanisms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Lung toxicity and cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      MORTALITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20840495\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7202\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7202|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/19/20797\" title=\"figure 1\">",
"      The effect of cadmium exposure on renal function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/11/1215\" title=\"figure 2\">",
"      The effect of cadmium on renal stone risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/44/719\" title=\"figure 3\">",
"      The effect of age on cadmium-induced nephrotoxicity",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/37/16978?source=related_link\">",
"      Patient information: Cadmium toxicity (Cadmium poisoning) (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_11_24761="Gestational trophoblastic disease: Epidemiology, clinical manifestations and diagnosis";
var content_f24_11_24761=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Gestational trophoblastic disease: Epidemiology, clinical manifestations and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/11/24761/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/11/24761/contributors\">",
"     Jing Wang Chiang, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/11/24761/contributors\">",
"     Jonathan S Berek, MD, MMS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/11/24761/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/11/24761/contributors\">",
"     Barbara Goff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/11/24761/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/11/24761/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/11/24761/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gestational trophoblastic disease (GTD) is a proliferative disorder of trophoblastic cells. It defines a heterogeneous group of interrelated lesions arising from the trophoblastic epithelium of the placenta. All forms of GTD are characterized by a distinct tumor marker, the beta subunit of human chorionic gonadotropin (hCG). The pathogenesis of GTD is unique because the maternal tumor arises from gestational rather than maternal tissue.",
"   </p>",
"   <p>",
"    There are several histologically distinct types of GTD (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/31/13816?source=see_link\">",
"     \"Gestational trophoblastic disease: Pathology\"",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hydatidiform mole (complete or partial)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Persistent/invasive",
"      </span>",
"      gestational trophoblastic neoplasia (GTN)",
"     </li>",
"     <li>",
"      Choriocarcinoma",
"     </li>",
"     <li>",
"      Placental site trophoblastic tumors",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Complete and partial hydatidiform moles are noninvasive, localized tumors that develop as a result of an aberrant fertilization event that leads to a proliferative process. They comprise 90 percent of GTD cases. The other three categories of GTD represent malignant disease because of their potential for local invasion and metastases. Malignant GTD can develop from a molar pregnancy or can arise after any gestational experience: spontaneous or induced abortion, ectopic pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/3,4\">",
"     3,4",
"    </a>",
"    ], or preterm and term pregnancy. Malignant transformation of trophoblastic tissue is probably related to activation of oncogenes and inactivation of tumor suppressor genes.",
"   </p>",
"   <p>",
"    The epidemiology, clinical manifestations, and diagnosis of GTD will be reviewed here. The pathology, staging, and treatment of GTD are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/31/13816?source=see_link\">",
"     \"Gestational trophoblastic disease: Pathology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/30/23015?source=see_link\">",
"     \"Gestational trophoblastic disease: Management of hydatidiform mole\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42234?source=see_link\">",
"     \"Gestational trophoblastic neoplasia: Staging and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of GTD varies widely in different regions of the world [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/5\">",
"     5",
"    </a>",
"    ]. The incidence of hydatidiform mole ranges from 23 to 1299 cases per 100,000 pregnancies, while malignant GTD is less common. North American and European countries tend to report low or intermediate rates of disease (1 per 1000 to 1500 pregnancies), whereas Asian and Latin American nations often have high rates (1 per 12 to 500 pregnancies).",
"   </p>",
"   <p>",
"    One reason for this variation is that epidemiologic data on GTD are limited by the rarity of the disease and inaccurate ascertainment of the number of cases as a function of the number of gestational events in the population. As an example, the incidence of GTD has been inflated in some reports by not taking into account a large number of births that occurred at home or outside the referral center [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. In addition, differences in diet, such as deficiencies in carotene and animal fat, also may contribute to these variations [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two main risk factors for GTD are extremes of maternal age (over age 35 years) and a history of previous GTD [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/8-11\">",
"     8-11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Extremes of age &mdash; The most well-established risk factor for GTD is maternal age. Compared to the risk of GTD in the general population of reproductive-age women, the risk is significantly increased in those older than age 35 and slightly increased in those under age 20 [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/6,8,12-16\">",
"       6,8,12-16",
"      </a>",
"      ]. Nevertheless, most cases of GTD occur in women under age 35 because of the greater number of pregnancies among younger women. Paternal age does not appear to influence the risk of GTD.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Assisted reproductive technology has enhanced the fertility potential of older women, which may increase the proportion of cases in this age group. This is of concern because malignant sequelae occur more frequently in older patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/6,17\">",
"     6,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      History of previous GTD &mdash; Studies from the United States and England have found that women with a history of one molar pregnancy (partial, complete, or persistent GTN) have an approximately 1 percent chance of recurrence in subsequent pregnancies (compared to a 0.1 percent incidence in the general population of the United States) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/18-22\">",
"       18-22",
"      </a>",
"      ]. The recurrence rate is much higher after two molar pregnancies (16 to 28 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/20-22\">",
"       20-22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other risk factors that have been associated with GTD include current smoking (&gt;15 cigarettes per day), maternal blood type AB, A, or B, history of infertility, nulliparity, and use of oral contraceptives (however, oral contraceptives do not increase the risk of developing postmolar GTD [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/23\">",
"     23",
"    </a>",
"    ]) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/5,8,10,13,24,25\">",
"     5,8,10,13,24,25",
"    </a>",
"    ]. The mechanism for these associations has not been explained and increased risk has not been demonstrated consistently. Populations with deficiency in vitamin A also have an increased incidence of GTD [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical manifestations of GTD include, in decreasing order of frequency:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Vaginal bleeding",
"     </li>",
"     <li>",
"      Enlarged uterus",
"     </li>",
"     <li>",
"      Pelvic pressure or pain",
"     </li>",
"     <li>",
"      Theca lutein cysts",
"     </li>",
"     <li>",
"      Anemia",
"     </li>",
"     <li>",
"      Hyperemesis gravidarum",
"     </li>",
"     <li>",
"      Hyperthyroidism",
"     </li>",
"     <li>",
"      Preeclampsia before 20 weeks of gestation",
"     </li>",
"     <li>",
"      Vaginal passage of hydropic vesicles",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Women with GTD who present with these clinical features are often misdiagnosed. Since pregnancy is by far the most common source of human chorionic gonadotropin (hCG), clinicians most often initially suspect a pregnancy complication (threatened or missed abortion, ectopic pregnancy) rather than GTD in women who present with vaginal bleeding, an enlarged uterus, and pelvic discomfort and have a positive pregnancy test.",
"   </p>",
"   <p>",
"    Clinical hyperthyroidism develops in approximately 5 percent of women with GTD [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/26\">",
"     26",
"    </a>",
"    ]. As noted above, hCG has thyroid-stimulating activity; the development of hyperthyroidism requires the elevation of hCG &gt;200,000",
"    <span class=\"nowrap\">",
"     mIU/mL",
"    </span>",
"    for several weeks. GTD-associated hyperthyroidism will resolve with treatment of the GTD. Some patients will require antithyroid therapy until GTD treatment is complete. The criteria for treatment and approach to therapy are the same as for other hCG-mediated hyperthyroidism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/48/42760?source=see_link\">",
"     \"Hyperthyroidism during pregnancy: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Hydatidiform mole",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complete and partial moles occur after aberrant fertilization with proliferation of trophoblastic tissue, not after a clinical pregnancy (spontaneous or induced abortion, ectopic pregnancy, or preterm or term pregnancy). Women with this disorder typically present to their obstetrical provider with missed menstrual periods, a positive pregnancy test, and signs and symptoms consistent with early pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/1,2,27,28\">",
"     1,2,27,28",
"    </a>",
"    ]. Vaginal bleeding, which results from separation of the tumor from the underlying decidua, is common and often initially attributed to threatened abortion.",
"   </p>",
"   <p>",
"    Characteristics of complete versus partial hydatidiform more are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef75598 \" href=\"UTD.htm?13/63/14332\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Complete hydatidiform mole",
"    </span>",
"    &nbsp;&mdash;&nbsp;A complete mole is a result of fertilization of an empty ovum by two sperms or a single sperm that duplicates, resulting in a 46 XX or 46 XY karyotype. The presence of a complete mole (which lacks a fetus) often leads to excessive uterine size for the expected \"gestational age\" (number of weeks since the last normal menstrual period). Uterine enlargement is due to the tumor itself",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    intrauterine hemorrhage with retained clot.",
"   </p>",
"   <p>",
"    The marked elevation in serum hCG associated with a complete mole can lead to complications. These include ovarian enlargement due to theca lutein cysts; hyperemesis gravidarum; early development of preeclampsia (before 20 weeks of gestation); and hyperthyroidism, which is most often subclinical [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/29-32\">",
"     29-32",
"    </a>",
"    ]. These complications occur in approximately 25 percent of patients with uterine size greater than 14 to 16 weeks of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is considerable homology between the beta-subunits of hCG and TSH. As a result, hCG has weak thyroid-stimulating activity. In one human thyroid cell-culture assay, 1 mcU of hCG was equivalent to 0.0013 mcU of TSH [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/34\">",
"     34",
"    </a>",
"    ]. Activity has varied in other assays, and abnormal forms of hCG, such as partially desialylated forms, tend to have greater thyroid-stimulating activity. Unlike patients with Graves' hyperthyroidism, patients with GTD usually do not have a high serum",
"    <span class=\"nowrap\">",
"     T3/T4",
"    </span>",
"    ratio, probably because of the severe nonthyroidal illness caused by the tumor, and they do not have ophthalmopathy.",
"   </p>",
"   <p>",
"    Theca lutein cysts are a form of ovarian hyperstimulation resulting from high circulating levels of hCG that are associated with GTD. These cysts are multiloculated, often bilateral, and resolve a few weeks or months after treatment of GTD.",
"   </p>",
"   <p>",
"    The routine availability of both ultrasonography and sensitive quantitative measurement of the serum concentration of the beta subunit of hCG has led to earlier diagnosis of GTD, often before complications are manifested. The change in clinical presentation of GTD since routine availability of ultrasonography in the 1980s can be illustrated by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one report, 74 women with complete hydatidiform mole diagnosed between 1988 and 1993 (study group) were compared with 306 historic controls diagnosed between 1965 and 1975 [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/2\">",
"       2",
"      </a>",
"      ]. Vaginal bleeding was the most common presenting symptom in both groups (84 and 97 percent in the study group and historic controls, respectively). Compared with historic controls, women in the study group showed substantial reductions in the prevalence of anemia (5 versus 54 percent), excessive uterine size (28 versus 51 percent), preeclampsia (1 versus 27 percent), and hyperemesis (8 versus 26 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ten percent of women in the study group had a sonographic diagnosis made before the onset of symptoms. Despite this, the incidence of malignant GTD was not reduced by early diagnosis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A second study compared cases of complete hydatidiform mole diagnosed from 1994 and 1997 (study group) to those diagnosed from 1969 to 1975 (historic controls) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/27\">",
"       27",
"      </a>",
"      ]. Compared with historic controls, the mean gestational age at evacuation of women in the study group was significantly earlier (8.5 versus 17 weeks) and the pathologic changes were less pronounced.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Partial hydatidiform mole",
"    </span>",
"    &nbsp;&mdash;&nbsp;A partial mole is the result of fertilization of a haploid ovum by two sperm or duplication of one sperm, resulting in a triploid karyotype (69 XXY, 69 XXX, 69 XYY). Partial moles are the only type of GTD that are associated with the presence of a fetus, and fetal cardiac activity may be detected. However, there is a high rate of intrauterine death related to triploidy. Thus, a partial mole is often misdiagnosed as an incomplete or missed abortion and the correct diagnosis of GTD is made only after histologic review of the surgical specimen [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/35\">",
"     35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/31/13816?source=see_link\">",
"     \"Gestational trophoblastic disease: Pathology\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These pregnancies are infrequently associated with excessive uterine size, ovarian enlargement, preeclampsia, hyperemesis, or hyperthyroidism because hCG levels are generally lower than those observed with a complete mole. As an example, a review of 81 women with a partial hydatidiform mole found that only five had excessive uterine size or preeclampsia and only two of 30 had serum hCG concentrations above 100,000",
"    <span class=\"nowrap\">",
"     mIU/mL,",
"    </span>",
"    which are common findings in complete molar pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/35\">",
"     35",
"    </a>",
"    ]. Partial moles are less likely to become malignant.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Malignant GTD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignant GTD can develop after molar or nonmolar pregnancies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     After a molar pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persistent GTN is typically diagnosed in asymptomatic women undergoing routine hCG monitoring after evacuation of a molar pregnancy, accounting for greater than 90 percent of malignant GTN. Rates of persistent disease are 15 to 20 percent after a complete mole, and 3 to 5 percent after a partial mole. While GTN is rare after a partial mole, both localized or metastatic disease can occur [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/36\">",
"     36",
"    </a>",
"    ]. The most common symptom is vaginal bleeding. Uterine rupture resulting in hemoperitoneum is rare, but may occur in patients who do not comply with recommended follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 15 percent of patients have localized disease after evacuation of a molar pregnancy and another 4 percent have metastatic disease [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/1\">",
"     1",
"    </a>",
"    ]. Most cases of localized GTN are due to invasive mole, but a few are due to choriocarcinoma, which may be localized at presentation. Metastatic disease is virtually always due to choriocarcinoma as metastasis of invasive mole occurs, but is uncommon. Placental site trophoblastic tumors are rare.",
"   </p>",
"   <p>",
"    Characteristics that increase the likelihood of GTN after molar evacuation include large theca lutein cysts (&ge;6 cm), excessively enlarged uterus for dates, age over 40, previous GTD, initial hCG &gt;100,000",
"    <span class=\"nowrap\">",
"     mIU/mL,",
"    </span>",
"    the presence of hyperplasia or atypia on histology, and heterozygosity (dispermic moles) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/38-45\">",
"     38-45",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/30/23015?source=see_link\">",
"     \"Gestational trophoblastic disease: Management of hydatidiform mole\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Large theca lutein cysts are particularly worrisome. In one series, GTN developed after a molar pregnancy in 50 to 75 percent of patients whose ovaries were larger than 5 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. Infection, hemorrhage, or rupture of the cysts complicate theca lutein cysts in approximately 3 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     After a nonmolar pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignant GTD after a nonmolar pregnancy is diagnosed histologically or clinically by plateau or rise in hCG. &nbsp;The diagnosis is virtually always choriocarcinoma, rarely a placental site trophoblastic tumor (PSTT).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Choriocarcinoma &mdash; Choriocarcinoma arising from cytotrophoblast occurs in approximately 1 in 16,000 normal gestations, 1 in 15,000 abortions, and 1 in 40 complete molar pregnancies. About 50 percent of cases of choriocarcinoma arise from complete hydatidiform mole, an additional 25 percent arise after normal pregnancies, and 25 percent follow spontaneous abortion or ectopic pregnancy (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef59971 \" href=\"UTD.htm?23/3/23604\">",
"       image 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Choriocarcinoma is the most aggressive GTN, and is characterized by early vascular invasion and widespread metastases. Irregular vaginal bleeding is the most frequent symptom. The typical clinical presentation is late postpartum bleeding, which persists beyond the usual six to eight weeks. Primary or secondary postpartum hemorrhage are other common presentations [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/46\">",
"     46",
"    </a>",
"    ]. However, abnormal vaginal bleeding may develop a year or more after an antecedent pregnancy. Hemorrhage can be severe if the tumor erodes through the myometrium or uterine vessels [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Respiratory symptoms (eg, cough, chest pain, hemoptysis) or signs of gastrointestinal, urologic, and intracerebral bleeding are indicative of metastatic disease. Hepatic involvement from advanced disease may cause epigastric or right upper quadrant pain.",
"   </p>",
"   <p>",
"    Physical examination often reveals an enlarged uterus and bilateral ovarian cysts. Vaginal metastases are present in about 30 percent of cases; these lesions are very vascular and prone to bleeding; they may also become infected.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Placental site trophoblastic tumors &mdash; Placental site trophoblastic tumors (PSTT) are rare, slowly-growing malignant tumors that are derived from intermediate cytotrophoblast cells that are present in the placenta (unlike choriocarcinoma, which arises from villous trophoblast). They account for &lt;0.2 percent of all cases of GTD [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    PSTT generally present months to years after a term gestation. Irregular vaginal bleeding and an enlarged uterus are common, amenorrhea or virilization may occur, and nephrotic syndrome has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/50-55\">",
"     50-55",
"    </a>",
"    ]. Compared to the other GTDs, the serum hCG concentration in PSTT is relatively low relative to the tumor volume [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/56\">",
"     56",
"    </a>",
"    ]. More than 30 percent of patients already have metastases at presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/49,57\">",
"     49,57",
"    </a>",
"    ]. Lymph node metastases occur in 6 percent of women with PSTT [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The possibility of GTD should be considered in any premenopausal woman with abnormal vaginal bleeding. An hCG level should be obtained and, if elevated, ultrasound examination is indicated. First, an existing pregnancy (normal intrauterine pregnancy, ectopic pregnancy, spontaneous abortion) is ruled out. Malignant GTD is a rare cause of postmenopausal bleeding. A complete history, physical examination, and metastatic work-up are essential for optimal management.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Human chorionic gonadotropin",
"    </span>",
"    &nbsp;&mdash;&nbsp;HCG is a family of pituitary and placental glycoprotein hormones that share the same alpha subunit and differs in the beta subunit from follicle stimulating hormone, luteinizing hormone, and thyroid stimulating hormone. Different assays detect intact or fragments of beta-hCG by enzyme linked sandwich assays (radioimmunoassay). The serum hCG concentration is always elevated in women with GTD and is usually higher than that observed with intrauterine or ectopic pregnancies of the same gestational age. About 40 percent of complete moles are associated with hCG levels &gt;100,000",
"    <span class=\"nowrap\">",
"     mIU/mL",
"    </span>",
"    (normal nonpregnant &lt;5",
"    <span class=\"nowrap\">",
"     mIU/mL",
"    </span>",
"    and peak normal pregnancy level typically &lt;100,000",
"    <span class=\"nowrap\">",
"     mIU/mL).",
"    </span>",
"    Compared to other types of GTD, PSTT is associated with lower levels of hCG relative to tumor size because of the lack of syncytiotrophoblastic proliferation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/49,56\">",
"     49,56",
"    </a>",
"    ]. In one report of 62 patients with PSTT, serum levels of hCG were raised in all patients, but in 41 (69 percent), the level was only moderately increased (&lt;1000",
"    <span class=\"nowrap\">",
"     mIU/mL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/31/13816?source=see_link\">",
"     \"Gestational trophoblastic disease: Pathology\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Falsely elevated hCG can occur due to heterophilic antibodies in the assay. This is due to human anti-mouse Ab (HAMA), reacting with mouse Ab used in assays. It does not pass into urine so hCG should be negative. Another way to rule out this lab error is to retest with another type of assay that uses serial dilutions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Ultrasound findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;An ultrasound examination is used to assess a pregnancy can detect the characteristic sonographic appearance of GTD. However, molar pregnancies are frequently misdiagnosed as an incomplete or missed abortion. This was illustrated in a series of 1053 consecutive patients referred to a trophoblastic disease center with a diagnosis of possible or probable hydatidiform mole in whom results of preevacuation ultrasound examination and postoperative histology were correlated [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/59\">",
"     59",
"    </a>",
"    ]. The sensitivity of routine preevacuation ultrasound examination for detection of hydatidiform mole of any type was only 44 percent, and specificity was 74 percent.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complete mole &mdash; Sonographic features suggestive of a complete hydatidiform mole include, but are not limited to [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/60\">",
"       60",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The absence of an embryo or fetus",
"     </li>",
"     <li>",
"      No amniotic fluid",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Central heterogeneous mass with numerous discrete anechoic spaces, which correspond to diffuse hydatidiform swelling of the hydropic chorionic villi. This has classically been described as a \"snowstorm pattern\" on older ultrasounds (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef66877 graphicRef57523 \" href=\"UTD.htm?18/37/19032\">",
"       image 2A-B",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Theca lutein cysts (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef70450 \" href=\"UTD.htm?38/39/39540\">",
"       image 3",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The small cystic areas correspond to the hydropic villi, which are one of the characteristic gross and microscopic pathological findings. The sonographic appearance of complete mole is variable. There may be a large, central fluid collection that mimics an anembryonic gestation (missed or incomplete abortion) or a central mass of variable echogenicity without anechoic spaces, presumably because the hydropic villi are too small to visualize sonographically.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Partial mole &mdash; Sonographic features suggestive of a partial molar pregnancy include, but are not limited to (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef52538 graphicRef79947 \" href=\"UTD.htm?18/25/18840\">",
"       image 4A-B",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/61\">",
"       61",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A fetus is present, may be viable, and is often growth restricted",
"     </li>",
"     <li>",
"      Amniotic fluid is present, but may be reduced",
"     </li>",
"     <li>",
"      Focal anechoic spaces",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      increased echogenicity of chorionic villi (swiss cheese pattern)",
"     </li>",
"     <li>",
"      Increased transverse diameter of the gestational sac",
"     </li>",
"     <li>",
"      Theca lutein cysts are usually absent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ultrasound incorrectly diagnoses partial mole as a missed or incomplete abortion in 15 to 60 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/59,62\">",
"     59,62",
"    </a>",
"    ]. These misdiagnoses are more common for partial mole than for other types of GTD because only partial moles are associated with a fetus and amniotic fluid. When a fetus is present, it can be particularly challenging to distinguish partial moles from a complete mole with a normal twin.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Invasive mole &mdash; Invasive mole typically appears as one or more poorly defined masses in the uterus with anechoic areas. Color Doppler of the anechoic areas reveals high vascular flow. Invasion into the myometrium may be visualized.",
"     </li>",
"     <li>",
"      Choriocarcinoma and PSTT &mdash; Choriocarcinoma appears as a mass enlarging the uterus, with a heterogeneous appearance that correlates with areas of necrosis and hemorrhage (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef75900 \" href=\"UTD.htm?17/0/17412\">",
"       image 5",
"      </a>",
"      ). The tumor is usually markedly hypervascular on color Doppler (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef52443 \" href=\"UTD.htm?18/21/18774\">",
"       image 6",
"      </a>",
"      ). The tumor may extend into the parametrium.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    PSTT also appears as a hyperechoic-intrauterine mass, usually with less hemorrhage than observed with choriocarcinoma. Both cystic and solid lesions areas can be present, with or without a central component. The mass usually invades the myometrial wall.",
"   </p>",
"   <p>",
"    GTD lesions are highly vascular and can be associated with arterial-venous malformations (AVM) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef56972 graphicRef64599 \" href=\"UTD.htm?12/50/13097\">",
"     image 7A-B",
"    </a>",
"    ). Thus, hemorrhage is common, especially with repeated trauma by dilation and curettage. Life-threatening hemorrhage may necessitate embolization or hysterectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Complete and partial mole",
"    </span>",
"    &nbsp;&mdash;&nbsp;When complete or partial mole is suspected based upon sonographic findings and hCG determination, the diagnosis must be confirmed by histologic examination of tissue. The accuracy of histologic diagnosis is further enhanced by flow cytometry to determine the karyotype [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/64-66\">",
"     64-66",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/31/13816?source=see_link&amp;anchor=H8#H8\">",
"     \"Gestational trophoblastic disease: Pathology\", section on 'Genetics'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tissue is obtained by evacuation of the uterine contents by suction curettage. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/30/23015?source=see_link\">",
"     \"Gestational trophoblastic disease: Management of hydatidiform mole\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Twin pregnancy may be complicated by GTD: either a mole (partial or complete) and a viable fetus or two moles. The diagnosis of mole is suggested by ultrasound examination and confirmed by cytogenetic studies and histopathologic examination. Management of women with a viable fetus is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/30/23015?source=see_link&amp;anchor=H12#H12\">",
"     \"Gestational trophoblastic disease: Management of hydatidiform mole\", section on 'Coexistent viable fetus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Malignant disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment for invasive mole or choriocarcinoma is generally the same; both are usually treated with chemotherapy. Therefore, an exact histologic diagnosis is not usually required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     After a molar pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;hCG levels should be monitored serially after treatment of a molar pregnancy. In a representative study, the average times to normalization of serum hCG after a complete or partial mole were 99 and 59 days, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/67\">",
"     67",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/30/23015?source=see_link\">",
"     \"Gestational trophoblastic disease: Management of hydatidiform mole\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    According to FIGO criteria, the presence of persistent (malignant) GTD after evacuation of a complete or partial molar pregnancy should be suspected if any of the following is present [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/68\">",
"     68",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A serum hCG concentration that plateaus (decline of less than 10 percent for at least four values over three weeks)",
"     </li>",
"     <li>",
"      A serum hCG concentration that rises (increase more than 10 percent of three values over two consecutive weeks eg, day 1, 7, 14)",
"     </li>",
"     <li>",
"      Persistence of detectable serum hCG for more than six months after molar evacuation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Approximately 90 percent of these cases represent invasive mole, and &lt;10 percent are choriocarcinomas; PSTTs are rare.",
"   </p>",
"   <p>",
"    The presence of metastatic disease usually implies the presence of choriocarcinoma rather than invasive mole. A repeat suction curettage has attendant risks, such as uterine perforation or life-threatening hemorrhage. In addition, invasion can be difficult to diagnose microscopically because the samples obtained by curettage may not contain the intact myometrium required for this assessment; hysterectomy is usually necessary for histologic diagnosis. A histologic diagnosis is not necessary because the treatment is the same for both invasive mole and choriocarcinoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42234?source=see_link\">",
"     \"Gestational trophoblastic neoplasia: Staging and treatment\"",
"    </a>",
"    .) However if PSTT is suspected based on large mass associated with low hCG levels, histologic diagnosis may change management to surgical removal as it is highly resistant to chemotherapy.",
"   </p>",
"   <p>",
"    Ectopic or intrauterine pregnancy must also be ruled out as part of the evaluation by serial hCG levels and ultrasounds. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44808?source=see_link\">",
"     \"Clinical manifestations and diagnosis of early pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     After a nonmolar pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum hCG values typically return to normal within two to four weeks after a delivery or abortion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/69-73\">",
"     69-73",
"    </a>",
"    ]. Persistent elevation of serum hCG levels after a nonmolar pregnancy (eg, abortion or ectopic or",
"    <span class=\"nowrap\">",
"     preterm/term",
"    </span>",
"    pregnancy) is always due to choriocarcinoma or PSTT [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum hCG monitoring is not routinely performed after nonmolar pregnancies, unless the patient has had a previous molar pregnancy. Women who develop GTD after a nonmolar pregnancy usually undergo evaluation with serum hCG and ultrasound only after they become symptomatic, which may be months to years after the pregnancy. Thus, it may not be clear whether GTD is a new event (complete or partial mole) or malignant sequelae (choriocarcinoma or PSTT) of the antecedent pregnancy. Therefore, histologic confirmation of ultrasound findings that are suggestive of malignant GTD is required unless there is evidence of metastatic disease, in which case the possibility of a complete or partial hydatidiform mole is excluded.",
"   </p>",
"   <p>",
"    <span class=\"nowrap\">",
"     Intrauterine/ectopic",
"    </span>",
"    pregnancy and germ cell tumors of the ovary should also be excluded. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/37/5721?source=see_link\">",
"     \"Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rarely, a persistent low level of hCG is seen and the origin is unclear. The percentage hyperglycosylated hCG (hCG-H) may be a sensitive new tumor marker for active GTD. It may be useful for earlier diagnosis of active disease and to distinguish active from quiescent GTD so that unnecessary chemotherapy or surgical intervention can be avoided. Interventions such as hysterectomy or chemotherapy can be held if the proportion of hyperglycosylated hCG is &lt;40 percent, until levels increase to &gt;3000",
"    <span class=\"nowrap\">",
"     IU/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/74,75\">",
"     74,75",
"    </a>",
"    ]. This promising marker deserves further study. In the meantime, recommendation is to exclude heterophile antibodies, rule out clinical evidence of disease, and to follow the patient closely with hCG, then to treat only when a sustained rise in total hCG is observed.",
"   </p>",
"   <p>",
"    PSTT is rare but should be considered in women with an intrauterine mass and persistently low elevations in serum hCG levels (often less than 100",
"    <span class=\"nowrap\">",
"     mIU/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/74\">",
"     74",
"    </a>",
"    ]) after a normal term pregnancy. However, PSTT usually presents years after an antecedent gestational event. It can be challenging distinguishing PSTT from quiescent GTD or inactive choriocarcinoma. The percentage of the free beta-subunit of total hCG has been found to be the main form of hCG in PSTT compared to other forms of GTD. This may be a useful method of making the diagnosis without pathology, so that appropriate intervention can be initiated [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One may consider diagnostic suction curettage to assist in counseling the patient regarding possible hysterectomy, which is the treatment of choice for this disorder in the absence of metastatic disease (in contrast to other forms of malignant GTD which are treated with chemotherapy). A risk to this approach is that massive bleeding following dilation and curettage has been reported in the hypervascular type of PSTT. Thus, we try to avoid diagnostic curettage when prominent vascularity of suspected PSTT is found sonographically [",
"    <a class=\"abstract\" href=\"UTD.htm?24/11/24761/abstract/50,77-79\">",
"     50,77-79",
"    </a>",
"    ]. Since PSTT is so rare, excluding this diagnosis is not usually clinically important. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42234?source=see_link\">",
"     \"Gestational trophoblastic neoplasia: Staging and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complete and partial hydatidiform moles are usually benign forms of gestational trophoblastic disease (GTD). These tumors develop as a result of an aberrant fertilization event leading to proliferative trophoblastic tissue. Invasive mole, choriocarcinoma, and placental site trophoblastic tumors are malignant. All can develop after a molar pregnancy, but choriocarcinoma and placental site trophoblastic tumor (PSTT) also occur after spontaneous or induced abortion, ectopic pregnancy, or",
"      <span class=\"nowrap\">",
"       preterm/term",
"      </span>",
"      pregnancy. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The two main risk factors for gestational trophoblastic disease are extremes of maternal age (over age 35 or under 20) and previous GTD. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All GTDs are associated with an elevated serum hCG concentration. Vaginal bleeding, an enlarged uterus, and pelvic discomfort are the most common clinical manifestations. Since pregnancy is by far the most common source of hCG, clinicians generally initially suspect a pregnancy complication (threatened or missed abortion, ectopic pregnancy) rather than GTD in women who present with these complaints in the setting of a positive pregnancy test. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Initial evaluation consists of a quantitative test for hCG and pelvic ultrasound examination. Serum hCG is often much higher in patients with GTD than in those with intrauterine or ectopic pregnancies. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In contrast to all other types of GTD, a partial mole contains a fetus and fetal cardiac activity may be detected. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Partial hydatidiform mole'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Ultrasound findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of complete or partial mole must be confirmed by histologic examination of tissue. Tissue diagnosis is not required for diagnosis of persistent disease. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Complete and partial mole'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/1\">",
"      Berkowitz RS, Goldstein DP. Chorionic tumors. N Engl J Med 1996; 335:1740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/2\">",
"      Soto-Wright V, Bernstein M, Goldstein DP, Berkowitz RS. The changing clinical presentation of complete molar pregnancy. Obstet Gynecol 1995; 86:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/3\">",
"      Cort&eacute;s-Charry R, Figueira LM, Garc&iacute;a-Barriola V, et al. Gestational trophoblastic disease in ectopic pregnancy: A case series. J Reprod Med 2006; 51:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/4\">",
"      Gillespie AM, Lidbury EA, Tidy JA, Hancock BW. The clinical presentation, treatment, and outcome of patients diagnosed with possible ectopic molar gestation. Int J Gynecol Cancer 2004; 14:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/5\">",
"      Altieri A, Franceschi S, Ferlay J, et al. Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol 2003; 4:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/6\">",
"      Palmer JR. Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med 1994; 39:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/7\">",
"      Berkowitz RS, Cramer DW, Bernstein MR, et al. Risk factors for complete molar pregnancy from a case-control study. Am J Obstet Gynecol 1985; 152:1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/8\">",
"      Moodley M, Tunkyi K, Moodley J. Gestational trophoblastic syndrome: an audit of 112 patients. A South African experience. Int J Gynecol Cancer 2003; 13:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/9\">",
"      Mittal KK, Kachru RB, Brewer JI. The HL-A and ABO antigens in trophoblastic disease. Tissue Antigens 1975; 6:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/10\">",
"      Messerli ML, Lilienfeld AM, Parmley T, et al. Risk factors for gestational trophoblastic neoplasia. Am J Obstet Gynecol 1985; 153:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/11\">",
"      Rice LW, Lage JM, Berkowitz RS, et al. Repetitive complete and partial hydatidiform mole. Obstet Gynecol 1989; 74:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/12\">",
"      Martin BH, Kim JH. Changes in gestational trophoblastic tumors over four decades. A Korean experience. J Reprod Med 1998; 43:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/13\">",
"      Smith HO. Gestational trophoblastic disease epidemiology and trends. Clin Obstet Gynecol 2003; 46:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/14\">",
"      Hayashi K, Bracken MB, Freeman DH Jr, Hellenbrand K. Hydatidiform mole in the United States (1970-1977): a statistical and theoretical analysis. Am J Epidemiol 1982; 115:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/15\">",
"      Di Cintio E, Parazzini F, Rosa C, et al. The epidemiology of gestational trophoblastic disease. Gen Diagn Pathol 1997; 143:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/16\">",
"      Altman AD, Bentley B, Murray S, Bentley JR. Maternal age-related rates of gestational trophoblastic disease. Obstet Gynecol 2008; 112:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/17\">",
"      Tsukamoto N, Iwasaka T, Kashimura Y, et al. Gestational trophoblastic disease in women aged 50 or more. Gynecol Oncol 1985; 20:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/18\">",
"      Berkowitz RS, Tuncer ZS, Bernstein MR, Goldstein DP. Management of gestational trophoblastic diseases: subsequent pregnancy experience. Semin Oncol 2000; 27:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/19\">",
"      Lorigan PC, Sharma S, Bright N, et al. Characteristics of women with recurrent molar pregnancies. Gynecol Oncol 2000; 78:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/20\">",
"      Bagshawe KD, Dent J, Webb J. Hydatidiform mole in England and Wales 1973-83. Lancet 1986; 2:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/21\">",
"      Berkowitz RS, Im SS, Bernstein MR, Goldstein DP. Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med 1998; 43:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/22\">",
"      Sand PK, Lurain JR, Brewer JI. Repeat gestational trophoblastic disease. Obstet Gynecol 1984; 63:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/23\">",
"      Costa HL, Doyle P. Influence of oral contraceptives in the development of post-molar trophoblastic neoplasia--a systematic review. Gynecol Oncol 2006; 100:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/24\">",
"      Bandy LC, Clarke-Pearson DL, Hammond CB. Malignant potential of gestational trophoblastic disease at the extreme ages of reproductive life. Obstet Gynecol 1984; 64:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/25\">",
"      Acaia B, Parazzini F, La Vecchia C, et al. Increased frequency of complete hydatidiform mole in women with repeated abortion. Gynecol Oncol 1988; 31:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/26\">",
"      Hershman JM. Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid. Best Pract Res Clin Endocrinol Metab 2004; 18:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/27\">",
"      Mosher R, Goldstein DP, Berkowitz R, et al. Complete hydatidiform mole. Comparison of clinicopathologic features, current and past. J Reprod Med 1998; 43:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/28\">",
"      Zalel Y, Dgani R. Gestational trophoblastic disease following the evacuation of partial hydatidiform mole: a review of 66 cases. Eur J Obstet Gynecol Reprod Biol 1997; 71:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/29\">",
"      Osathanondh R, Berkowitz RS, de Cholnoky C, et al. Hormonal measurements in patients with theca lutein cysts and gestational trophoblastic disease. J Reprod Med 1986; 31:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/30\">",
"      Norman RJ, Green-Thompson RW, Jialal I, et al. Hyperthyroidism in gestational trophoblastic neoplasia. Clin Endocrinol (Oxf) 1981; 15:395.",
"     </a>",
"    </li>",
"    <li>",
"     Soper JT, Lewis JL Jr, Hammond CB. Gestational trophoblastic disease. In: Principles and practice of gynecologic oncology, 2nd, Hoskins WJ, Perez CA, Young RC (Eds), Lippincott-Raven, Philadelphia 1997. p.1039.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/32\">",
"      Schlaerth JB, Morrow CP, Montz FJ, d'Ablaing G. Initial management of hydatidiform mole. Am J Obstet Gynecol 1988; 158:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/33\">",
"      Soper JT. Gestational trophoblastic disease. Obstet Gynecol 2006; 108:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/34\">",
"      Yamazaki K, Sato K, Shizume K, et al. Potent thyrotropic activity of human chorionic gonadotropin variants in terms of 125I incorporation and de novo synthesized thyroid hormone release in human thyroid follicles. J Clin Endocrinol Metab 1995; 80:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/35\">",
"      Berkowitz RS, Goldstein DP, Bernstein MR. Natural history of partial molar pregnancy. Obstet Gynecol 1985; 66:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/36\">",
"      Hancock BW, Nazir K, Everard JE. Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome. J Reprod Med 2006; 51:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/37\">",
"      Kennedy AW. Persistent nonmetastatic gestational trophoblastic disease. Semin Oncol 1995; 22:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/38\">",
"      Curry SL, Hammond CB, Tyrey L, et al. Hydatidiform mole: diagnosis, management, and long-term followup of 347 patients. Obstet Gynecol 1975; 45:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/39\">",
"      Montz FJ, Schlaerth JB, Morrow CP. The natural history of theca lutein cysts. Obstet Gynecol 1988; 72:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/40\">",
"      Berkowitz RS, Goldstein DP. Pathogenesis of gestational trophoblastic neoplasms. Pathobiol Annu 1981; 11:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/41\">",
"      Goldstein DP, Berkowitz RS, Bernstein MR. Management of molar pregnancy. J Reprod Med 1981; 26:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/42\">",
"      Murad TM, Longley JV, Lurain JR, Brewer JI. Hydatidiform mole: clinicopathologic associations with the development of postevacuation trophoblastic disease. Int J Gynaecol Obstet 1990; 32:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/43\">",
"      Ayhan A, Tuncer ZS, Halilzade H, K&uuml;&ccedil;&uuml;kali T. Predictors of persistent disease in women with complete hydatidiform mole. J Reprod Med 1996; 41:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/44\">",
"      Stone M, Bagshawe KD. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy. Br J Obstet Gynaecol 1979; 86:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/45\">",
"      Baasanjav B, Usui H, Kihara M, et al. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles. Hum Reprod 2010; 25:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/46\">",
"      Nugent D, Hassadia A, Everard J, et al. Postpartum choriocarcinoma presentation, management and survival. J Reprod Med 2006; 51:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/47\">",
"      Hammond CB, Hertz R, Ross GT, et al. Diagnostic problems of choriocarcinoma and related trophoblastic neoplasms. Obstet Gynecol 1967; 29:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/48\">",
"      Magrath IT, Golding PR, Bagshawe KD. Medical presentations of choriocarcinoma. Br Med J 1971; 2:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/49\">",
"      Schmid P, Nagai Y, Agarwal R, et al. Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study. Lancet 2009; 374:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/50\">",
"      Finkler NJ. Placental site trophoblastic tumor. Diagnosis, clinical behavior and treatment. J Reprod Med 1991; 36:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/51\">",
"      Vardar MA, Altintas A. Placental-site trophoblastic tumor. Principles of diagnosis, clinical behaviour and treatment. Eur J Gynaecol Oncol 1995; 16:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/52\">",
"      Hassadia A, Gillespie A, Tidy J, et al. Placental site trophoblastic tumour: clinical features and management. Gynecol Oncol 2005; 99:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/53\">",
"      Nagamani M, Kaspar HG, Van Dinh T, et al. Hyperthecosis of the ovaries in a woman with a placental site trophoblastic tumor. Obstet Gynecol 1990; 76:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/54\">",
"      Nagelberg SB, Rosen SW. Clinical and laboratory investigation of a virilized woman with placental-site trophoblastic tumor. Obstet Gynecol 1985; 65:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/55\">",
"      Zhao J, Xiang Y, Wan XR, et al. Clinical and pathologic characteristics and prognosis of placental site trophoblastic tumor. J Reprod Med 2006; 51:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/56\">",
"      Hoekstra AV, Keh P, Lurain JR. Placental site trophoblastic tumor: a review of 7 cases and their implications for prognosis and treatment. J Reprod Med 2004; 49:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/57\">",
"      Feltmate CM, Genest DR, Goldstein DP, Berkowitz RS. Advances in the understanding of placental site trophoblastic tumor. J Reprod Med 2002; 47:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/58\">",
"      Lan C, Li Y, He J, Liu J. Placental site trophoblastic tumor: lymphatic spread and possible target markers. Gynecol Oncol 2010; 116:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/59\">",
"      Fowler DJ, Lindsay I, Seckl MJ, Sebire NJ. Routine pre-evacuation ultrasound diagnosis of hydatidiform mole: experience of more than 1000 cases from a regional referral center. Ultrasound Obstet Gynecol 2006; 27:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/60\">",
"      Wagner BJ, Woodward PJ, Dickey GE. From the archives of the AFIP. Gestational trophoblastic disease: radiologic-pathologic correlation. Radiographics 1996; 16:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/61\">",
"      Fine C, Bundy AL, Berkowitz RS, et al. Sonographic diagnosis of partial hydatidiform mole. Obstet Gynecol 1989; 73:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/62\">",
"      Benson CB, Genest DR, Bernstein MR, et al. Sonographic appearance of first trimester complete hydatidiform moles. Ultrasound Obstet Gynecol 2000; 16:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/63\">",
"      Lim AK, Agarwal R, Seckl MJ, et al. Embolization of bleeding residual uterine vascular malformations in patients with treated gestational trophoblastic tumors. Radiology 2002; 222:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/64\">",
"      van de Kaa CA, Schijf CP, de Wilde PC, et al. The role of deoxyribonucleic acid image cytometric and interphase cytogenetic analyses in the differential diagnosis, prognosis, and clinical follow-up of hydatidiform moles. A report from the Central Molar Registration in The Netherlands. Am J Obstet Gynecol 1997; 177:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/65\">",
"      Cheung AN, Khoo US, Lai CY, et al. Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole: genotyping and chromosome in situ hybridization analysis. Cancer 2004; 100:1411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/66\">",
"      Niemann I, Hansen ES, Sunde L. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy. Gynecol Oncol 2007; 104:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/67\">",
"      Franke HR, Risse EK, Kenemans P, et al. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands. Obstet Gynecol 1983; 62:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/68\">",
"      Kohorn EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment. Int J Gynecol Cancer 2001; 11:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/69\">",
"      Aral K, G&uuml;rkan Zorlu C, G&ouml;kmen O. Plasma human chorionic gonadotropin levels after induced abortion. Adv Contracept 1996; 12:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/70\">",
"      Steier JA, Bergsj&oslash; P, Myking OL. Human chorionic gonadotropin in maternal plasma after induced abortion, spontaneous abortion, and removed ectopic pregnancy. Obstet Gynecol 1984; 64:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/71\">",
"      Korhonen J, Alfthan H, Yl&ouml;stalo P, et al. Disappearance of human chorionic gonadotropin and its alpha- and beta-subunits after term pregnancy. Clin Chem 1997; 43:2155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/72\">",
"      Marrs RP, Kletzky OA, Howard WF, Mishell DR Jr. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion. Am J Obstet Gynecol 1979; 135:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/73\">",
"      Barnhart KT, Sammel MD, Rinaudo PF, et al. Symptomatic patients with an early viable intrauterine pregnancy: HCG curves redefined. Obstet Gynecol 2004; 104:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/74\">",
"      Cole LA, Khanlian SA, Muller CY, et al. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors. Gynecol Oncol 2006; 102:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/75\">",
"      Cole LA, Muller CY. Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases. Gynecol Oncol 2010; 116:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/76\">",
"      Cole LA, Butler SA, Khanlian SA, et al. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia. Gynecol Oncol 2006; 102:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/77\">",
"      Sumi Y, Ozaki Y, Shindoh N, Katayama H. Placental site trophoblastic tumor: imaging findings. Radiat Med 1999; 17:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/78\">",
"      DeBaz BP, Lewis TJ. Imaging of gestational trophoblastic disease. Semin Oncol 1995; 22:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/11/24761/abstract/79\">",
"      Gungor T, Ekin M, Dumanli H, Gokmen O. Color Doppler ultrasonography in the earlier differentiation of benign molehydatidiforms from malignant gestational trophoblastic disease. Acta Obstet Gynecol Scand 1998; 77:860.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3243 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.131.240.2-593C6D74E4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_11_24761=[""].join("\n");
var outline_f24_11_24761=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Hydatidiform mole",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Complete hydatidiform mole",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Partial hydatidiform mole",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Malignant GTD",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - After a molar pregnancy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - After a nonmolar pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Human chorionic gonadotropin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Ultrasound findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Complete and partial mole",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Malignant disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - After a molar pregnancy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - After a nonmolar pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/3243\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/3243|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/3/23604\" title=\"diagnostic image 1\">",
"      Choriocarcinoma ectopic preg",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?32/3/32817\" title=\"diagnostic image 2A\">",
"      Sonogram complete mole",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?38/52/39748\" title=\"diagnostic image 2B\">",
"      U-S complete hydatid mole",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?38/39/39540\" title=\"diagnostic image 3\">",
"      U-S theca lutein cysts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?25/44/26304\" title=\"diagnostic image 4A\">",
"      Ultrasound partial mole",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?36/27/37301\" title=\"diagnostic image 4B\">",
"      U-S partial hydatid mole",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?17/0/17412\" title=\"diagnostic image 5\">",
"      U-S choriocarcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?18/21/18774\" title=\"diagnostic image 6\">",
"      Doppler U-S choriocarcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?24/11/24756\" title=\"diagnostic image 7A\">",
"      U-S choriocarcinoma and AVM A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?30/6/30820\" title=\"diagnostic image 7B\">",
"      U-S choriocarcinoma and AVM B",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/3243|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/63/14332\" title=\"table 1\">",
"      Complete versus partial mole",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/48/44808?source=related_link\">",
"      Clinical manifestations and diagnosis of early pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/30/23015?source=related_link\">",
"      Gestational trophoblastic disease: Management of hydatidiform mole",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/31/13816?source=related_link\">",
"      Gestational trophoblastic disease: Pathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42234?source=related_link\">",
"      Gestational trophoblastic neoplasia: Staging and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/48/42760?source=related_link\">",
"      Hyperthyroidism during pregnancy: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/37/5721?source=related_link\">",
"      Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_11_24762="Childhood Asthma Control Test for children aged 4 to 11 years";
var content_f24_11_24762=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81872&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81872&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 614px\">",
"   <div class=\"ttl\">",
"    Childhood Asthma Control Test for children aged 4 to 11 years",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 778px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Liu, AH, Zeiger, R, Sorkness, C, et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol 2007; 119:817. Copyright &copy; 2007 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_11_24762=[""].join("\n");
var outline_f24_11_24762=null;
var title_f24_11_24763="Elbow sensation strength";
var content_f24_11_24763=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F53902&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F53902&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Motor and sensory function of the nerves of the arm",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Nerve",
"       </td>",
"       <td class=\"subtitle1\">",
"        Motor function",
"       </td>",
"       <td class=\"subtitle1\">",
"        Sensory function",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Median",
"       </td>",
"       <td>",
"        <p>",
"         Wrist flexion and abduction",
"        </p>",
"        <p>",
"         Thumb and index finger flexion",
"        </p>",
"        <p>",
"         Thumb opposition",
"        </p>",
"       </td>",
"       <td>",
"        Palmar thumb and index finger",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ulnar",
"       </td>",
"       <td>",
"        <p>",
"         Wrist flexion and adduction",
"        </p>",
"        <p>",
"         Finger spread",
"        </p>",
"        <p>",
"         Flexion of distal phalanx of fifth digit",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Ulnar side of fourth digit",
"        </p>",
"        <p>",
"         Fifth digit",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Radial",
"       </td>",
"       <td>",
"        <p>",
"         Wrist extension",
"        </p>",
"        <p>",
"         Supination",
"        </p>",
"        <p>",
"         Thumb extension",
"        </p>",
"       </td>",
"       <td>",
"        Dorsal web space between thumb and index finger",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Musculocutaneous",
"       </td>",
"       <td>",
"        Elbow flexion",
"       </td>",
"       <td>",
"        Lateral forearm",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_11_24763=[""].join("\n");
var outline_f24_11_24763=null;
var title_f24_11_24764="Giftedness characteristics";
var content_f24_11_24764=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F83641&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F83641&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Presentation and characteristics of giftedness",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Characteristics of giftedness",
"       </td>",
"       <td class=\"subtitle1\">",
"        Example",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Early language development",
"       </td>",
"       <td>",
"        A 2-year-old who speaks in complex sentences",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Early reading and writing skills",
"       </td>",
"       <td>",
"        A preschooler who reads text with comprehension or writes in sentences with minimal or no instruction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Complaints of boredom at school, in the presence of clear academic success",
"       </td>",
"       <td>",
"        \"Why do I have to do the same thing over and over again?\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unusual academic skills in math",
"       </td>",
"       <td>",
"        Self-acquired ability and interest in numbers (eg, learning to multiply numbers mentally before formal schooling)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intense interests",
"       </td>",
"       <td>",
"        A strong preoccupation with an area of interest, academic or nonacademic (eg, airplanes)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clearly advanced skills in academic or non-academic areas, especially when identified by a teacher or a professional in an academic or non-academic domain",
"       </td>",
"       <td>",
"        Highly advanced drawing skills, athletic abilities, musical ability, etc",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Characteristics NOT indicative of school-house giftedness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Advanced motor skills, especially before 2 years of age*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        High scores on a developmental assessment tool, especially when administered before 3 years of age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        Advanced rote learning skills, such as letter identification, number identification, or reading decoding without text comprehension",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Advanced motor skills may be associated with giftedness in athletics or other kinesthetic domains.",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <ol>",
"      <li>",
"       Robinson NM, Olszewski-Kubilius PM. Gifted and talented children: issues for pediatricians. Pediatr Rev 1996; 17:427.",
"      </li>",
"      <li>",
"       Ruf DL. 5 Levels of Gifted: School Issues and Educational Options, Great Potential Press, Scottsdale, AZ 2009.",
"      </li>",
"      <li>",
"       Webb TJ, Amend ER, Webb NE, et al. Misdiagnosis and Dual Diagnosis of Gifted Children and Adults: ADHD, Bipolar, OCD, Asperger&rsquo;s, Depression, and Other Disorders, Great Potential Press, Scottsdale, AZ 2005.",
"      </li>",
"      <li>",
"       Winner E. Gifted Children: Myths and Realities, Basic Books, New York 1996.",
"      </li>",
"      <li>",
"       Winner E. Exceptionally high intelligence and schooling. American Psychologist 1997; 52:1070.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_11_24764=[""].join("\n");
var outline_f24_11_24764=null;
var title_f24_11_24765="Leukotriene synthesis AERD";
var content_f24_11_24765=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F50924&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F50924&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    5-LO pathway products: Key inflammatory mediators",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 304px; height: 418px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of leukotriene synthetic pathways and the enzymes catalyzing the specific reactions. The leukotrienes are shaded.",
"    <div class=\"footnotes\">",
"     FLAP: 5-lipoxygenase activating protein; HPETE: hydroperoxyeicosatetraenoic acid; HETE: hydroxyeicosatetraenoic acid; ETE: eicosatetraenoic acid; LT: leukotriene.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_11_24765=[""].join("\n");
var outline_f24_11_24765=null;
var title_f24_11_24766="otoscopy";
var content_f24_11_24766=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/70700/otoscopy_conv.mp4?title=otoscopy\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pneumatic otoscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Adele Karen Evans, MD, FAAP and Steven D Handler MD, MBE.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_11_24766=[""].join("\n");
var outline_f24_11_24766=null;
var title_f24_11_24767="Ketone response to treatment DKA";
var content_f24_11_24767=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F60366&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F60366&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 590px\">",
"   <div class=\"ttl\">",
"    Ketone response to treatment of diabetic ketoacidosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 570px; height: 438px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Comparative data in 37 patients with diabetic ketoacidosis with regard to plasma acetoacetic acid (AA) and &beta;-hydroxybutyric acid (&beta;OH) (top left); ratio of AA to &beta;OH (bottom left); and ketone bodies (nitroprusside reaction) in the urine (top right) and plasma (bottom right) before and during low-dose intravenous infusion of insulin for 48 hours.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Kitabchi AE, Fisher JN, Murphy MB, et al. Diabetic ketoacidosis and the hyperglycemic hyperosmolar nonketotic state. In: Joslin's Diabetes Mellitus, 13th edition, Kahn CR, Weir GC (Eds), Lea and Febiger, Philadelphia 1994. Copyright &copy; 1994 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_11_24767=[""].join("\n");
var outline_f24_11_24767=null;
